BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillère R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 2013;342:971-976. [PMID: 24264990 DOI: 10.1126/science.1240537] [Cited by in Crossref: 921] [Cited by in F6Publishing: 881] [Article Influence: 115.1] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Shao C, Shi Y, Han W. Lessons learned from the blockade of immune checkpoints in cancer immunotherapy. J Hematol Oncol. 2018;11:31. [PMID: 29482595 DOI: 10.1186/s13045-018-0578-4] [Cited by in Crossref: 102] [Cited by in F6Publishing: 102] [Article Influence: 34.0] [Reference Citation Analysis]
2 Rajpoot M, Sharma AK, Sharma A, Gupta GK. Understanding the microbiome: Emerging biomarkers for exploiting the microbiota for personalized medicine against cancer. Semin Cancer Biol. 2018;52:1-8. [PMID: 29425888 DOI: 10.1016/j.semcancer.2018.02.003] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 17.0] [Reference Citation Analysis]
3 Flórez AB, Sierra M, Ruas-Madiedo P, Mayo B. Susceptibility of lactic acid bacteria, bifidobacteria and other bacteria of intestinal origin to chemotherapeutic agents. Int J Antimicrob Agents 2016;48:547-50. [PMID: 27575730 DOI: 10.1016/j.ijantimicag.2016.07.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
4 Kovács T, Mikó E, Ujlaki G, Sári Z, Bai P. The Microbiome as a Component of the Tumor Microenvironment. Adv Exp Med Biol 2020;1225:137-53. [PMID: 32030653 DOI: 10.1007/978-3-030-35727-6_10] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 22.0] [Reference Citation Analysis]
5 Galluzzi L, Chan TA, Kroemer G, Wolchok JD, López-soto A. The hallmarks of successful anticancer immunotherapy. Sci Transl Med 2018;10:eaat7807. [DOI: 10.1126/scitranslmed.aat7807] [Cited by in Crossref: 211] [Cited by in F6Publishing: 208] [Article Influence: 70.3] [Reference Citation Analysis]
6 Cullin N, Azevedo Antunes C, Straussman R, Stein-Thoeringer CK, Elinav E. Microbiome and cancer. Cancer Cell 2021;39:1317-41. [PMID: 34506740 DOI: 10.1016/j.ccell.2021.08.006] [Reference Citation Analysis]
7 Akrami M, Menzies R, Chamoto K, Miyajima M, Suzuki R, Sato H, Nishii A, Tomura M, Fagarasan S, Honjo T. Circulation of gut-preactivated naïve CD8+ T cells enhances antitumor immunity in B cell-defective mice. Proc Natl Acad Sci U S A 2020;117:23674-83. [PMID: 32907933 DOI: 10.1073/pnas.2010981117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Scheid AD, Beadnell TC, Welch DR. The second genome: Effects of the mitochondrial genome on cancer progression. Adv Cancer Res 2019;142:63-105. [PMID: 30885364 DOI: 10.1016/bs.acr.2019.01.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
9 Wang E, Yuan Z, Wang K, Gao D, Liu Z, Liles MR. Consumption of florfenicol-medicated feed alters the composition of the channel catfish intestinal microbiota including enriching the relative abundance of opportunistic pathogens. Aquaculture 2019;501:111-8. [DOI: 10.1016/j.aquaculture.2018.11.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 8.5] [Reference Citation Analysis]
10 Shlyakhtina Y, Moran KL, Portal MM. Genetic and Non-Genetic Mechanisms Underlying Cancer Evolution. Cancers (Basel) 2021;13:1380. [PMID: 33803675 DOI: 10.3390/cancers13061380] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ma T, Chen Y, Li LJ, Zhang LS. Opportunities and Challenges for Gut Microbiota in Acute Leukemia. Front Oncol 2021;11:692951. [PMID: 34307157 DOI: 10.3389/fonc.2021.692951] [Reference Citation Analysis]
12 Goubet A, Daillère R, Routy B, Derosa L, M. Roberti P, Zitvogel L. The impact of the intestinal microbiota in therapeutic responses against cancer. Comptes Rendus Biologies 2018;341:284-9. [DOI: 10.1016/j.crvi.2018.03.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 12.3] [Reference Citation Analysis]
13 Xu S, Tan H, Yang Q, Wang R, Tian C, Ji Y, Zhao P, Xia Q, Wang F. Fabrication of a Silk Sericin Hydrogel System Delivering Human Lactoferrin Using Genetically Engineered Silk with Improved Bioavailability to Alleviate Chemotherapy-Induced Immunosuppression. ACS Appl Mater Interfaces 2021;13:45175-90. [PMID: 34525798 DOI: 10.1021/acsami.1c08409] [Reference Citation Analysis]
14 Tao J, Li S, Gan RY, Zhao CN, Meng X, Li HB. Targeting gut microbiota with dietary components on cancer: Effects and potential mechanisms of action. Crit Rev Food Sci Nutr 2020;60:1025-37. [PMID: 30632784 DOI: 10.1080/10408398.2018.1555789] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 13.5] [Reference Citation Analysis]
15 Heshiki Y, Vazquez-Uribe R, Li J, Ni Y, Quainoo S, Imamovic L, Li J, Sørensen M, Chow BKC, Weiss GJ, Xu A, Sommer MOA, Panagiotou G. Predictable modulation of cancer treatment outcomes by the gut microbiota. Microbiome 2020;8:28. [PMID: 32138779 DOI: 10.1186/s40168-020-00811-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 26.0] [Reference Citation Analysis]
16 Fournier Q, Serra JC, Williams C, Bavcar S. Chemotherapy-induced diarrhoea in dogs and its management with smectite: Results of a monocentric open-label randomized clinical trial. Vet Comp Oncol 2021;19:25-33. [PMID: 32562450 DOI: 10.1111/vco.12631] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Schwabe RF, Greten TF. Gut microbiome in HCC - Mechanisms, diagnosis and therapy. J Hepatol. 2020;72:230-238. [PMID: 31954488 DOI: 10.1016/j.jhep.2019.08.016] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 51.0] [Reference Citation Analysis]
18 Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res 2020;30:492-506. [PMID: 32433595 DOI: 10.1038/s41422-020-0332-7] [Cited by in Crossref: 226] [Cited by in F6Publishing: 234] [Article Influence: 226.0] [Reference Citation Analysis]
19 Sun L, Suo C, Li ST, Zhang H, Gao P. Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect. Biochim Biophys Acta Rev Cancer. 2018;1870:51-66. [PMID: 29959989 DOI: 10.1016/j.bbcan.2018.06.005] [Cited by in Crossref: 61] [Cited by in F6Publishing: 76] [Article Influence: 20.3] [Reference Citation Analysis]
20 Fessler J, Matson V, Gajewski TF. Exploring the emerging role of the microbiome in cancer immunotherapy. J Immunother Cancer 2019;7:108. [PMID: 30995949 DOI: 10.1186/s40425-019-0574-4] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 42.0] [Reference Citation Analysis]
21 Sacchetti B, Botticelli A, Pierelli L, Nuti M, Alimandi M. CAR-T with License to Kill Solid Tumors in Search of a Winning Strategy. Int J Mol Sci 2019;20:E1903. [PMID: 30999624 DOI: 10.3390/ijms20081903] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
22 Meyers DE, Banerji S. Biomarkers of immune checkpoint inhibitor efficacy in cancer. Curr Oncol 2020;27:S106-14. [PMID: 32368180 DOI: 10.3747/co.27.5549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
23 Pederzoli F, Bandini M, Raggi D, Marandino L, Basile G, Alfano M, Colombo R, Salonia A, Briganti A, Gallina A, Montorsi F, Necchi A. Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? Eur Urol 2021;80:319-22. [PMID: 34053782 DOI: 10.1016/j.eururo.2021.05.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Dupaul-chicoine J, Arabzadeh A, Dagenais M, Douglas T, Champagne C, Morizot A, Rodrigue-gervais I, Breton V, Colpitts S, Beauchemin N, Saleh M. The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity. Immunity 2015;43:751-63. [DOI: 10.1016/j.immuni.2015.08.013] [Cited by in Crossref: 136] [Cited by in F6Publishing: 136] [Article Influence: 22.7] [Reference Citation Analysis]
25 Inamura K. Gut microbiota contributes towards immunomodulation against cancer: New frontiers in precision cancer therapeutics. Semin Cancer Biol 2021;70:11-23. [PMID: 32580023 DOI: 10.1016/j.semcancer.2020.06.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
26 Gajewski TF, Corrales L, Williams J, Horton B, Sivan A, Spranger S. Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment. Adv Exp Med Biol 2017;1036:19-31. [PMID: 29275462 DOI: 10.1007/978-3-319-67577-0_2] [Cited by in Crossref: 94] [Cited by in F6Publishing: 99] [Article Influence: 31.3] [Reference Citation Analysis]
27 Tang C, Sun J, Zhou B, Jin C, Liu J, Kan J, Qian C, Zhang N. Effects of polysaccharides from purple sweet potatoes on immune response and gut microbiota composition in normal and cyclophosphamide treated mice. Food Funct 2018;9:937-50. [DOI: 10.1039/c7fo01302g] [Cited by in Crossref: 77] [Cited by in F6Publishing: 14] [Article Influence: 25.7] [Reference Citation Analysis]
28 Theilgaard-mönch K. Gut microbiota sustains hematopoiesis. Blood 2017;129:662-3. [DOI: 10.1182/blood-2016-12-754481] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
29 Severyn CJ, Brewster R, Andermann TM. Microbiota modification in hematology: still at the bench or ready for the bedside? Blood Adv 2019;3:3461-72. [PMID: 31714965 DOI: 10.1182/bloodadvances.2019000365] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
30 Rosen CE, Palm NW. Functional Classification of the Gut Microbiota: The Key to Cracking the Microbiota Composition Code: Functional classifications of the gut microbiota reveal previously hidden contributions of indigenous gut bacteria to human health and disease. Bioessays 2017;39. [PMID: 28976007 DOI: 10.1002/bies.201700032] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
31 Douchet G, Aspeslagh S. [What is the place of the combinations for immunotherapy with chemotherapy or with other immune checkpoint inhibitors?]. Bull Cancer 2017;104:485-93. [PMID: 28433197 DOI: 10.1016/j.bulcan.2017.03.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
32 Miyahira AK, Kissick HT, Bishop JL, Takeda DY, Barbieri CE, Simons JW, Pienta KJ, Soule HR. Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meeting. Prostate 2015;75:337-47. [PMID: 25358693 DOI: 10.1002/pros.22920] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
33 Kuczma MP, Ding ZC, Li T, Habtetsion T, Chen T, Hao Z, Bryan L, Singh N, Kochenderfer JN, Zhou G. The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells. Oncotarget. 2017;8:111931-111942. [PMID: 29340102 DOI: 10.18632/oncotarget.22953] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
34 Gopalakrishnan V, Weiner B, Ford C, Sellman B, Hammond S, Freeman D, Dennis P, Soria J, Wortman J, Henn M. Intervention strategies for microbial therapeutics in cancer immunotherapy. Immuno-Oncology Technology 2020;6:9-17. [DOI: 10.1016/j.iotech.2020.05.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
35 Vacchelli E, Aranda F, Eggermont A, Galon J, Sautès-Fridman C, Cremer I, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology. 2014;3:e27878. [PMID: 24800173 DOI: 10.4161/onci.27878] [Cited by in Crossref: 99] [Cited by in F6Publishing: 102] [Article Influence: 14.1] [Reference Citation Analysis]
36 Temraz S, Nassar F, Kreidieh F, Mukherji D, Shamseddine A, Nasr R. Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome. Int J Mol Sci 2021;22:7800. [PMID: 34360566 DOI: 10.3390/ijms22157800] [Reference Citation Analysis]
37 Wang YJ, Fletcher R, Yu J, Zhang L. Immunogenic effects of chemotherapy-induced tumor cell death. Genes Dis 2018;5:194-203. [PMID: 30320184 DOI: 10.1016/j.gendis.2018.05.003] [Cited by in Crossref: 101] [Cited by in F6Publishing: 103] [Article Influence: 33.7] [Reference Citation Analysis]
38 Riquelme E, McAllister F. Bacteria and fungi: The counteracting modulators of immune responses to radiation therapy in cancer. Cancer Cell 2021;39:1173-5. [PMID: 34478640 DOI: 10.1016/j.ccell.2021.08.004] [Reference Citation Analysis]
39 Merlano MC, Granetto C, Fea E, Ricci V, Garrone O. Heterogeneity of colon cancer: from bench to bedside. ESMO Open 2017;2:e000218. [PMID: 29209524 DOI: 10.1136/esmoopen-2017-000218] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
40 Dong M, Meng Z, Kuerban K, Qi F, Liu J, Wei Y, Wang Q, Jiang S, Feng M, Ye L. Diosgenin promotes antitumor immunity and PD-1 antibody efficacy against melanoma by regulating intestinal microbiota. Cell Death Dis 2018;9:1039. [PMID: 30305604 DOI: 10.1038/s41419-018-1099-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 9.7] [Reference Citation Analysis]
41 Wang C, Wen D, Gu Z. Cellular Bioparticulates with Therapeutics for Cancer Immunotherapy. Bioconjugate Chem 2018;29:702-8. [DOI: 10.1021/acs.bioconjchem.7b00619] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
42 Shi T, Ma Y, Yu L, Jiang J, Shen S, Hou Y, Wang T. Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints. Int J Mol Sci 2018;19:E1389. [PMID: 29735917 DOI: 10.3390/ijms19051389] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 13.3] [Reference Citation Analysis]
43 Toker A, Ohashi PS. Expression of costimulatory and inhibitory receptors in FoxP3+ regulatory T cells within the tumor microenvironment: Implications for combination immunotherapy approaches. Adv Cancer Res 2019;144:193-261. [PMID: 31349899 DOI: 10.1016/bs.acr.2019.05.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
44 Liu X, Chen Y, Zhang S, Dong L. Gut microbiota-mediated immunomodulation in tumor. J Exp Clin Cancer Res 2021;40:221. [PMID: 34217349 DOI: 10.1186/s13046-021-01983-x] [Reference Citation Analysis]
45 Wang W, Wang J, Li J, Yan P, Jin Y, Zhang R, Yue W, Guo Q, Geng J. Cholecystectomy Damages Aging-Associated Intestinal Microbiota Construction. Front Microbiol. 2018;9:1402. [PMID: 29988510 DOI: 10.3389/fmicb.2018.01402] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
46 Singh V, Yeoh BS, Vijay-Kumar M. Gut microbiome as a novel cardiovascular therapeutic target. Curr Opin Pharmacol 2016;27:8-12. [PMID: 26828626 DOI: 10.1016/j.coph.2016.01.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
47 Silva M, Brunner V, Tschurtschenthaler M. Microbiota and Colorectal Cancer: From Gut to Bedside. Front Pharmacol 2021;12:760280. [PMID: 34658896 DOI: 10.3389/fphar.2021.760280] [Reference Citation Analysis]
48 Pingili AK, Chaib M, Sipe LM, Miller EJ, Teng B, Sharma R, Yarbro JR, Asemota S, Al Abdallah Q, Mims TS, Marion TN, Daria D, Sekhri R, Hamilton AM, Troester MA, Jo H, Choi HY, Hayes DN, Cook KL, Narayanan R, Pierre JF, Makowski L. Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer. Cell Rep 2021;35:109285. [PMID: 34161764 DOI: 10.1016/j.celrep.2021.109285] [Reference Citation Analysis]
49 Pagès F, Granier C, Kirilovsky A, Elsissy C, Tartour E. Biomarqueurs prédictifs de réponse aux traitements bloquant les voies de costimulation inhibitrices. Bull Cancer 2016;103 Suppl 1:S151-9. [PMID: 28057179 DOI: 10.1016/S0007-4551(16)30373-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Cuozzo M, Castelli V, Avagliano C, Cimini A, d'Angelo M, Cristiano C, Russo R. Effects of Chronic Oral Probiotic Treatment in Paclitaxel-Induced Neuropathic Pain. Biomedicines 2021;9:346. [PMID: 33808052 DOI: 10.3390/biomedicines9040346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
51 Reticker-flynn NE, Engleman EG. A gut punch fights cancer and infection. Nature 2019;565:573-4. [DOI: 10.1038/d41586-019-00133-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
52 Saab S, Zalzale H, Rahal Z, Khalifeh Y, Sinjab A, Kadara H. Insights Into Lung Cancer Immune-Based Biology, Prevention, and Treatment. Front Immunol 2020;11:159. [PMID: 32117295 DOI: 10.3389/fimmu.2020.00159] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
53 Yu ZK, Xie RL, You R, Liu YP, Chen XY, Chen MY, Huang PY. The role of the bacterial microbiome in the treatment of cancer. BMC Cancer 2021;21:934. [PMID: 34412621 DOI: 10.1186/s12885-021-08664-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Wong SH, Yu J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol. 2019;16:690-704. [PMID: 31554963 DOI: 10.1038/s41575-019-0209-8] [Cited by in Crossref: 164] [Cited by in F6Publishing: 153] [Article Influence: 82.0] [Reference Citation Analysis]
55 Sharma A, Buschmann MM, Gilbert JA. Pharmacomicrobiomics: The Holy Grail to Variability in Drug Response? Clin Pharmacol Ther 2019;106:317-28. [PMID: 30937887 DOI: 10.1002/cpt.1437] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 15.5] [Reference Citation Analysis]
56 Nuytens F, Dabakuyo-Yonli TS, Meunier B, Gagnière J, Collet D, D'Journo XB, Brigand C, Perniceni T, Carrère N, Mabrut JY, Msika S, Peschaud F, Prudhomme M, Markar SR, Piessen G; Fédération de Recherche en Chirurgie (FRENCH) and French Eso-Gastric Tumors (FREGAT) Working Groups. Five-Year Survival Outcomes of Hybrid Minimally Invasive Esophagectomy in Esophageal Cancer: Results of the MIRO Randomized Clinical Trial. JAMA Surg 2021;156:323-32. [PMID: 33595631 DOI: 10.1001/jamasurg.2020.7081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
57 Liu JTC, Glaser AK, Bera K, True LD, Reder NP, Eliceiri KW, Madabhushi A. Harnessing non-destructive 3D pathology. Nat Biomed Eng 2021;5:203-18. [PMID: 33589781 DOI: 10.1038/s41551-020-00681-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
58 Chen D, Chen G, Ding Y, Wan P, Peng Y, Chen C, Ye H, Zeng X, Ran L. Polysaccharides from the flowers of tea (Camellia sinensis L.) modulate gut health and ameliorate cyclophosphamide-induced immunosuppression. Journal of Functional Foods 2019;61:103470. [DOI: 10.1016/j.jff.2019.103470] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 14.5] [Reference Citation Analysis]
59 Yang K, Hou Y, Zhang Y, Liang H, Sharma A, Zheng W, Wang L, Torres R, Tatebe K, Chmura SJ, Pitroda SP, Gilbert JA, Fu YX, Weichselbaum RR. Suppression of local type I interferon by gut microbiota-derived butyrate impairs antitumor effects of ionizing radiation. J Exp Med 2021;218:e20201915. [PMID: 33496784 DOI: 10.1084/jem.20201915] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
60 Mann JE, Ludwig ML, Kulkarni A, Scheftz EB, Murray IR, Zhai J, Gensterblum-Miller E, Jiang H, Brenner JC. Microbe-Mediated Activation of Toll-like Receptor 2 Drives PDL1 Expression in HNSCC. Cancers (Basel) 2021;13:4782. [PMID: 34638266 DOI: 10.3390/cancers13194782] [Reference Citation Analysis]
61 Alexander JL, Kohoutova D, Powell N. Science in Focus: The Microbiome and Cancer Therapy. Clin Oncol (R Coll Radiol) 2019;31:1-4. [PMID: 30301591 DOI: 10.1016/j.clon.2018.09.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
62 Youssef M, Ahmed HY, Zongo A, Korin A, Zhan F, Hady E, Umair M, Shahid Riaz Rajoka M, Xiong Y, Li B. Probiotic Supplements: Their Strategies in the Therapeutic and Prophylactic of Human Life-Threatening Diseases. Int J Mol Sci 2021;22:11290. [PMID: 34681948 DOI: 10.3390/ijms222011290] [Reference Citation Analysis]
63 Feng M, Xiong G, Cao Z, Yang G, Zheng S, Song X, You L, Zheng L, Zhang T, Zhao Y. PD-1/PD-L1 and immunotherapy for pancreatic cancer. Cancer Lett. 2017;407:57-65. [PMID: 28826722 DOI: 10.1016/j.canlet.2017.08.006] [Cited by in Crossref: 113] [Cited by in F6Publishing: 108] [Article Influence: 28.3] [Reference Citation Analysis]
64 Picardo SL, Coburn B, Hansen AR. The microbiome and cancer for clinicians. Crit Rev Oncol Hematol. 2019;141:1-12. [PMID: 31202124 DOI: 10.1016/j.critrevonc.2019.06.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 16.5] [Reference Citation Analysis]
65 Leite ML, da Cunha NB, Costa FF. Antimicrobial peptides, nanotechnology, and natural metabolites as novel approaches for cancer treatment. Pharmacology & Therapeutics 2018;183:160-76. [DOI: 10.1016/j.pharmthera.2017.10.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 9.3] [Reference Citation Analysis]
66 Chilakapati SR, Ricciuti J, Zsiros E. Microbiome and cancer immunotherapy. Curr Opin Biotechnol 2020;65:114-7. [PMID: 32192986 DOI: 10.1016/j.copbio.2020.02.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
67 Galluzzi L, Rudqvist NP. Preface: More than two decades of modern tumor immunology. Methods Enzymol 2020;635:xix-xxxviii. [PMID: 32122557 DOI: 10.1016/S0076-6879(20)30077-X] [Reference Citation Analysis]
68 Wu C, Lai R, Li J, Zhang J, Zhao Y, Zhang X, Zhao Y, Guo Z. Antibiotics Modulate Chemotherapy Efficacy in Patients with Esophageal Cancer. Cancer Manag Res 2020;12:4991-7. [PMID: 32612386 DOI: 10.2147/CMAR.S248130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
69 Carmody RN, Turnbaugh PJ. Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics. J Clin Invest 2014;124:4173-81. [PMID: 25105361 DOI: 10.1172/JCI72335] [Cited by in Crossref: 155] [Cited by in F6Publishing: 86] [Article Influence: 22.1] [Reference Citation Analysis]
70 Spranger S, Sivan A, Corrales L, Gajewski TF. Tumor and Host Factors Controlling Antitumor Immunity and Efficacy of Cancer Immunotherapy.Adv Immunol. 2016;130:75-93. [PMID: 26923000 DOI: 10.1016/bs.ai.2015.12.003] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 10.4] [Reference Citation Analysis]
71 Rosenbaum JT, Lin P, Asquith M, Costello ME, Kenna TJ, Brown MA. Does the microbiome play a causal role in spondyloarthritis? Clin Rheumatol 2014;33:763-7. [PMID: 24810703 DOI: 10.1007/s10067-014-2664-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
72 He Y, Chevillet JR, Liu G, Kim TK, Wang K. The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs. Br J Pharmacol 2015;172:2733-47. [PMID: 25296724 DOI: 10.1111/bph.12968] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
73 McPherson AC, Pandey SP, Bender MJ, Meisel M. Systemic Immunoregulatory Consequences of Gut Commensal Translocation. Trends Immunol 2021;42:137-50. [PMID: 33422410 DOI: 10.1016/j.it.2020.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
74 Song W, Tiruthani K, Wang Y, Shen L, Hu M, Dorosheva O, Qiu K, Kinghorn KA, Liu R, Huang L. Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis. Adv Mater 2018;30:e1805007. [PMID: 30387230 DOI: 10.1002/adma.201805007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 19.0] [Reference Citation Analysis]
75 Vacchelli E, Aranda F, Obrist F, Eggermont A, Galon J, Cremer I, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Immunostimulatory cytokines in cancer therapy. Oncoimmunology 2014;3:e29030. [PMID: 25083328 DOI: 10.4161/onci.29030] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
76 Qiu Q, Lin Y, Ma Y, Li X, Liang J, Chen Z, Liu K, Huang Y, Luo H, Huang R, Luo L. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy. Front Immunol 2020;11:612202. [PMID: 33488618 DOI: 10.3389/fimmu.2020.612202] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
77 Oliva M, Mulet-Margalef N, Ochoa-De-Olza M, Napoli S, Mas J, Laquente B, Alemany L, Duell EJ, Nuciforo P, Moreno V. Tumor-Associated Microbiome: Where Do We Stand? Int J Mol Sci 2021;22:1446. [PMID: 33535583 DOI: 10.3390/ijms22031446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Thomas S, Izard J, Walsh E, Batich K, Chongsathidkiet P, Clarke G, Sela DA, Muller AJ, Mullin JM, Albert K, Gilligan JP, DiGuilio K, Dilbarova R, Alexander W, Prendergast GC. The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists. Cancer Res 2017;77:1783-812. [PMID: 28292977 DOI: 10.1158/0008-5472.CAN-16-2929] [Cited by in Crossref: 133] [Cited by in F6Publishing: 85] [Article Influence: 33.3] [Reference Citation Analysis]
79 杨珍妮, 刘丹, 刘冰熔. 肠道菌群与结直肠癌发病关系的研究进展. 世界华人消化杂志 2014; 22(18): 2547-2552 [DOI: 10.11569/wcjd.v22.i18.2547] [Reference Citation Analysis]
80 Pontoppidan PE, Shen RL, Cilieborg MS, Jiang P, Kissow H, Petersen BL, Thymann T, Heilmann C, Müller K, Sangild PT. Bovine Colostrum Modulates Myeloablative Chemotherapy-Induced Gut Toxicity in Piglets. J Nutr 2015;145:1472-80. [PMID: 26019247 DOI: 10.3945/jn.114.203430] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
81 Shui L, Yang X, Li J, Yi C, Sun Q, Zhu H. Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy.Front Immunol. 2019;10:2989. [PMID: 32010123 DOI: 10.3389/fimmu.2019.02989] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 27.0] [Reference Citation Analysis]
82 Rescigno M. A 'fit' microbiota to potentiate cancer immunotherapy. Genome Med 2015;7:131. [PMID: 26689196 DOI: 10.1186/s13073-015-0256-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
83 Vallianou NG, Tzortzatou-Stathopoulou F. Microbiota and cancer: an update. J Chemother 2019;31:59-63. [PMID: 30646834 DOI: 10.1080/1120009X.2018.1541046] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
84 Routy B, Gopalakrishnan V, Daillère R, Zitvogel L, Wargo JA, Kroemer G. The gut microbiota influences anticancer immunosurveillance and general health. Nat Rev Clin Oncol 2018;15:382-96. [PMID: 29636538 DOI: 10.1038/s41571-018-0006-2] [Cited by in Crossref: 167] [Cited by in F6Publishing: 154] [Article Influence: 83.5] [Reference Citation Analysis]
85 Kim J, Lee HK. The Role of Gut Microbiota in Modulating Tumor Growth and Anticancer Agent Efficacy. Mol Cells 2021;44:356-62. [PMID: 33972463 DOI: 10.14348/molcells.2021.0032] [Reference Citation Analysis]
86 Ritter B, Greten FR. Modulating inflammation for cancer therapy. J Exp Med 2019;216:1234-43. [PMID: 31023715 DOI: 10.1084/jem.20181739] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 21.0] [Reference Citation Analysis]
87 Manzoor SS, Doedens A, Burns MB. The promise and challenge of cancer microbiome research. Genome Biol 2020;21:131. [PMID: 32487228 DOI: 10.1186/s13059-020-02037-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
88 Lalani AA, Xie W, Braun DA, Kaymakcalan M, Bossé D, Steinharter JA, Martini DJ, Simantov R, Lin X, Wei XX, Mcgregor BA, Mckay RR, Harshman LC, Choueiri TK. Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma. European Urology Oncology 2020;3:372-81. [DOI: 10.1016/j.euo.2019.09.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 24.0] [Reference Citation Analysis]
89 Zhang Y, Li CX, Zhang XZ. Bacteriophage-mediated modulation of microbiota for diseases treatment. Adv Drug Deliv Rev 2021;:113856. [PMID: 34237403 DOI: 10.1016/j.addr.2021.113856] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Cheng H, Wang Z, Cui L, Wen Y, Chen X, Gong F, Yi H. Opportunities and Challenges of the Human Microbiome in Ovarian Cancer. Front Oncol 2020;10:163. [PMID: 32133297 DOI: 10.3389/fonc.2020.00163] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
91 Yang X, Lu D, Zhuo J, Lin Z, Yang M, Xu X. The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases. Int J Biol Sci 2020;16:2357-66. [PMID: 32760203 DOI: 10.7150/ijbs.46405] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
92 Cocozza F, Menay F, Tsacalian R, Elisei A, Sampedro P, Soria I, Waldner C, Gravisaco MJ, Mongini C. Cyclophosphamide enhances the release of tumor exosomes that elicit a specific immune response in vivo in a murine T-cell lymphoma. Vaccine 2019;37:1565-76. [PMID: 30777349 DOI: 10.1016/j.vaccine.2019.02.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
93 Mussap M, Loddo C, Fanni C, Fanos V. Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics. Expert Rev Clin Pharmacol 2020;13:115-34. [PMID: 31958027 DOI: 10.1080/17512433.2020.1713750] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
94 Dubin K, Callahan MK, Ren B, Khanin R, Viale A, Ling L, No D, Gobourne A, Littmann E, Huttenhower C, Pamer EG, Wolchok JD. Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis. Nat Commun 2016;7:10391. [PMID: 26837003 DOI: 10.1038/ncomms10391] [Cited by in Crossref: 421] [Cited by in F6Publishing: 394] [Article Influence: 84.2] [Reference Citation Analysis]
95 Shi H, Chang Y, Gao Y, Wang X, Chen X, Wang Y, Xue C, Tang Q. Dietary fucoidan of Acaudina molpadioides alters gut microbiota and mitigates intestinal mucosal injury induced by cyclophosphamide. Food Funct 2017;8:3383-93. [PMID: 28861559 DOI: 10.1039/c7fo00932a] [Cited by in Crossref: 51] [Cited by in F6Publishing: 6] [Article Influence: 17.0] [Reference Citation Analysis]
96 Li T, Wu B, Yang T, Zhang L, Jin K. The outstanding antitumor capacity of CD4+ T helper lymphocytes. Biochim Biophys Acta Rev Cancer 2020;1874:188439. [PMID: 32980465 DOI: 10.1016/j.bbcan.2020.188439] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
97 Elkrief A, Derosa L, Kroemer G, Zitvogel L, Routy B. The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor? Ann Oncol 2019;30:1572-9. [PMID: 31268133 DOI: 10.1093/annonc/mdz206] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 56.0] [Reference Citation Analysis]
98 Miller MO, Kashyap PC, Becker SL, Thomas RM, Hodin RA, Miller G, Hundeyin M, Pushalkar S, Cohen D, Saxena D, Shogan BD, Morris-Stiff GJ. SSAT State-of-the-Art Conference: Advancements in the Microbiome. J Gastrointest Surg 2021;25:1885-95. [PMID: 32989690 DOI: 10.1007/s11605-020-04551-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Heine A, Flores C, Gevensleben H, Diehl L, Heikenwalder M, Ringelhan M, Janssen KP, Nitsche U, Garbi N, Brossart P, Knolle PA, Kurts C, Höchst B. Targeting myeloid derived suppressor cells with all-trans retinoic acid is highly time-dependent in therapeutic tumor vaccination. Oncoimmunology 2017;6:e1338995. [PMID: 28920004 DOI: 10.1080/2162402X.2017.1338995] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
100 Foligné B, Plé C, Titécat M, Dendooven A, Pagny A, Daniel C, Singer E, Pottier M, Bertin B, Neut C, Deplanque D, Dubuquoy L, Desreumaux P, Capron M, Standaert A. Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights. Cells 2019;8:E577. [PMID: 31212833 DOI: 10.3390/cells8060577] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
101 Raza MH, Gul K, Arshad A, Riaz N, Waheed U, Rauf A, Aldakheel F, Alduraywish S, Rehman MU, Abdullah M, Arshad M. Microbiota in cancer development and treatment. J Cancer Res Clin Oncol 2019;145:49-63. [PMID: 30542789 DOI: 10.1007/s00432-018-2816-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
102 Bibbò S, Ianiro G, Giambò F, Settanni CR, Cammarota G, Gasbarrini A. Role of gut microbiome on immunotherapy efficacy in melanoma. Hum Vaccin Immunother 2021;:1-6. [PMID: 34190675 DOI: 10.1080/21645515.2021.1926759] [Reference Citation Analysis]
103 Ducasse H, Arnal A, Vittecoq M, Daoust SP, Ujvari B, Jacqueline C, Tissot T, Ewald P, Gatenby RA, King KC, Bonhomme F, Brodeur J, Renaud F, Solary E, Roche B, Thomas F. Cancer: an emergent property of disturbed resource-rich environments? Ecology meets personalized medicine. Evol Appl 2015;8:527-40. [PMID: 26136819 DOI: 10.1111/eva.12232] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
104 Ding C, Tang W, Fan X, Wu G. Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics. Onco Targets Ther 2018;11:4797-810. [PMID: 30147331 DOI: 10.2147/OTT.S170626] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 7.7] [Reference Citation Analysis]
105 Pitt JM, André F, Amigorena S, Soria JC, Eggermont A, Kroemer G, Zitvogel L. Dendritic cell-derived exosomes for cancer therapy. J Clin Invest 2016;126:1224-32. [PMID: 27035813 DOI: 10.1172/JCI81137] [Cited by in Crossref: 196] [Cited by in F6Publishing: 136] [Article Influence: 39.2] [Reference Citation Analysis]
106 Yu LX, Schwabe RF. The gut microbiome and liver cancer: mechanisms and clinical translation. Nat Rev Gastroenterol Hepatol 2017;14:527-39. [PMID: 28676707 DOI: 10.1038/nrgastro.2017.72] [Cited by in Crossref: 176] [Cited by in F6Publishing: 168] [Article Influence: 44.0] [Reference Citation Analysis]
107 Eggermont AMM, Crittenden M, Wargo J. Combination Immunotherapy Development in Melanoma. Am Soc Clin Oncol Educ Book 2018;38:197-207. [PMID: 30231333 DOI: 10.1200/EDBK_201131] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
108 Abdul Rahman R, Lamarca A, Hubner RA, Valle JW, McNamara MG. The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer. Cancers (Basel) 2021;13:3779. [PMID: 34359684 DOI: 10.3390/cancers13153779] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Swan D, Gurney M, Krawczyk J, Ryan AE, O'Dwyer M. Beyond DNA Damage: Exploring the Immunomodulatory Effects of Cyclophosphamide in Multiple Myeloma. Hemasphere 2020;4:e350. [PMID: 32309787 DOI: 10.1097/HS9.0000000000000350] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
110 Bienenstock J, Kunze WA, Forsythe P. Disruptive physiology: olfaction and the microbiome-gut-brain axis: Olfaction and gut-brain axis. Biol Rev 2018;93:390-403. [DOI: 10.1111/brv.12348] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
111 Li B, Chan HL, Chen P. Immune Checkpoint Inhibitors: Basics and Challenges. Curr Med Chem 2019;26:3009-25. [PMID: 28782469 DOI: 10.2174/0929867324666170804143706] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 19.5] [Reference Citation Analysis]
112 da Gama Duarte J, Woods K, Andrews MC, Behren A. The good, the (not so) bad and the ugly of immune homeostasis in melanoma. Immunol Cell Biol 2018;96:497-506. [PMID: 29392770 DOI: 10.1111/imcb.12001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
113 Massari F, Mollica V, Di Nunno V, Gatto L, Santoni M, Scarpelli M, Cimadamore A, Lopez-Beltran A, Cheng L, Battelli N, Montironi R, Brandi G. The Human Microbiota and Prostate Cancer: Friend or Foe? Cancers (Basel) 2019;11:E459. [PMID: 30935126 DOI: 10.3390/cancers11040459] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 8.5] [Reference Citation Analysis]
114 Pardieck IN, Jawahier PA, Swets M, van de Velde CJ, Kuppen PJ. Novel avenues in immunotherapies for colorectal cancer. Expert Review of Gastroenterology & Hepatology 2016;10:465-80. [DOI: 10.1586/17474124.2016.1122522] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
115 Iezzi G, Cremonesi E, Majno PE. Pro-tumoral role of gut bacteria: sabotaging immune cell recruitment. Ann Transl Med 2019;7:59. [PMID: 30906763 DOI: 10.21037/atm.2018.12.56] [Reference Citation Analysis]
116 Wong-Rolle A, Wei HK, Zhao C, Jin C. Unexpected guests in the tumor microenvironment: microbiome in cancer. Protein Cell 2021;12:426-35. [PMID: 33296049 DOI: 10.1007/s13238-020-00813-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
117 Buchta Rosean CM, Rutkowski MR. The influence of the commensal microbiota on distal tumor-promoting inflammation. Semin Immunol 2017;32:62-73. [PMID: 28687194 DOI: 10.1016/j.smim.2017.06.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
118 Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, Iribarren K, Mondragón L, Jacquelot N, Qu B, Ferrere G, Clémenson C, Mezquita L, Masip JR, Naltet C, Brosseau S, Kaderbhai C, Richard C, Rizvi H, Levenez F, Galleron N, Quinquis B, Pons N, Ryffel B, Minard-Colin V, Gonin P, Soria JC, Deutsch E, Loriot Y, Ghiringhelli F, Zalcman G, Goldwasser F, Escudier B, Hellmann MD, Eggermont A, Raoult D, Albiges L, Kroemer G, Zitvogel L. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 2018;359:91-7. [PMID: 29097494 DOI: 10.1126/science.aan3706] [Cited by in Crossref: 1735] [Cited by in F6Publishing: 1606] [Article Influence: 433.8] [Reference Citation Analysis]
119 Tao C, Zeng W, Zhang Q, Liu G, Wu F, Shen H, Zhang W, Bo H, Shao H. Effects of the prebiotic inulin-type fructans on post-antibiotic reconstitution of the gut microbiome. J Appl Microbiol 2021;130:634-49. [PMID: 32813896 DOI: 10.1111/jam.14827] [Reference Citation Analysis]
120 Kuntz TM, Gilbert JA. Introducing the Microbiome into Precision Medicine. Trends in Pharmacological Sciences 2017;38:81-91. [DOI: 10.1016/j.tips.2016.10.001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 13.5] [Reference Citation Analysis]
121 Adashek JJ, Salgia MM, Posadas EM, Figlin RA, Gong J. Role of Biomarkers in Prediction of Response to Therapeutics in Metastatic Renal-Cell Carcinoma. Clinical Genitourinary Cancer 2019;17:e454-60. [DOI: 10.1016/j.clgc.2019.01.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
122 García-González AP, Ritter AD, Shrestha S, Andersen EC, Yilmaz LS, Walhout AJM. Bacterial Metabolism Affects the C. elegans Response to Cancer Chemotherapeutics. Cell 2017;169:431-441.e8. [PMID: 28431244 DOI: 10.1016/j.cell.2017.03.046] [Cited by in Crossref: 107] [Cited by in F6Publishing: 92] [Article Influence: 26.8] [Reference Citation Analysis]
123 Stroncek DF, Butterfield LH, Cannarile MA, Dhodapkar MV, Greten TF, Grivel JC, Kaufman DR, Kong HH, Korangy F, Lee PP, Marincola F, Rutella S, Siebert JC, Trinchieri G, Seliger B. Systematic evaluation of immune regulation and modulation. J Immunother Cancer 2017;5:21. [PMID: 28331613 DOI: 10.1186/s40425-017-0223-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
124 Wu R, Mei X, Ye Y, Xue T, Wang J, Sun W, Lin C, Xue R, Zhang J, Xu D. Zn(II)-curcumin solid dispersion impairs hepatocellular carcinoma growth and enhances chemotherapy by modulating gut microbiota-mediated zinc homeostasis. Pharmacol Res 2019;150:104454. [PMID: 31526871 DOI: 10.1016/j.phrs.2019.104454] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
125 Tuddenham S, Sears CL. The intestinal microbiome and health. Curr Opin Infect Dis. 2015;28:464-470. [PMID: 26237547 DOI: 10.1097/qco.0000000000000196] [Cited by in Crossref: 83] [Cited by in F6Publishing: 42] [Article Influence: 16.6] [Reference Citation Analysis]
126 Reens AL, Cabral DJ, Liang X, Norton JE Jr, Therien AG, Hazuda DJ, Swaminathan G. Immunomodulation by the Commensal Microbiome During Immune-Targeted Interventions: Focus on Cancer Immune Checkpoint Inhibitor Therapy and Vaccination. Front Immunol 2021;12:643255. [PMID: 34054810 DOI: 10.3389/fimmu.2021.643255] [Reference Citation Analysis]
127 Chauhan V, Kanwar SS. Lipopeptide(s) associated with human microbiome as potent cancer drug. Semin Cancer Biol 2021;70:128-33. [PMID: 32574814 DOI: 10.1016/j.semcancer.2020.06.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Wang D, Cheng J, Zhang J, Zhou F, He X, Shi Y, Tao Y. The Role of Respiratory Microbiota in Lung Cancer. Int J Biol Sci 2021;17:3646-58. [PMID: 34512172 DOI: 10.7150/ijbs.51376] [Reference Citation Analysis]
129 Moaven O, Mangieri CW, Stauffer JA, Anastasiadis PZ, Borad MJ. Strategies to Develop Potent Oncolytic Viruses and Enhance Their Therapeutic Efficacy. JCO Precis Oncol 2021;5:PO. [PMID: 34250395 DOI: 10.1200/PO.21.00003] [Reference Citation Analysis]
130 Galloway-Peña JR, Jenq RR, Shelburne SA. Can Consideration of the Microbiome Improve Antimicrobial Utilization and Treatment Outcomes in the Oncology Patient? Clin Cancer Res 2017;23:3263-8. [PMID: 28298544 DOI: 10.1158/1078-0432.CCR-16-3173] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
131 Cong J, Zhang X. How human microbiome talks to health and disease. Eur J Clin Microbiol Infect Dis 2018;37:1595-601. [PMID: 29682676 DOI: 10.1007/s10096-018-3263-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
132 Rébé C, Ghiringhelli F. Cytotoxic effects of chemotherapy on cancer and immune cells: how can it be modulated to generate novel therapeutic strategies? Future Oncol 2015;11:2645-54. [PMID: 26376787 DOI: 10.2217/fon.15.198] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
133 Ding ZC, Aboelella NS, Bryan L, Shi H, Zhou G. The Monocytes That Repopulate in Mice After Cyclophosphamide Treatment Acquire a Neutrophil Precursor Gene Signature and Immunosuppressive Activity. Front Immunol 2020;11:594540. [PMID: 33569051 DOI: 10.3389/fimmu.2020.594540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Huo W, Feng Z, Hu S, Cui L, Qiao T, Dai L, Qi P, Zhang L, Liu Y, Li J. Effects of polysaccharides from wild morels on immune response and gut microbiota composition in non-treated and cyclophosphamide-treated mice. Food Funct 2020;11:4291-303. [PMID: 32356856 DOI: 10.1039/d0fo00597e] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
135 Papanicolas LE, Sims SK, Taylor SL, Miller SJ, Karapetis CS, Wesselingh SL, Gordon DL, Rogers GB. Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome. BMC Cancer 2021;21:591. [PMID: 34022842 DOI: 10.1186/s12885-021-08296-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
136 Chau J, Zhang J. Tying Small Changes to Large Outcomes: The Cautious Promise in Incorporating the Microbiome into Immunotherapy. Int J Mol Sci 2021;22:7900. [PMID: 34360663 DOI: 10.3390/ijms22157900] [Reference Citation Analysis]
137 Sommer F, Bäckhed F. Know your neighbor: Microbiota and host epithelial cells interact locally to control intestinal function and physiology. Bioessays 2016;38:455-64. [PMID: 26990415 DOI: 10.1002/bies.201500151] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 7.8] [Reference Citation Analysis]
138 Ma Y, Pitt JM, Li Q, Yang H. The renaissance of anti-neoplastic immunity from tumor cell demise. Immunol Rev 2017;280:194-206. [PMID: 29027231 DOI: 10.1111/imr.12586] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 8.7] [Reference Citation Analysis]
139 Zhang H, Hui D, Li Y, Xiong G, Fu X. Canmei Formula Reduces Colitis-Associated Colorectal Carcinogenesis in Mice by Modulating the Composition of Gut Microbiota. Front Oncol 2019;9:1149. [PMID: 31803606 DOI: 10.3389/fonc.2019.01149] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
140 Plantamura E, Dzutsev A, Chamaillard M, Djebali S, Moudombi L, Boucinha L, Grau M, Macari C, Bauché D, Dumitrescu O, Rasigade JP, Lippens S, Plateroti M, Kress E, Cesaro A, Bondu C, Rothermel U, Heikenwälder M, Lina G, Bentaher-Belaaouaj A, Marie JC, Caux C, Trinchieri G, Marvel J, Michallet MC. MAVS deficiency induces gut dysbiotic microbiota conferring a proallergic phenotype. Proc Natl Acad Sci U S A 2018;115:10404-9. [PMID: 30249647 DOI: 10.1073/pnas.1722372115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
141 Calcinotto A, Kohli J, Zagato E, Pellegrini L, Demaria M, Alimonti A. Cellular Senescence: Aging, Cancer, and Injury. Physiol Rev 2019;99:1047-78. [PMID: 30648461 DOI: 10.1152/physrev.00020.2018] [Cited by in Crossref: 134] [Cited by in F6Publishing: 135] [Article Influence: 67.0] [Reference Citation Analysis]
142 Bossù G, Di Sario R, Argentiero A, Esposito S. Antimicrobial Prophylaxis and Modifications of the Gut Microbiota in Children with Cancer. Antibiotics (Basel) 2021;10:152. [PMID: 33546312 DOI: 10.3390/antibiotics10020152] [Reference Citation Analysis]
143 Classen AY, Henze L, von Lilienfeld-Toal M, Maschmeyer G, Sandherr M, Graeff LD, Alakel N, Christopeit M, Krause SW, Mayer K, Neumann S, Cornely OA, Penack O, Weißinger F, Wolf HH, Vehreschild JJ. Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO). Ann Hematol 2021;100:1603-20. [PMID: 33846857 DOI: 10.1007/s00277-021-04452-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
144 Dalal P, Sharma D. Microbe defines the efficacy of chemotherapeutic drug: a complete paradigm. FEMS Microbiol Lett 2021;368:fnab116. [PMID: 34448860 DOI: 10.1093/femsle/fnab116] [Reference Citation Analysis]
145 Koulouridi A, Messaritakis I, Gouvas N, Tsiaoussis J, Souglakos J. Immunotherapy in Solid Tumors and Gut Microbiota: The Correlation-A Special Reference to Colorectal Cancer. Cancers (Basel) 2020;13:E43. [PMID: 33375686 DOI: 10.3390/cancers13010043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
146 Bindels LB, Delzenne NM, Cani PD, Walter J. Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol. 2015;12:303-310. [PMID: 25824997 DOI: 10.1038/nrgastro.2015.47] [Cited by in Crossref: 406] [Cited by in F6Publishing: 344] [Article Influence: 67.7] [Reference Citation Analysis]
147 Azvolinsky A. Gut checkpoint: A rising cancer treatment may get a boost from intestinal bacteria. Nat Med 2018;24:251-3. [PMID: 29509755 DOI: 10.1038/nm0318-251] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
148 Manfredo Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, Costa FRC, Tiniakou E, Greiling T, Ruff W, Barbieri A, Kriegel C, Mehta SS, Knight JR, Jain D, Goodman AL, Kriegel MA. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science. 2018;359:1156-1161. [PMID: 29590047 DOI: 10.1126/science.aar7201] [Cited by in Crossref: 276] [Cited by in F6Publishing: 255] [Article Influence: 92.0] [Reference Citation Analysis]
149 Zhou A, Tang L, Zeng S, Lei Y, Yang S, Tang B. Gut microbiota: A new piece in understanding hepatocarcinogenesis. Cancer Lett 2020;474:15-22. [PMID: 31917160 DOI: 10.1016/j.canlet.2020.01.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
150 Chen DS, Mellman I. Elements of cancer immunity and the cancer–immune set point. Nature 2017;541:321-30. [DOI: 10.1038/nature21349] [Reference Citation Analysis]
151 Wang Y, Xie W, Humeau J, Chen G, Liu P, Pol J, Zhang Z, Kepp O, Kroemer G. Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy. J Immunother Cancer 2020;8:e000462. [PMID: 32221018 DOI: 10.1136/jitc-2019-000462] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 16.0] [Reference Citation Analysis]
152 Gopalakrishnan V, Helmink BA, Spencer CN, Reuben A, Wargo JA. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy. Cancer Cell. 2018;33:570-580. [PMID: 29634945 DOI: 10.1016/j.ccell.2018.03.015] [Cited by in Crossref: 371] [Cited by in F6Publishing: 350] [Article Influence: 185.5] [Reference Citation Analysis]
153 Sadowska-Klasa A, Piekarska A, Prejzner W, Bieniaszewska M, Hellmann A. Colonization with multidrug-resistant bacteria increases the risk of complications and a fatal outcome after allogeneic hematopoietic cell transplantation. Ann Hematol 2018;97:509-17. [PMID: 29255911 DOI: 10.1007/s00277-017-3205-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
154 Zhang X, Pan Z. Influence of microbiota on immunity and immunotherapy for gastric and esophageal cancers. Gastroenterol Rep (Oxf) 2020;8:206-14. [PMID: 32665852 DOI: 10.1093/gastro/goaa014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
155 Marongiu L, Burkard M, Venturelli S, Allgayer H. Dietary Modulation of Bacteriophages as an Additional Player in Inflammation and Cancer. Cancers (Basel) 2021;13:2036. [PMID: 33922485 DOI: 10.3390/cancers13092036] [Reference Citation Analysis]
156 Erdman SE, Poutahidis T. Gut bacteria and cancer. Biochim Biophys Acta 2015;1856:86-90. [PMID: 26050963 DOI: 10.1016/j.bbcan.2015.05.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
157 Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, Petaccia de Macedo M, Cotechini T, Kumar T, Chen WS, Reddy SM, Szczepaniak Sloane R, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LM, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Marcelo Riquelme Sanchez E, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018;359:97-103. [PMID: 29097493 DOI: 10.1126/science.aan4236] [Cited by in Crossref: 1482] [Cited by in F6Publishing: 1372] [Article Influence: 370.5] [Reference Citation Analysis]
158 Dzutsev A, Goldszmid RS, Viaud S, Zitvogel L, Trinchieri G. The role of the microbiota in inflammation, carcinogenesis, and cancer therapy. European journal of immunology. 2015;45:17-31. [PMID: 25328099 DOI: 10.1002/eji.201444972] [Cited by in Crossref: 106] [Cited by in F6Publishing: 99] [Article Influence: 15.1] [Reference Citation Analysis]
159 Rausch S, Kruck S, Stenzl A, Bedke J. IMA901 for metastatic renal cell carcinoma in the context of new approaches to immunotherapy. Future Oncology 2014;10:937-48. [DOI: 10.2217/fon.14.61] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
160 Wang Y, Yang G, You L, Yang J, Feng M, Qiu J, Zhao F, Liu Y, Cao Z, Zheng L, Zhang T, Zhao Y. Role of the microbiome in occurrence, development and treatment of pancreatic cancer. Mol Cancer. 2019;18:173. [PMID: 31785619 DOI: 10.1186/s12943-019-1103-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
161 Pitt JM, Vétizou M, Daillère R, Roberti MP, Yamazaki T, Routy B, Lepage P, Boneca IG, Chamaillard M, Kroemer G, Zitvogel L. Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors. Immunity 2016;44:1255-69. [PMID: 27332730 DOI: 10.1016/j.immuni.2016.06.001] [Cited by in Crossref: 438] [Cited by in F6Publishing: 443] [Article Influence: 109.5] [Reference Citation Analysis]
162 Scheich S, Reinheimer C, Brandt C, Wichelhaus TA, Hogardt M, Kempf VAJ, Brunnberg U, Brandts C, Ballo O, von Metzler I, Kessel J, Serve H, Steffen B. Clinical Impact of Colonization with Multidrug-Resistant Organisms on Outcome after Autologous Stem Cell Transplantation: A Retrospective Single-Center Study. Biol Blood Marrow Transplant 2017;23:1455-62. [PMID: 28528711 DOI: 10.1016/j.bbmt.2017.05.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
163 Clanton R, Saucier D, Ford J, Akabani G. Microbial influences on hormesis, oncogenesis, and therapy: A review of the literature. Environ Res 2015;142:239-56. [PMID: 26183884 DOI: 10.1016/j.envres.2015.06.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
164 Liguori G, Lamas B, Richard ML, Brandi G, da Costa G, Hoffmann TW, Di Simone MP, Calabrese C, Poggioli G, Langella P, Campieri M, Sokol H. Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients. J Crohns Colitis 2016;10:296-305. [PMID: 26574491 DOI: 10.1093/ecco-jcc/jjv209] [Cited by in Crossref: 125] [Cited by in F6Publishing: 116] [Article Influence: 20.8] [Reference Citation Analysis]
165 Sfanos KS, Markowski MC, Peiffer LB, Ernst SE, White JR, Pienta KJ, Antonarakis ES, Ross AE. Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies. Prostate Cancer Prostatic Dis 2018;21:539-48. [PMID: 29988102 DOI: 10.1038/s41391-018-0061-x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 15.3] [Reference Citation Analysis]
166 Liu Q, Sun Z, Chen L. Memory T cells: strategies for optimizing tumor immunotherapy. Protein Cell 2020;11:549-64. [PMID: 32221812 DOI: 10.1007/s13238-020-00707-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
167 Abdollahi-Roodsaz S, Abramson SB, Scher JU. The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions. Nat Rev Rheumatol. 2016;12:446-455. [PMID: 27256713 DOI: 10.1038/nrrheum.2016.68] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 13.4] [Reference Citation Analysis]
168 Gaines S, Shao C, Hyman N, Alverdy JC. Gut microbiome influences on anastomotic leak and recurrence rates following colorectal cancer surgery. Br J Surg. 2018;105:e131-e141. [PMID: 29341151 DOI: 10.1002/bjs.10760] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 20.0] [Reference Citation Analysis]
169 Xu C, Ruan B, Jiang Y, Xue T, Wang Z, Lu H, Wei M, Wang S, Ye Z, Zhai D, Wang L, Lu Z. Antibiotics-induced gut microbiota dysbiosis promotes tumor initiation via affecting APC-Th1 development in mice. Biochem Biophys Res Commun 2017;488:418-24. [PMID: 28506830 DOI: 10.1016/j.bbrc.2017.05.071] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
170 Weide B, Di Giacomo AM, Fonsatti E, Zitvogel L. Immunologic correlates in the course of treatment with immunomodulating antibodies. Semin Oncol 2015;42:448-58. [PMID: 25965363 DOI: 10.1053/j.seminoncol.2015.02.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
171 Innamarato P, Pilon-Thomas S. Reactive myelopoiesis and the onset of myeloid-mediated immune suppression: Implications for adoptive cell therapy. Cell Immunol 2021;361:104277. [PMID: 33476931 DOI: 10.1016/j.cellimm.2020.104277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Bull JMC. A review of immune therapy in cancer and a question: can thermal therapy increase tumor response? Int J Hyperthermia 2018;34:840-52. [PMID: 28974121 DOI: 10.1080/02656736.2017.1387938] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
173 Benson Z, Manjili SH, Habibi M, Guruli G, Toor AA, Payne KK, Manjili MH. Conditioning neoadjuvant therapies for improved immunotherapy of cancer. Biochem Pharmacol 2017;145:12-7. [PMID: 28803721 DOI: 10.1016/j.bcp.2017.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
174 Zhao Y, Liu Y, Li S, Peng Z, Liu X, Chen J, Zheng X. Role of lung and gut microbiota on lung cancer pathogenesis. J Cancer Res Clin Oncol 2021;147:2177-86. [PMID: 34018055 DOI: 10.1007/s00432-021-03644-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
175 Park R, Umar S, Kasi A. Immunotherapy in Colorectal Cancer: Potential of Fecal Transplant and Microbiota-augmented Clinical Trials. Curr Colorectal Cancer Rep 2020;16:81-8. [PMID: 32607098 DOI: 10.1007/s11888-020-00456-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
176 Perez-Chanona E, Jobin C. From promotion to management: the wide impact of bacteria on cancer and its treatment. Bioessays 2014;36:658-64. [PMID: 24752750 DOI: 10.1002/bies.201400015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
177 Becattini S, Taur Y, Pamer EG. Antibiotic-Induced Changes in the Intestinal Microbiota and Disease. Trends Mol Med. 2016;22:458-478. [PMID: 27178527 DOI: 10.1016/j.molmed.2016.04.003] [Cited by in Crossref: 331] [Cited by in F6Publishing: 297] [Article Influence: 66.2] [Reference Citation Analysis]
178 Bhatt AP, Redinbo MR, Bultman SJ. The role of the microbiome in cancer development and therapy. CA Cancer J Clin. 2017;67:326-344. [PMID: 28481406 DOI: 10.3322/caac.21398] [Cited by in Crossref: 191] [Cited by in F6Publishing: 182] [Article Influence: 47.8] [Reference Citation Analysis]
179 Jenkins SV, Robeson MS 2nd, Griffin RJ, Quick CM, Siegel ER, Cannon MJ, Vang KB, Dings RPM. Gastrointestinal Tract Dysbiosis Enhances Distal Tumor Progression through Suppression of Leukocyte Trafficking. Cancer Res 2019;79:5999-6009. [PMID: 31591154 DOI: 10.1158/0008-5472.CAN-18-4108] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
180 Smoak P, Harman N, Flores V, Kisiolek J, Pullen NA, Lisano J, Hayward R, Stewart LK. Kefir Is a Viable Exercise Recovery Beverage for Cancer Survivors Enrolled in a Structured Exercise Program. Med Sci Sports Exerc 2021;53:2045-53. [PMID: 34519716 DOI: 10.1249/MSS.0000000000002690] [Reference Citation Analysis]
181 Galloway-Peña JR, Smith DP, Sahasrabhojane P, Ajami NJ, Wadsworth WD, Daver NG, Chemaly RF, Marsh L, Ghantoji SS, Pemmaraju N, Garcia-Manero G, Rezvani K, Alousi AM, Wargo JA, Shpall EJ, Futreal PA, Guindani M, Petrosino JF, Kontoyiannis DP, Shelburne SA. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia. Cancer 2016;122:2186-96. [PMID: 27142181 DOI: 10.1002/cncr.30039] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 13.4] [Reference Citation Analysis]
182 Wang W, Green M, Rebecca Liu J, Lawrence TS, Zou W. CD8+ T Cells in Immunotherapy, Radiotherapy, and Chemotherapy. In: Zitvogel L, Kroemer G, editors. Oncoimmunology. Cham: Springer International Publishing; 2018. pp. 23-39. [DOI: 10.1007/978-3-319-62431-0_3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
183 Payne KK. Lymphocyte-mediated Immune Regulation in Health and Disease: The Treg and γδ T Cell Co-conspiracy. Immunol Invest 2016;45:767-75. [PMID: 27617588 DOI: 10.1080/08820139.2016.1213278] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
184 Pala L, Conforti F. The effect of patient sex on the efficacy and safety of anticancer immunotherapy. Expert Opin Drug Saf 2021;:1-10. [PMID: 34468257 DOI: 10.1080/14740338.2021.1939672] [Reference Citation Analysis]
185 Liang W, Yang Y, Wang H, Wang H, Yu X, Lu Y, Shen S, Teng L. Gut microbiota shifts in patients with gastric cancer in perioperative period. Medicine (Baltimore) 2019;98:e16626. [PMID: 31464899 DOI: 10.1097/MD.0000000000016626] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
186 Farhana L, Banerjee HN, Verma M, Majumdar APN. Role of Microbiome in Carcinogenesis Process and Epigenetic Regulation of Colorectal Cancer. Methods Mol Biol 2018;1856:35-55. [PMID: 30178245 DOI: 10.1007/978-1-4939-8751-1_3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
187 Vétizou M, Daillère R, Zitvogel L. [Gut microbiota and efficacy of cancer therapies]. Biol Aujourdhui 2017;211:51-67. [PMID: 28682227 DOI: 10.1051/jbio/2017009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
188 Viaud S, Daillère R, Yamazaki T, Lepage P, Boneca I, Goldszmid R, Trinchieri G, Zitvogel L. Why should we need the gut microbiota to respond to cancer therapies? Oncoimmunology 2014;3:e27574. [PMID: 24800167 DOI: 10.4161/onci.27574] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
189 Koliarakis I, Messaritakis I, Nikolouzakis TK, Hamilos G, Souglakos J, Tsiaoussis J. Oral Bacteria and Intestinal Dysbiosis in Colorectal Cancer. Int J Mol Sci 2019;20:E4146. [PMID: 31450675 DOI: 10.3390/ijms20174146] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 19.5] [Reference Citation Analysis]
190 Georgiou K, Marinov B, Farooqi AA, Gazouli M. Gut Microbiota in Lung Cancer: Where Do We Stand? Int J Mol Sci 2021;22:10429. [PMID: 34638770 DOI: 10.3390/ijms221910429] [Reference Citation Analysis]
191 Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature. 2016;535:75-84. [PMID: 27383982 DOI: 10.1038/nature18848] [Cited by in Crossref: 741] [Cited by in F6Publishing: 680] [Article Influence: 148.2] [Reference Citation Analysis]
192 Dougé A, Bay JO, Ravinet A, Scanzi J. [Intestinal microbiota and allogeneic stem cell transplantation]. Bull Cancer 2020;107:72-83. [PMID: 31582175 DOI: 10.1016/j.bulcan.2019.08.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
193 Marinelli L, Tenore GC, Novellino E. Probiotic species in the modulation of the anticancer immune response. Semin Cancer Biol. 2017;46:182-190. [PMID: 28844794 DOI: 10.1016/j.semcancer.2017.08.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
194 Yu F, Gong W, Xu F, Wu J, Shakya S, Zhu H. Influence of Nutritional Status on the Absorption of Polyphyllin I, an Anticancer Candidate from Paris polyphylla in Rats. Eur J Drug Metab Pharmacokinet 2018;43:587-97. [DOI: 10.1007/s13318-018-0473-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
195 Ballo O, Tarazzit I, Stratmann J, Reinheimer C, Hogardt M, Wichelhaus TA, Kempf V, Serve H, Finkelmeier F, Brandts C. Colonization with multidrug resistant organisms determines the clinical course of patients with acute myeloid leukemia undergoing intensive induction chemotherapy. PLoS One 2019;14:e0210991. [PMID: 30673776 DOI: 10.1371/journal.pone.0210991] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
196 Guo R, Chen LH, Xing C, Liu T. Pain regulation by gut microbiota: molecular mechanisms and therapeutic potential. Br J Anaesth 2019;123:637-54. [PMID: 31551115 DOI: 10.1016/j.bja.2019.07.026] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 27.0] [Reference Citation Analysis]
197 Masters GA, Krilov L, Bailey HH, Brose MS, Burstein H, Diller LR, Dizon DS, Fine HA, Kalemkerian GP, Moasser M, Neuss MN, O'day SJ, Odenike O, Ryan CJ, Schilsky RL, Schwartz GK, Venook AP, Wong SL, Patel JD. Clinical Cancer Advances 2015: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. JCO 2015;33:786-809. [DOI: 10.1200/jco.2014.59.9746] [Cited by in Crossref: 78] [Cited by in F6Publishing: 33] [Article Influence: 13.0] [Reference Citation Analysis]
198 Opzoomer JW, Sosnowska D, Anstee JE, Spicer JF, Arnold JN. Cytotoxic Chemotherapy as an Immune Stimulus: A Molecular Perspective on Turning Up the Immunological Heat on Cancer. Front Immunol 2019;10:1654. [PMID: 31379850 DOI: 10.3389/fimmu.2019.01654] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
199 Aarnoutse R, Ziemons J, Penders J, Rensen SS, de Vos-Geelen J, Smidt ML. The Clinical Link between Human Intestinal Microbiota and Systemic Cancer Therapy. Int J Mol Sci 2019;20:E4145. [PMID: 31450659 DOI: 10.3390/ijms20174145] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
200 Iida N, Mizukoshi E, Yamashita T, Terashima T, Arai K, Seishima J, Kaneko S. Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinoma. Int J Cancer. 2019;145:2701-2711. [PMID: 30980680 DOI: 10.1002/ijc.32339] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
201 Aranda F, Bloy N, Pesquet J, Petit B, Chaba K, Sauvat A, Kepp O, Khadra N, Enot D, Pfirschke C, Pittet M, Zitvogel L, Kroemer G, Senovilla L. Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer. Oncogene 2015;34:3053-62. [PMID: 25065595 DOI: 10.1038/onc.2014.234] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 6.9] [Reference Citation Analysis]
202 Clavel T, Lagkouvardos I, Hiergeist A. Microbiome sequencing: challenges and opportunities for molecular medicine. Expert Review of Molecular Diagnostics 2016;16:795-805. [DOI: 10.1080/14737159.2016.1184574] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
203 Sato H, Shirai T, Fujii H, Ishii T, Harigae H. Cyclophosphamide-associated enteritis presenting with severe protein-losing enteropathy in granulomatosis with polyangiitis: A case report. World J Gastroenterol 2021; 27(20): 2657-2663 [PMID: 34092982 DOI: 10.3748/wjg.v27.i20.2657] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
204 Laplane L, Duluc D, Bikfalvi A, Larmonier N, Pradeu T. Beyond the tumour microenvironment. Int J Cancer 2019;145:2611-8. [PMID: 30989643 DOI: 10.1002/ijc.32343] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
205 Gori S, Inno A, Belluomini L, Bocus P, Bisoffi Z, Russo A, Arcaro G. Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy. Crit Rev Oncol Hematol 2019;143:139-47. [PMID: 31634731 DOI: 10.1016/j.critrevonc.2019.09.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 17.5] [Reference Citation Analysis]
206 Saghafian-hedengren S, Söderström I, Sverremark-ekström E, Nilsson A. Insights into defective serological memory after acute lymphoblastic leukaemia treatment: The role of the plasma cell survival niche, memory B-cells and gut microbiota in vaccine responses. Blood Reviews 2018;32:71-80. [DOI: 10.1016/j.blre.2017.08.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
207 Hylander BL, Repasky EA. Temperature as a modulator of the gut microbiome: what are the implications and opportunities for thermal medicine? Int J Hyperthermia 2019;36:83-9. [PMID: 31795833 DOI: 10.1080/02656736.2019.1647356] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
208 Raskov H, Burcharth J, Pommergaard HC. Linking Gut Microbiota to Colorectal Cancer. J Cancer. 2017;8:3378-3395. [PMID: 29151921 DOI: 10.7150/jca.20497] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 13.0] [Reference Citation Analysis]
209 Laborda-Illanes A, Sanchez-Alcoholado L, Dominguez-Recio ME, Jimenez-Rodriguez B, Lavado R, Comino-Méndez I, Alba E, Queipo-Ortuño MI. Breast and Gut Microbiota Action Mechanisms in Breast Cancer Pathogenesis and Treatment. Cancers (Basel) 2020;12:E2465. [PMID: 32878124 DOI: 10.3390/cancers12092465] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
210 Chunxi L, Haiyue L, Yanxia L, Jianbing P, Jin S. The Gut Microbiota and Respiratory Diseases: New Evidence. J Immunol Res 2020;2020:2340670. [PMID: 32802893 DOI: 10.1155/2020/2340670] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
211 Greenhill C. Gut microbiota: Anti-cancer therapies affected by gut microbiota. Nat Rev Gastroenterol Hepatol 2014;11:1. [PMID: 24322902 DOI: 10.1038/nrgastro.2013.238] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
212 Lehouritis P, Cummins J, Stanton M, Murphy CT, McCarthy FO, Reid G, Urbaniak C, Byrne WL, Tangney M. Local bacteria affect the efficacy of chemotherapeutic drugs. Sci Rep 2015;5:14554. [PMID: 26416623 DOI: 10.1038/srep14554] [Cited by in Crossref: 87] [Cited by in F6Publishing: 89] [Article Influence: 14.5] [Reference Citation Analysis]
213 Savignac HM, Kiely B, Dinan TG, Cryan JF. Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice. Neurogastroenterol Motil 2014;26:1615-27. [DOI: 10.1111/nmo.12427] [Cited by in Crossref: 226] [Cited by in F6Publishing: 197] [Article Influence: 32.3] [Reference Citation Analysis]
214 Champer M, Wong A, Champer J, Brito I, Messer P, Hou J, Wright J. The role of the vaginal microbiome in gynaecological cancer. BJOG: Int J Obstet Gy 2018;125:309-15. [DOI: 10.1111/1471-0528.14631] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 12.8] [Reference Citation Analysis]
215 Zambirinis CP, Pushalkar S, Saxena D, Miller G. Pancreatic cancer, inflammation, and microbiome. Cancer J. 2014;20:195-202. [PMID: 24855007 DOI: 10.1097/ppo.0000000000000045] [Cited by in Crossref: 105] [Cited by in F6Publishing: 63] [Article Influence: 17.5] [Reference Citation Analysis]
216 Wong SH, Kwong TNY, Wu CY, Yu J. Clinical applications of gut microbiota in cancer biology. Semin Cancer Biol 2019;55:28-36. [PMID: 29782923 DOI: 10.1016/j.semcancer.2018.05.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 13.3] [Reference Citation Analysis]
217 Sobhani I, Rotkopf H, Khazaie K. Bacteria-related changes in host DNA methylation and the risk for CRC. Gut Microbes 2020;12:1800898. [PMID: 32931352 DOI: 10.1080/19490976.2020.1800898] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
218 Sethi V, Vitiello GA, Saxena D, Miller G, Dudeja V. The Role of the Microbiome in Immunologic Development and its Implication For Pancreatic Cancer Immunotherapy. Gastroenterology 2019;156:2097-2115.e2. [DOI: 10.1053/j.gastro.2018.12.045] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 18.5] [Reference Citation Analysis]
219 Elinav E, Garrett WS, Trinchieri G, Wargo J. The cancer microbiome. Nat Rev Cancer 2019;19:371-6. [PMID: 31186547 DOI: 10.1038/s41568-019-0155-3] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 31.0] [Reference Citation Analysis]
220 Shalapour S, Karin M. Immunity, inflammation, and cancer: an eternal fight between good and evil. J Clin Invest. 2015;125:3347-3355. [PMID: 26325032 DOI: 10.1172/jci80007] [Cited by in Crossref: 370] [Cited by in F6Publishing: 259] [Article Influence: 61.7] [Reference Citation Analysis]
221 Biedermann L, Rogler G. The intestinal microbiota: its role in health and disease. Eur J Pediatr. 2015;174:151-167. [PMID: 25563215 DOI: 10.1007/s00431-014-2476-2] [Cited by in Crossref: 85] [Cited by in F6Publishing: 70] [Article Influence: 14.2] [Reference Citation Analysis]
222 Johnson CH, Spilker ME, Goetz L, Peterson SN, Siuzdak G. Metabolite and Microbiome Interplay in Cancer Immunotherapy. Cancer Res 2016;76:6146-52. [PMID: 27729325 DOI: 10.1158/0008-5472.CAN-16-0309] [Cited by in Crossref: 48] [Cited by in F6Publishing: 29] [Article Influence: 9.6] [Reference Citation Analysis]
223 Choudhry H. The Microbiome and Its Implications in Cancer Immunotherapy. Molecules 2021;26:E206. [PMID: 33401586 DOI: 10.3390/molecules26010206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
224 Luke JJ, Pal SK. Further evidence to support judicious use of antibiotics in patients with cancer. Ann Oncol 2018;29:1349-51. [PMID: 29688263 DOI: 10.1093/annonc/mdy153] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
225 Belkaid Y, Harrison OJ. Homeostatic Immunity and the Microbiota. Immunity. 2017;46:562-576. [PMID: 28423337 DOI: 10.1016/j.immuni.2017.04.008] [Cited by in Crossref: 414] [Cited by in F6Publishing: 383] [Article Influence: 103.5] [Reference Citation Analysis]
226 Lam KC, Araya RE, Huang A, Chen Q, Di Modica M, Rodrigues RR, Lopès A, Johnson SB, Schwarz B, Bohrnsen E, Cogdill AP, Bosio CM, Wargo JA, Lee MP, Goldszmid RS. Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment. Cell 2021;184:5338-5356.e21. [PMID: 34624222 DOI: 10.1016/j.cell.2021.09.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
227 Singh A, Nayak N, Rathi P, Verma D, Sharma R, Chaudhary A, Agarwal A, Tripathi YB, Garg N. Microbiome and host crosstalk: A new paradigm to cancer therapy. Semin Cancer Biol 2021;70:71-84. [PMID: 32479952 DOI: 10.1016/j.semcancer.2020.05.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
228 Dong Z, Abbas MN, Kausar S, Yang J, Li L, Tan L, Cui H. Biological Functions and Molecular Mechanisms of Antibiotic Tigecycline in the Treatment of Cancers. Int J Mol Sci 2019;20:E3577. [PMID: 31336613 DOI: 10.3390/ijms20143577] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
229 Fong W, Li Q, Yu J. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer. Oncogene. 2020;39:4925-4943. [PMID: 32514151 DOI: 10.1038/s41388-020-1341-1] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 57.0] [Reference Citation Analysis]
230 Gligorijević V, Malod-Dognin N, Pržulj N. Integrative methods for analyzing big data in precision medicine. Proteomics 2016;16:741-58. [PMID: 26677817 DOI: 10.1002/pmic.201500396] [Cited by in Crossref: 107] [Cited by in F6Publishing: 70] [Article Influence: 21.4] [Reference Citation Analysis]
231 Zhang X, Chen BD, Zhao LD, Li H. The Gut Microbiota: Emerging Evidence in Autoimmune Diseases. Trends Mol Med. 2020;26:862-873. [PMID: 32402849 DOI: 10.1016/j.molmed.2020.04.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 28.0] [Reference Citation Analysis]
232 Scheid AD, Beadnell TC, Welch DR. Roles of mitochondria in the hallmarks of metastasis. Br J Cancer 2021;124:124-35. [PMID: 33144695 DOI: 10.1038/s41416-020-01125-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
233 Li J, Li J, Lyu N, Ma Y, Liu F, Feng Y, Yao L, Hou Z, Song X, Zhao H, Li X, Wang Y, Xiao C, Zhu B. Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX. Ther Adv Chronic Dis 2020;11:2040622320904293. [PMID: 32153743 DOI: 10.1177/2040622320904293] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
234 Li W, Deng X, Chen T. Exploring the Modulatory Effects of Gut Microbiota in Anti-Cancer Therapy. Front Oncol 2021;11:644454. [PMID: 33928033 DOI: 10.3389/fonc.2021.644454] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
235 Cheema AK, Maier I, Dowdy T, Wang Y, Singh R, Ruegger PM, Borneman J, Fornace AJ Jr, Schiestl RH. Chemopreventive Metabolites Are Correlated with a Change in Intestinal Microbiota Measured in A-T Mice and Decreased Carcinogenesis. PLoS One 2016;11:e0151190. [PMID: 27073845 DOI: 10.1371/journal.pone.0151190] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
236 Bingula R, Filaire E, Molnar I, Delmas E, Berthon JY, Vasson MP, Bernalier-Donadille A, Filaire M. Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: a cross-sectional clinical trial. Respir Res 2020;21:129. [PMID: 32450847 DOI: 10.1186/s12931-020-01392-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
237 Schubert ML, Rohrbach R, Schmitt M, Stein-Thoeringer CK. The Potential Role of the Intestinal Micromilieu and Individual Microbes in the Immunobiology of Chimeric Antigen Receptor T-Cell Therapy. Front Immunol 2021;12:670286. [PMID: 34135898 DOI: 10.3389/fimmu.2021.670286] [Reference Citation Analysis]
238 Tomela K, Pietrzak B, Schmidt M, Mackiewicz A. The Tumor and Host Immune Signature, and the Gut Microbiota as Predictive Biomarkers for Immune Checkpoint Inhibitor Response in Melanoma Patients. Life (Basel) 2020;10:E219. [PMID: 32992737 DOI: 10.3390/life10100219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
239 Sepich-poore GD, Zitvogel L, Straussman R, Hasty J, Wargo JA, Knight R. The microbiome and human cancer. Science 2021;371:eabc4552. [DOI: 10.1126/science.abc4552] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 27.0] [Reference Citation Analysis]
240 Khuat LT, Dave M, Murphy WJ. The emerging roles of the gut microbiome in allogeneic hematopoietic stem cell transplantation. Gut Microbes 2021;13:1966262. [PMID: 34455917 DOI: 10.1080/19490976.2021.1966262] [Reference Citation Analysis]
241 Routy B, Letendre C, Enot D, Chénard-Poirier M, Mehraj V, Séguin NC, Guenda K, Gagnon K, Woerther PL, Ghez D, Lachance S. The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation. Oncoimmunology 2017;6:e1258506. [PMID: 28197380 DOI: 10.1080/2162402X.2016.1258506] [Cited by in Crossref: 39] [Cited by in F6Publishing: 21] [Article Influence: 7.8] [Reference Citation Analysis]
242 Bao Y, Tang J, Qian Y, Sun T, Chen H, Chen Z, Sun D, Zhong M, Chen H, Hong J, Chen Y, Fang JY. Long noncoding RNA BFAL1 mediates enterotoxigenic Bacteroides fragilis-related carcinogenesis in colorectal cancer via the RHEB/mTOR pathway. Cell Death Dis 2019;10:675. [PMID: 31515468 DOI: 10.1038/s41419-019-1925-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
243 Galon J, Bruni D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat Rev Drug Discov 2019;18:197-218. [PMID: 30610226 DOI: 10.1038/s41573-018-0007-y] [Cited by in Crossref: 655] [Cited by in F6Publishing: 673] [Article Influence: 327.5] [Reference Citation Analysis]
244 Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B, Alegre ML, Chang EB, Gajewski TF. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015;350:1084-1089. [PMID: 26541606 DOI: 10.1126/science.aac4255] [Cited by in Crossref: 1472] [Cited by in F6Publishing: 1409] [Article Influence: 245.3] [Reference Citation Analysis]
245 Michaud M, Xie X, Bravo-San Pedro JM, Zitvogel L, White E, Kroemer G. An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy. Oncoimmunology 2014;3:e944047. [PMID: 25610726 DOI: 10.4161/21624011.2014.944047] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 7.7] [Reference Citation Analysis]
246 Nagasaka M, Sexton R, Alhasan R, Rahman S, Azmi AS, Sukari A. Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review. Crit Rev Oncol Hematol 2020;145:102841. [PMID: 31884204 DOI: 10.1016/j.critrevonc.2019.102841] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
247 Falana K, Knight R, Martin CR, Goldszmid R, Greathouse KL, Gere J, Young H, Kuo WP. Short Course in the Microbiome. J Circ Biomark 2015;4:8. [PMID: 28936244 DOI: 10.5772/61257] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
248 Iqbal S, Quigley EMM. Progress in Our Understanding of the Gut Microbiome: Implications for the Clinician. Curr Gastroenterol Rep 2016;18. [DOI: 10.1007/s11894-016-0524-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
249 Galan-Ros J, Ramos-Arenas V, Conesa-Zamora P. Predictive values of colon microbiota in the treatment response to colorectal cancer. Pharmacogenomics 2020;21:1045-59. [PMID: 32896201 DOI: 10.2217/pgs-2020-0044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
250 Brown JM, Hazen SL. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu Rev Med. 2015;66:343-359. [PMID: 25587655 DOI: 10.1146/annurev-med-060513-093205] [Cited by in Crossref: 198] [Cited by in F6Publishing: 181] [Article Influence: 33.0] [Reference Citation Analysis]
251 Thomsen M, Clarke S, Vitetta L. The role of adjuvant probiotics to attenuate intestinal inflammatory responses due to cancer treatments. Benef Microbes 2018;9:899-916. [PMID: 30232908 DOI: 10.3920/BM2017.0172] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
252 Joukar F, Mavaddati S, Mansour-Ghanaei F, Samadani AA. Gut Microbiota as a Positive Potential Therapeutic Factor in Carcinogenesis: an Overview of Microbiota-Targeted Therapy. J Gastrointest Cancer 2020;51:363-78. [PMID: 31025167 DOI: 10.1007/s12029-019-00237-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
253 Salmon H, Remark R, Gnjatic S, Merad M. Host tissue determinants of tumour immunity. Nat Rev Cancer 2019;19:215-27. [PMID: 30867580 DOI: 10.1038/s41568-019-0125-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 55] [Article Influence: 18.5] [Reference Citation Analysis]
254 Flint TR, Fearon DT, Janowitz T. Connecting the Metabolic and Immune Responses to Cancer. Trends Mol Med 2017;23:451-64. [PMID: 28396056 DOI: 10.1016/j.molmed.2017.03.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 8.5] [Reference Citation Analysis]
255 López de Las Hazas MC, Mosele JI, Macià A, Ludwig IA, Motilva MJ. Exploring the Colonic Metabolism of Grape and Strawberry Anthocyanins and Their in Vitro Apoptotic Effects in HT-29 Colon Cancer Cells. J Agric Food Chem 2017;65:6477-87. [PMID: 27790915 DOI: 10.1021/acs.jafc.6b04096] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 7.4] [Reference Citation Analysis]
256 Peric Z, Botti S, Stringer J, Krawczyk J, van der Werf S, van Biezen A, Aljurf M, Murray J, Liptrott S, Greenfield DM, Duarte RF, Ruutu T, Basak GW. Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMT. Bone Marrow Transplant 2018;53:1030-7. [PMID: 29515252 DOI: 10.1038/s41409-018-0137-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
257 Chen L, Tai WC, Brar MS, Leung FC, Hsiao WL. Tumor grafting induces changes of gut microbiota in athymic nude mice in the presence and absence of medicinal Gynostemma saponins. PLoS One. 2015;10:e0126807. [PMID: 25992551 DOI: 10.1371/journal.pone.0126807] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
258 Bisson JL, Fournier Q, Johnston E, Handel I, Bavcar S. Evaluation of a 0.75 × 109 /L absolute neutrophil count cut-off for antimicrobial prophylaxis in canine cancer chemotherapy patients. Vet Comp Oncol 2020;18:258-68. [PMID: 31600416 DOI: 10.1111/vco.12544] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
259 Matson V, Chervin CS, Gajewski TF. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy. Gastroenterology 2021;160:600-13. [PMID: 33253684 DOI: 10.1053/j.gastro.2020.11.041] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
260 Shono Y, van den Brink MRM. Empiric antibiotic use in allogeneic hematopoietic cell transplantation: should we avoid anaerobe coverage? Blood Adv 2017;1:2325-8. [PMID: 29296882 DOI: 10.1182/bloodadvances.2017005108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
261 Huyghe N, Baldin P, Van den Eynde M. Immunotherapy with immune checkpoint inhibitors in colorectal cancer: what is the future beyond deficient mismatch-repair tumours? Gastroenterol Rep (Oxf) 2020;8:11-24. [PMID: 32104582 DOI: 10.1093/gastro/goz061] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 13.0] [Reference Citation Analysis]
262 Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R. The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018;15:397-411. [PMID: 29748586 DOI: 10.1038/s41575-018-0011-z] [Cited by in Crossref: 301] [Cited by in F6Publishing: 300] [Article Influence: 150.5] [Reference Citation Analysis]
263 Garyu JW, Meffre E, Cotsapas C, Herold KC. Progress and challenges for treating Type 1 diabetes. J Autoimmun 2016;71:1-9. [PMID: 27210268 DOI: 10.1016/j.jaut.2016.04.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
264 Xu Y, Jia Y, Chen L, Gao J, Yang D. Effect of Streptococcus anginosus on biological response of tongue squamous cell carcinoma cells. BMC Oral Health 2021;21:141. [PMID: 33743656 DOI: 10.1186/s12903-021-01505-3] [Reference Citation Analysis]
265 Idris A, Hasnain SZ, Huat LZ, Koh D. Human diseases, immunity and the oral microbiota—Insights gained from metagenomic studies. Oral Science International 2017;14:27-32. [DOI: 10.1016/s1348-8643(16)30024-6] [Cited by in Crossref: 19] [Article Influence: 4.8] [Reference Citation Analysis]
266 Sampsell K, Hao D, Reimer RA. The Gut Microbiota: A Potential Gateway to Improved Health Outcomes in Breast Cancer Treatment and Survivorship. Int J Mol Sci 2020;21:E9239. [PMID: 33287442 DOI: 10.3390/ijms21239239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
267 Luo X, Zheng Y, Wen R, Deng X, Zhou L, Liao H. Effects of ceftriaxone induced intestinal dysbacteriosis on lymphocytes in different tissues in mice. Immunobiology 2016;221:994-1000. [DOI: 10.1016/j.imbio.2016.04.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
268 Xiao D, Ren W, Bin P, Chen S, Yin J, Gao W, Liu G, Nan Z, Hu X, He J. Chitosan lowers body weight through intestinal microbiota and reduces IL-17 expression via mTOR signalling. Journal of Functional Foods 2016;22:166-76. [DOI: 10.1016/j.jff.2016.01.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 4.4] [Reference Citation Analysis]
269 Kabwe M, Dashper S, Bachrach G, Tucci J. Bacteriophage manipulation of the microbiome associated with tumour microenvironments-can this improve cancer therapeutic response? FEMS Microbiol Rev 2021:fuab017. [PMID: 33765142 DOI: 10.1093/femsre/fuab017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
270 Chen L, Brar MS, Leung FC, Hsiao WL. Triterpenoid herbal saponins enhance beneficial bacteria, decrease sulfate-reducing bacteria, modulate inflammatory intestinal microenvironment and exert cancer preventive effects in ApcMin/+ mice. Oncotarget 2016;7:31226-42. [PMID: 27121311 DOI: 10.18632/oncotarget.8886] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 8.3] [Reference Citation Analysis]
271 Chen Y, Liu B, Wei Y, Kuang DM. Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy. Pharmacol Res 2021;174:105966. [PMID: 34728366 DOI: 10.1016/j.phrs.2021.105966] [Reference Citation Analysis]
272 Uchiyama AAT, Silva PAIA, Lopes MSM, Yen CT, Ricardo ED, Mutão T, Pimenta JR, Machado LM, Shimba DS, Peixoto RD. Proton Pump Inhibitors and Oncologic Treatment Efficacy: A Practical Review of the Literature for Oncologists. Curr Oncol 2021;28:783-99. [PMID: 33546228 DOI: 10.3390/curroncol28010076] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
273 Zitvogel L, Ayyoub M, Routy B, Kroemer G. Microbiome and Anticancer Immunosurveillance. Cell. 2016;165:276-287. [PMID: 27058662 DOI: 10.1016/j.cell.2016.03.001] [Cited by in Crossref: 203] [Cited by in F6Publishing: 192] [Article Influence: 40.6] [Reference Citation Analysis]
274 Crusz SM, Balkwill FR. Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol. 2015;12:584-596. [PMID: 26122183 DOI: 10.1038/nrclinonc.2015.105] [Cited by in Crossref: 466] [Cited by in F6Publishing: 466] [Article Influence: 77.7] [Reference Citation Analysis]
275 Araya RE, Goldszmid RS. Two Bugs a NOD Away from Improving Cancer Therapy Efficacy. Immunity 2016;45:714-6. [PMID: 27760335 DOI: 10.1016/j.immuni.2016.10.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
276 Grajeda-Iglesias C, Durand S, Daillère R, Iribarren K, Lemaitre F, Derosa L, Aprahamian F, Bossut N, Nirmalathasan N, Madeo F, Zitvogel L, Kroemer G. Oral administration of Akkermansia muciniphila elevates systemic antiaging and anticancer metabolites. Aging (Albany NY) 2021;13:6375-405. [PMID: 33653967 DOI: 10.18632/aging.202739] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
277 Mukaida N. Intestinal microbiota: unexpected alliance with tumor therapy. Immunotherapy 2014;6:231-3. [PMID: 24762069 DOI: 10.2217/imt.13.170] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
278 Peng J, Xu H, Chen Y, Wang W, Zhu L, Shao Y, Wang J. Screening for therapeutic targets of tumor angiogenesis signatures in 31 cancer types and potential insights. Biochem Biophys Res Commun 2019;508:465-71. [PMID: 30503499 DOI: 10.1016/j.bbrc.2018.11.095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
279 Wang D, Zhu X, Tang X, Li H, Yizhen X, Chen D. Auxiliary antitumor effects of fungal proteins from Hericium erinaceus by target on the gut microbiota. J Food Sci 2020;85:1872-90. [PMID: 32460371 DOI: 10.1111/1750-3841.15134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
280 Wang F, Wang S, Zhou Q. The Resistance Mechanisms of Lung Cancer Immunotherapy. Front Oncol 2020;10:568059. [PMID: 33194652 DOI: 10.3389/fonc.2020.568059] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
281 He Y, Wen Q, Yao F, Xu D, Huang Y, Wang J. Gut-lung axis: The microbial contributions and clinical implications. Crit Rev Microbiol 2017;43:81-95. [PMID: 27781554 DOI: 10.1080/1040841X.2016.1176988] [Cited by in Crossref: 79] [Cited by in F6Publishing: 55] [Article Influence: 15.8] [Reference Citation Analysis]
282 Alexander JL, Wilson ID, Teare J, Marchesi JR, Nicholson JK, Kinross JM. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol. 2017;14:356-365. [PMID: 28270698 DOI: 10.1038/nrgastro.2017.20] [Cited by in Crossref: 285] [Cited by in F6Publishing: 284] [Article Influence: 71.3] [Reference Citation Analysis]
283 Chen Y, Yang Y, Gu J. Clinical Implications of the Associations Between Intestinal Microbiome and Colorectal Cancer Progression. Cancer Manag Res 2020;12:4117-28. [PMID: 32606919 DOI: 10.2147/CMAR.S240108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
284 Vetizou M, Trinchieri G. Anti-PD1 in the wonder-gut-land. Cell Res 2018;28:263-4. [PMID: 29336431 DOI: 10.1038/cr.2018.12] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
285 Mehrian-Shai R, Reichardt JKV, Harris CC, Toren A. The Gut-Brain Axis, Paving the Way to Brain Cancer. Trends Cancer 2019;5:200-7. [PMID: 30961828 DOI: 10.1016/j.trecan.2019.02.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
286 Behrouzi A, Nafari AH, Siadat SD. The significance of microbiome in personalized medicine. Clin Transl Med 2019;8:16. [PMID: 31081530 DOI: 10.1186/s40169-019-0232-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 12.5] [Reference Citation Analysis]
287 Liu Y, Han Y, Zeng S, Shen H. In respond to commensal bacteria: γδT cells play a pleiotropic role in tumor immunity. Cell Biosci 2021;11:48. [PMID: 33653419 DOI: 10.1186/s13578-021-00565-w] [Reference Citation Analysis]
288 Topol EJ. Individualized medicine from prewomb to tomb. Cell 2014;157:241-53. [PMID: 24679539 DOI: 10.1016/j.cell.2014.02.012] [Cited by in Crossref: 175] [Cited by in F6Publishing: 139] [Article Influence: 25.0] [Reference Citation Analysis]
289 Zama D, Biagi E, Masetti R, Gasperini P, Prete A, Candela M, Brigidi P, Pession A. Gut microbiota and hematopoietic stem cell transplantation: where do we stand? Bone Marrow Transplant 2017;52:7-14. [PMID: 27348539 DOI: 10.1038/bmt.2016.173] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
290 Kim SY, Shin JS, Chung KS, Han HS, Lee HH, Lee JH, Kim SY, Ji YW, Ha Y, Kang J, Rhee YK, Lee KT. Immunostimulatory Effects of Live Lactobacillus sakei K040706 on the CYP-Induced Immunosuppression Mouse Model. Nutrients 2020;12:E3573. [PMID: 33266362 DOI: 10.3390/nu12113573] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
291 Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature. 2017;541:321-330. [PMID: 28102259 DOI: 10.1038/nature21349] [Cited by in Crossref: 1633] [Cited by in F6Publishing: 1588] [Article Influence: 408.3] [Reference Citation Analysis]
292 Hou Q, Xu H. Rational Discovery of Response Biomarkers: Candidate Prognostic Factors and Biomarkers for Checkpoint Inhibitor-Based Immunotherapy. Adv Exp Med Biol 2020;1248:143-66. [PMID: 32185710 DOI: 10.1007/978-981-15-3266-5_7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
293 Schaupp L, Muth S, Rogell L, Kofoed-Branzk M, Melchior F, Lienenklaus S, Ganal-Vonarburg SC, Klein M, Guendel F, Hain T, Schütze K, Grundmann U, Schmitt V, Dorsch M, Spanier J, Larsen PK, Schwanz T, Jäckel S, Reinhardt C, Bopp T, Danckwardt S, Mahnke K, Heinz GA, Mashreghi MF, Durek P, Kalinke U, Kretz O, Huber TB, Weiss S, Wilhelm C, Macpherson AJ, Schild H, Diefenbach A, Probst HC. Microbiota-Induced Type I Interferons Instruct a Poised Basal State of Dendritic Cells. Cell 2020;181:1080-1096.e19. [PMID: 32380006 DOI: 10.1016/j.cell.2020.04.022] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 32.0] [Reference Citation Analysis]
294 García-Castillo V, Sanhueza E, McNerney E, Onate SA, García A. Microbiota dysbiosis: a new piece in the understanding of the carcinogenesis puzzle. J Med Microbiol 2016;65:1347-62. [PMID: 27902422 DOI: 10.1099/jmm.0.000371] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 8.8] [Reference Citation Analysis]
295 Teoh F, Pavelka N. How Chemotherapy Increases the Risk of Systemic Candidiasis in Cancer Patients: Current Paradigm and Future Directions. Pathogens 2016;5:E6. [PMID: 26784236 DOI: 10.3390/pathogens5010006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
296 Frank M, Hennenberg EM, Eyking A, Rünzi M, Gerken G, Scott P, Parkhill J, Walker AW, Cario E. TLR signaling modulates side effects of anticancer therapy in the small intestine. J Immunol 2015;194:1983-95. [PMID: 25589072 DOI: 10.4049/jimmunol.1402481] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 8.8] [Reference Citation Analysis]
297 Sun S, Wang F. Molecular Events Behind Adverse Effects. Adv Exp Med Biol 2020;1248:119-41. [PMID: 32185709 DOI: 10.1007/978-981-15-3266-5_6] [Reference Citation Analysis]
298 Chattopadhyay I, Nandi D, Nag A. The pint- sized powerhouse: Illuminating the mighty role of the gut microbiome in improving the outcome of anti- cancer therapy. Semin Cancer Biol 2021;70:98-111. [PMID: 32739479 DOI: 10.1016/j.semcancer.2020.07.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
299 Li H, He J, Jia W. The influence of gut microbiota on drug metabolism and toxicity. Expert Opin Drug Metab Toxicol 2016;12:31-40. [PMID: 26569070 DOI: 10.1517/17425255.2016.1121234] [Cited by in Crossref: 98] [Cited by in F6Publishing: 89] [Article Influence: 16.3] [Reference Citation Analysis]
300 Ursell LK, Haiser HJ, Van Treuren W, Garg N, Reddivari L, Vanamala J, Dorrestein PC, Turnbaugh PJ, Knight R. The intestinal metabolome: an intersection between microbiota and host. Gastroenterology 2014;146:1470-6. [PMID: 24631493 DOI: 10.1053/j.gastro.2014.03.001] [Cited by in Crossref: 133] [Cited by in F6Publishing: 117] [Article Influence: 19.0] [Reference Citation Analysis]
301 Zitvogel L, Daillère R, Roberti MP, Routy B, Kroemer G. Anticancer effects of the microbiome and its products. Nat Rev Microbiol 2017;15:465-78. [PMID: 28529325 DOI: 10.1038/nrmicro.2017.44] [Cited by in Crossref: 205] [Cited by in F6Publishing: 179] [Article Influence: 51.3] [Reference Citation Analysis]
302 Bingula R, Filaire M, Radosevic-Robin N, Berthon JY, Bernalier-Donadille A, Vasson MP, Thivat E, Kwiatkowski F, Filaire E. Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma: Study protocol for case-control observational trial. Medicine (Baltimore) 2018;97:e13676. [PMID: 30558074 DOI: 10.1097/MD.0000000000013676] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
303 Halsey T, Ologun G, Wargo J, Jenq RR. Uncovering the role of the gut microbiota in immune checkpoint blockade therapy: A mini-review. Semin Hematol 2020;57:13-8. [PMID: 32690139 DOI: 10.1053/j.seminhematol.2020.05.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
304 Karin M, Jobin C, Balkwill F. Chemotherapy, immunity and microbiota--a new triumvirate? Nat Med 2014;20:126-7. [PMID: 24504404 DOI: 10.1038/nm.3473] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
305 Pérez-ruiz E, Jiménez-castro J, Berciano-guerrero M, Valdivia J, Estalella-mendoza S, Toscano F, Rodriguez de la Borbolla Artacho M, Garrido-siles M, Martínez-bautista MJ, Villatoro Roldan R, Rivas-ruiz F, Nogales-fernández E, Morales C, Pérez-valderrama B, De la Cruz-merino L, Rueda A. Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice. Clin Transl Oncol 2020;22:1778-85. [DOI: 10.1007/s12094-020-02315-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
306 Yeruva T, Lee CH. Regulation of Vaginal Microbiome by Nitric Oxide. Curr Pharm Biotechnol 2019;20:17-31. [PMID: 30727888 DOI: 10.2174/1389201020666190207092850] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
307 Cario E. Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity. Current Opinion in Supportive & Palliative Care 2016;10:157-64. [DOI: 10.1097/spc.0000000000000202] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 5.2] [Reference Citation Analysis]
308 Manfredonia C, Muraro MG, Hirt C, Mele V, Governa V, Papadimitropoulos A, Däster S, Soysal SD, Droeser RA, Mechera R, Oertli D, Rosso R, Bolli M, Zettl A, Terracciano LM, Spagnoli GC, Martin I, Iezzi G. Maintenance of Primary Human Colorectal Cancer Microenvironment Using a Perfusion Bioreactor-Based 3D Culture System. Adv Biosyst 2019;3:e1800300. [PMID: 32627426 DOI: 10.1002/adbi.201800300] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
309 Bisson JL, Argyle DJ, Argyle SA. Antibiotic prophylaxis in veterinary cancer chemotherapy: A review and recommendations. Vet Comp Oncol 2018;16:301-10. [PMID: 29892997 DOI: 10.1111/vco.12406] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
310 Wang WL, Xu SY, Ren ZG, Tao L, Jiang JW, Zheng SS. Application of metagenomics in the human gut microbiome. World J Gastroenterol 2015; 21(3): 803-814 [PMID: 25624713 DOI: 10.3748/wjg.v21.i3.803] [Cited by in CrossRef: 174] [Cited by in F6Publishing: 128] [Article Influence: 29.0] [Reference Citation Analysis]
311 Fu YP, Feng B, Zhu ZK, Feng X, Chen SF, Li LX, Yin ZQ, Huang C, Chen XF, Zhang BZ, Jia RY, Song X, Lv C, Yue GZ, Ye G, Liang XX, He CL, Yin LZ, Zou YF. The Polysaccharides from Codonopsis pilosula Modulates the Immunity and Intestinal Microbiota of Cyclophosphamide-Treated Immunosuppressed Mice. Molecules 2018;23:E1801. [PMID: 30037030 DOI: 10.3390/molecules23071801] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 11.0] [Reference Citation Analysis]
312 Li Y, Liu H, Qi H, Tang W, Zhang C, Liu Z, Liu Y, Wei X, Kong Z, Jia S, Du B, Yuan J, Wang C, Li M. Probiotic fermentation of Ganoderma lucidum fruiting body extracts promoted its immunostimulatory activity in mice with dexamethasone-induced immunosuppression. Biomed Pharmacother 2021;141:111909. [PMID: 34328088 DOI: 10.1016/j.biopha.2021.111909] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
313 Grainger J, Daw R, Wemyss K. Systemic instruction of cell-mediated immunity by the intestinal microbiome. F1000Res 2018;7:F1000 Faculty Rev-1910. [PMID: 30631436 DOI: 10.12688/f1000research.14633.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
314 Shono Y, Docampo MD, Peled JU, Perobelli SM, Jenq RR. Intestinal microbiota-related effects on graft-versus-host disease. Int J Hematol 2015;101:428-37. [PMID: 25812838 DOI: 10.1007/s12185-015-1781-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
315 Lucafò M, Franzin M, Lagatolla C, Franca R, Bramuzzo M, Stocco G, Decorti G. Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients. Clin Transl Sci 2020;13:238-59. [PMID: 31675176 DOI: 10.1111/cts.12722] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
316 Fidelle M, Yonekura S, Picard M, Cogdill A, Hollebecque A, Roberti MP, Zitvogel L. Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota. Front Immunol 2020;11:600886. [PMID: 33381121 DOI: 10.3389/fimmu.2020.600886] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
317 Feng P, Cao Z, Wang X, Li J, Liu J. On‐Demand Bacterial Reactivation by Restraining within a Triggerable Nanocoating. Adv Mater 2020;32:2002406. [DOI: 10.1002/adma.202002406] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
318 Gudiol C, Albasanz-Puig A, Cuervo G, Carratalà J. Understanding and Managing Sepsis in Patients With Cancer in the Era of Antimicrobial Resistance. Front Med (Lausanne) 2021;8:636547. [PMID: 33869250 DOI: 10.3389/fmed.2021.636547] [Reference Citation Analysis]
319 Chen L, Zhai Y, Wang Y, Fearon ER, Núñez G, Inohara N, Cho KR. Altering the Microbiome Inhibits Tumorigenesis in a Mouse Model of Oviductal High-Grade Serous Carcinoma. Cancer Res 2021;81:3309-18. [PMID: 33863776 DOI: 10.1158/0008-5472.CAN-21-0106] [Reference Citation Analysis]
320 VanSeggelen H, Hammill JA, Dvorkin-Gheva A, Tantalo DG, Kwiecien JM, Denisova GF, Rabinovich B, Wan Y, Bramson JL. T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice. Mol Ther 2015;23:1600-10. [PMID: 26122933 DOI: 10.1038/mt.2015.119] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 7.3] [Reference Citation Analysis]
321 Patterson AD, Turnbaugh PJ. Microbial determinants of biochemical individuality and their impact on toxicology and pharmacology. Cell Metab 2014;20:761-8. [PMID: 25156450 DOI: 10.1016/j.cmet.2014.07.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
322 Lv L, Mu D, Du Y, Yan R, Jiang H. Mechanism of the Immunomodulatory Effect of the Combination of Live Bifidobacterium, Lactobacillus, Enterococcus, and Bacillus on Immunocompromised Rats. Front Immunol 2021;12:694344. [PMID: 34211480 DOI: 10.3389/fimmu.2021.694344] [Reference Citation Analysis]
323 Haiser HJ, Seim KL, Balskus EP, Turnbaugh PJ. Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics. Gut Microbes 2014;5:233-8. [PMID: 24637603 DOI: 10.4161/gmic.27915] [Cited by in Crossref: 85] [Cited by in F6Publishing: 67] [Article Influence: 12.1] [Reference Citation Analysis]
324 Zhang YJ, Li S, Gan RY, Zhou T, Xu DP, Li HB. Impacts of gut bacteria on human health and diseases. Int J Mol Sci. 2015;16:7493-7519. [PMID: 25849657 DOI: 10.3390/ijms16047493] [Cited by in Crossref: 325] [Cited by in F6Publishing: 278] [Article Influence: 54.2] [Reference Citation Analysis]
325 Liu H, Li J, Guo X, Liang Y, Wang W. Yeast culture dietary supplementation modulates gut microbiota, growth and biochemical parameters of grass carp. Microb Biotechnol 2018;11:551-65. [PMID: 29578305 DOI: 10.1111/1751-7915.13261] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
326 Guglielmi G. How gut microbes are joining the fight against cancer. Nature 2018;557:482-4. [PMID: 29795257 DOI: 10.1038/d41586-018-05208-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
327 Obermajer N, Dahlke MH. (Compl)Ex-Th17-Treg cell inter-relationship. Oncoimmunology 2016;5:e1040217. [PMID: 26942054 DOI: 10.1080/2162402X.2015.1040217] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
328 Fischer JC, Bscheider M, Eisenkolb G, Lin CC, Wintges A, Otten V, Lindemans CA, Heidegger S, Rudelius M, Monette S, Porosnicu Rodriguez KA, Calafiore M, Liebermann S, Liu C, Lienenklaus S, Weiss S, Kalinke U, Ruland J, Peschel C, Shono Y, Docampo M, Velardi E, Jenq RR, Hanash AM, Dudakov JA, Haas T, van den Brink MRM, Poeck H. RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury. Sci Transl Med 2017;9:eaag2513. [PMID: 28424327 DOI: 10.1126/scitranslmed.aag2513] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 15.3] [Reference Citation Analysis]
329 Sharma AK, Jaiswal SK, Chaudhary N, Sharma VK. A novel approach for the prediction of species-specific biotransformation of xenobiotic/drug molecules by the human gut microbiota. Sci Rep 2017;7:9751. [PMID: 28852076 DOI: 10.1038/s41598-017-10203-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
330 Lione L, Salvatori E, Petrazzuolo A, Massacci A, Maggio R, Confroti A, Compagnone M, Aurisicchio L, Ciliberto G, Palombo F. Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition. Oncoimmunology 2021;10:1898832. [PMID: 33796408 DOI: 10.1080/2162402X.2021.1898832] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
331 Cheng WY, Wu CY, Yu J. The role of gut microbiota in cancer treatment: friend or foe? Gut 2020;69:1867-76. [PMID: 32759302 DOI: 10.1136/gutjnl-2020-321153] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 25.0] [Reference Citation Analysis]
332 Cavallari M, De Libero G. From Immunologically Archaic to Neoteric Glycovaccines. Vaccines (Basel) 2017;5:E4. [PMID: 28134792 DOI: 10.3390/vaccines5010004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
333 Vacante M, Ciuni R, Basile F, Biondi A. Gut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence. Biomedicines. 2020;8. [PMID: 33182693 DOI: 10.3390/biomedicines8110489] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
334 Mosedale M, Watkins PB. Understanding Idiosyncratic Toxicity: Lessons Learned from Drug-Induced Liver Injury. J Med Chem 2020;63:6436-61. [PMID: 32037821 DOI: 10.1021/acs.jmedchem.9b01297] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 13.0] [Reference Citation Analysis]
335 Miyahira AK, Roychowdhury S, Goswami S, Ippolito JE, Priceman SJ, Pritchard CC, Sfanos KS, Subudhi SK, Simons JW, Pienta KJ, Soule HR. Beyond Seed and Soil: Understanding and Targeting Metastatic Prostate Cancer; Report From the 2016 Coffey-Holden Prostate Cancer Academy Meeting. Prostate 2017;77:123-44. [PMID: 27679977 DOI: 10.1002/pros.23260] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
336 Bingula R, Filaire M, Radosevic-Robin N, Bey M, Berthon JY, Bernalier-Donadille A, Vasson MP, Filaire E. Desired Turbulence? Gut-Lung Axis, Immunity, and Lung Cancer. J Oncol 2017;2017:5035371. [PMID: 29075294 DOI: 10.1155/2017/5035371] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 17.3] [Reference Citation Analysis]
337 Fiebiger U, Bereswill S, Heimesaat MM. Dissecting the Interplay Between Intestinal Microbiota and Host Immunity in Health and Disease: Lessons Learned from Germfree and Gnotobiotic Animal Models. Eur J Microbiol Immunol (Bp) 2016;6:253-71. [PMID: 27980855 DOI: 10.1556/1886.2016.00036] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 13.4] [Reference Citation Analysis]
338 Daillère R, Vétizou M, Waldschmitt N, Yamazaki T, Isnard C, Poirier-Colame V, Duong CPM, Flament C, Lepage P, Roberti MP, Routy B, Jacquelot N, Apetoh L, Becharef S, Rusakiewicz S, Langella P, Sokol H, Kroemer G, Enot D, Roux A, Eggermont A, Tartour E, Johannes L, Woerther PL, Chachaty E, Soria JC, Golden E, Formenti S, Plebanski M, Madondo M, Rosenstiel P, Raoult D, Cattoir V, Boneca IG, Chamaillard M, Zitvogel L. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. Immunity 2016;45:931-43. [PMID: 27717798 DOI: 10.1016/j.immuni.2016.09.009] [Cited by in Crossref: 298] [Cited by in F6Publishing: 282] [Article Influence: 59.6] [Reference Citation Analysis]
339 Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E. Dysbiosis and the immune system. Nat Rev Immunol 2017;17:219-32. [DOI: 10.1038/nri.2017.7] [Cited by in Crossref: 464] [Cited by in F6Publishing: 432] [Article Influence: 116.0] [Reference Citation Analysis]
340 Englinger B, Pirker C, Heffeter P, Terenzi A, Kowol CR, Keppler BK, Berger W. Metal Drugs and the Anticancer Immune Response. Chem Rev 2019;119:1519-624. [DOI: 10.1021/acs.chemrev.8b00396] [Cited by in Crossref: 108] [Cited by in F6Publishing: 91] [Article Influence: 36.0] [Reference Citation Analysis]
341 Jenkins SV, Alimohammadi M, Terry AS, Griffin RJ, Tackett AJ, Leung JW, Vang KB, Byrum SD, Dings RPM. Dysbiotic stress increases the sensitivity of the tumor vasculature to radiotherapy and c-Met inhibitors. Angiogenesis 2021;24:597-611. [PMID: 33629198 DOI: 10.1007/s10456-021-09771-z] [Reference Citation Analysis]
342 Zhu G, Jiang Y, Yao Y, Wu N, Luo J, Hu M, Tu Y, Xu M. Ovotransferrin ameliorates the dysbiosis of immunomodulatory function and intestinal microbiota induced by cyclophosphamide. Food Funct 2019;10:1109-22. [PMID: 30724290 DOI: 10.1039/c8fo02312c] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 11.5] [Reference Citation Analysis]
343 Chase D, Goulder A, Zenhausern F, Monk B, Herbst-Kralovetz M. The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment. Gynecol Oncol. 2015;138:190-200. [PMID: 25957158 DOI: 10.1016/j.ygyno.2015.04.036] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 9.8] [Reference Citation Analysis]
344 Pflug N, Kluth S, Vehreschild JJ, Bahlo J, Tacke D, Biehl L, Eichhorst B, Fischer K, Cramer P, Fink AM, von Bergwelt-Baildon M, Stilgenbauer S, Hallek M, Cornely OA, Vehreschild MJ. Efficacy of antineoplastic treatment is associated with the use of antibiotics that modulate intestinal microbiota. Oncoimmunology 2016;5:e1150399. [PMID: 27471619 DOI: 10.1080/2162402X.2016.1150399] [Cited by in Crossref: 44] [Cited by in F6Publishing: 20] [Article Influence: 8.8] [Reference Citation Analysis]
345 Ma Y, Yang H, Pitt JM, Kroemer G, Zitvogel L. Therapy-induced microenvironmental changes in cancer. J Mol Med 2016;94:497-508. [DOI: 10.1007/s00109-016-1401-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
346 Botticelli A, Zizzari I, Mazzuca F, Ascierto PA, Putignani L, Marchetti L, Napoletano C, Nuti M, Marchetti P. Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment. Oncotarget 2017;8:8890-9. [PMID: 27806346 DOI: 10.18632/oncotarget.12985] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 10.7] [Reference Citation Analysis]
347 Zhou J, Wu J, Wu CY, Long F, Shen H, Zhang W, Li SL. Herb-drug interaction: A case study of effects and involved mechanisms of cisplatin on the pharmacokinetics of ginsenoside Rb1 in tumor-bearing mice. Biomed Pharmacother 2019;110:95-104. [PMID: 30466007 DOI: 10.1016/j.biopha.2018.11.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
348 Plotnikoff GA. Three measurable and modifiable enteric microbial biotransformations relevant to cancer prevention and treatment. Glob Adv Health Med. 2014;3:33-43. [PMID: 24891992 DOI: 10.7453/gahmj.2014.021] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
349 Rajani C, Jia W. Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders. Clin Sci (Lond) 2018;132:791-811. [PMID: 29661926 DOI: 10.1042/CS20171328] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
350 Majchrzak K, Nelson MH, Bailey SR, Bowers JS, Yu XZ, Rubinstein MP, Himes RA, Paulos CM. Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic. Cancer Immunol Immunother 2016;65:247-59. [PMID: 26825102 DOI: 10.1007/s00262-016-1797-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
351 Nenclares P, Bhide SA, Sandoval-Insausti H, Pialat P, Gunn L, Melcher A, Newbold K, Nutting CM, Harrington KJ. Impact of antibiotic use during curative treatment of locally advanced head and neck cancers with chemotherapy and radiotherapy. Eur J Cancer 2020;131:9-15. [PMID: 32248073 DOI: 10.1016/j.ejca.2020.02.047] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
352 Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15:e493-e503. [PMID: 25281468 DOI: 10.1016/s1470-2045(14)70263-3] [Cited by in Crossref: 667] [Cited by in F6Publishing: 482] [Article Influence: 111.2] [Reference Citation Analysis]
353 Lu H, Ren Z, Li A, Zhang H, Jiang J, Xu S, Luo Q, Zhou K, Sun X, Zheng S, Li L. Deep sequencing reveals microbiota dysbiosis of tongue coat in patients with liver carcinoma. Sci Rep. 2016;6:33142. [PMID: 27605161 DOI: 10.1038/srep33142] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 10.0] [Reference Citation Analysis]
354 Papadimitriou K, Zoumpopoulou G, Foligné B, Alexandraki V, Kazou M, Pot B, Tsakalidou E. Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches. Front Microbiol 2015;6:58. [PMID: 25741323 DOI: 10.3389/fmicb.2015.00058] [Cited by in Crossref: 141] [Cited by in F6Publishing: 107] [Article Influence: 23.5] [Reference Citation Analysis]
355 Xu X, Yang J, Ning Z, Zhang X. Proteomic analysis of intestinal tissues from mice fed with Lentinula edodes-derived polysaccharides. Food Funct 2016;7:250-61. [DOI: 10.1039/c5fo00904a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
356 Rutkowski MR, Stephen TL, Svoronos N, Allegrezza MJ, Tesone AJ, Perales-Puchalt A, Brencicova E, Escovar-Fadul X, Nguyen JM, Cadungog MG. Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation. Cancer Cell. 2015;27:27-40. [PMID: 25533336 DOI: 10.1016/j.ccell.2014.11.009] [Cited by in Crossref: 167] [Cited by in F6Publishing: 154] [Article Influence: 23.9] [Reference Citation Analysis]
357 Andón FT, Fadeel B. Nanotoxicology: Towards Safety by Design. In: Alonso MJ, Garcia-fuentes M, editors. Nano-Oncologicals. Cham: Springer International Publishing; 2014. pp. 391-424. [DOI: 10.1007/978-3-319-08084-0_14] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
358 Mirouse A, Vigneron C, Llitjos JF, Chiche JD, Mira JP, Mokart D, Azoulay E, Pène F. Sepsis and Cancer: An Interplay of Friends and Foes. Am J Respir Crit Care Med 2020;202:1625-35. [PMID: 32813980 DOI: 10.1164/rccm.202004-1116TR] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
359 Chen B, Du G, Guo J, Zhang Y. Bugs, drugs, and cancer: can the microbiome be a potential therapeutic target for cancer management? Drug Discov Today 2019;24:1000-9. [PMID: 30818030 DOI: 10.1016/j.drudis.2019.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
360 Bikel S, Valdez-Lara A, Cornejo-Granados F, Rico K, Canizales-Quinteros S, Soberón X, Del Pozo-Yauner L, Ochoa-Leyva A. Combining metagenomics, metatranscriptomics and viromics to explore novel microbial interactions: towards a systems-level understanding of human microbiome. Comput Struct Biotechnol J 2015;13:390-401. [PMID: 26137199 DOI: 10.1016/j.csbj.2015.06.001] [Cited by in Crossref: 110] [Cited by in F6Publishing: 90] [Article Influence: 18.3] [Reference Citation Analysis]
361 Wang C, Yang S, Gao L, Wang L, Cao L. Carboxymethyl pachyman (CMP) reduces intestinal mucositis and regulates the intestinal microflora in 5-fluorouracil-treated CT26 tumour-bearing mice. Food Funct 2018;9:2695-704. [PMID: 29756138 DOI: 10.1039/c7fo01886j] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
362 Shao Y, Jiang Y, Li H, Zhang F, Hu Z, Zheng S. Characteristics of mouse intestinal microbiota during acute liver injury and repair following 50% partial hepatectomy. Exp Ther Med 2021;22:953. [PMID: 34335895 DOI: 10.3892/etm.2021.10385] [Reference Citation Analysis]
363 McQuade JL, Ologun GO, Arora R, Wargo JA. Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers. Curr Oncol Rep 2020;22:74. [PMID: 32577835 DOI: 10.1007/s11912-020-00913-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
364 Peled JU, Devlin SM, Staffas A, Lumish M, Khanin R, Littmann ER, Ling L, Kosuri S, Maloy M, Slingerland JB, Ahr KF, Porosnicu Rodriguez KA, Shono Y, Slingerland AE, Docampo MD, Sung AD, Weber D, Alousi AM, Gyurkocza B, Ponce DM, Barker JN, Perales MA, Giralt SA, Taur Y, Pamer EG, Jenq RR, van den Brink MRM. Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation. J Clin Oncol 2017;35:1650-9. [PMID: 28296584 DOI: 10.1200/JCO.2016.70.3348] [Cited by in Crossref: 141] [Cited by in F6Publishing: 92] [Article Influence: 35.3] [Reference Citation Analysis]
365 Yan X, Zhang S, Deng Y, Wang P, Hou Q, Xu H. Prognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New Evidences. Front Pharmacol 2018;9:1050. [PMID: 30294272 DOI: 10.3389/fphar.2018.01050] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
366 Brandi G, De Lorenzo S, Candela M, Pantaleo MA, Bellentani S, Tovoli F, Saccoccio G, Biasco G. Microbiota, NASH, HCC and the potential role of probiotics. Carcinogenesis 2017;38:231-40. [DOI: 10.1093/carcin/bgx007] [Cited by in Crossref: 104] [Cited by in F6Publishing: 47] [Article Influence: 26.0] [Reference Citation Analysis]
367 Wang Z, Xiao R, Huang J, Qin X, Hu D, Guo E, Liu C, Lu F, You L, Sun C, Chen G. The Diversity of Vaginal Microbiota Predicts Neoadjuvant Chemotherapy Responsiveness in Locally Advanced Cervical Cancer. Microb Ecol 2021. [PMID: 34405250 DOI: 10.1007/s00248-021-01800-0] [Reference Citation Analysis]
368 Spanogiannopoulos P, Bess EN, Carmody RN, Turnbaugh PJ. The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism. Nat Rev Microbiol. 2016;14:273-287. [PMID: 26972811 DOI: 10.1038/nrmicro.2016.17] [Cited by in Crossref: 341] [Cited by in F6Publishing: 298] [Article Influence: 68.2] [Reference Citation Analysis]
369 Staudinger T, Pène F. Current insights into severe sepsis in cancer patients. Rev Bras Ter Intensiva 2014;26:335-8. [PMID: 25607260 DOI: 10.5935/0103-507X.20140051] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.6] [Reference Citation Analysis]
370 Veziant J, Poirot K, Chevarin C, Cassagnes L, Sauvanet P, Chassaing B, Robin F, Godfraind C, Barnich N, Pezet D, Pereira B, Gagniere J, Bonnet M. Prognostic value of a combination of innovative factors (gut microbiota, sarcopenia, obesity, metabolic syndrome) to predict surgical/oncologic outcomes following surgery for sporadic colorectal cancer: a prospective cohort study protocol (METABIOTE). BMJ Open 2020;10:e031472. [PMID: 31915159 DOI: 10.1136/bmjopen-2019-031472] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
371 Cogdill AP, Gaudreau PO, Arora R, Gopalakrishnan V, Wargo JA. The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy. Trends Immunol 2018;39:900-20. [PMID: 30392721 DOI: 10.1016/j.it.2018.09.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 14.0] [Reference Citation Analysis]
372 Armstrong H, Bording-Jorgensen M, Dijk S, Wine E. The Complex Interplay between Chronic Inflammation, the Microbiome, and Cancer: Understanding Disease Progression and What We Can Do to Prevent It. Cancers (Basel) 2018;10:E83. [PMID: 29558443 DOI: 10.3390/cancers10030083] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 12.0] [Reference Citation Analysis]
373 Gunduz M, Murakami D, Gunduz I, Tamagawa S, Hiraoka M, Sugita G, Hotomi M. Recurrent bacterial translocation from gut and sepsis in Head and neck cancer patients and its prevention by probiotics. Med Hypotheses 2018;120:124-7. [PMID: 30220331 DOI: 10.1016/j.mehy.2018.08.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
374 Fang C, Wu L, Zhu C, Xie WZ, Hu H, Zeng XT. A potential therapeutic strategy for prostatic disease by targeting the oral microbiome. Med Res Rev 2021;41:1812-34. [PMID: 33377531 DOI: 10.1002/med.21778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
375 Rutkowski MR, Svoronos N, Perales-Puchalt A, Conejo-Garcia JR. The Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor Beds. Adv Cancer Res 2015;128:235-62. [PMID: 26216635 DOI: 10.1016/bs.acr.2015.04.011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 5.7] [Reference Citation Analysis]
376 Liu Y, Jiang H. Compositional differences of gut microbiome in matched hormone-sensitive and castration-resistant prostate cancer. Transl Androl Urol 2020;9:1937-44. [PMID: 33209658 DOI: 10.21037/tau-20-566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
377 Perez-Chanona E, Trinchieri G. The role of microbiota in cancer therapy. Curr Opin Immunol 2016;39:75-81. [PMID: 26820225 DOI: 10.1016/j.coi.2016.01.003] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 9.8] [Reference Citation Analysis]
378 Goc J, Hepworth MR, Sonnenberg GF. Group 3 innate lymphoid cells: regulating host-commensal bacteria interactions in inflammation and cancer. Int Immunol 2016;28:43-52. [PMID: 26451009 DOI: 10.1093/intimm/dxv056] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
379 Zhou CB, Zhou YL, Fang JY. Gut Microbiota in Cancer Immune Response and Immunotherapy. Trends Cancer 2021;7:647-60. [PMID: 33674230 DOI: 10.1016/j.trecan.2021.01.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
380 Krezalek MA, Skowron KB, Guyton KL, Shakhsheer B, Hyoju S, Alverdy JC. The intestinal microbiome and surgical disease. Curr Probl Surg 2016;53:257-93. [PMID: 27497246 DOI: 10.1067/j.cpsurg.2016.06.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
381 Delahousse J, Skarbek C, Desbois M, Perfettini JL, Chaput N, Paci A. Oxazaphosphorines combined with immune checkpoint blockers: dose-dependent tuning between immune and cytotoxic effects. J Immunother Cancer 2020;8:e000916. [PMID: 32784216 DOI: 10.1136/jitc-2020-000916] [Reference Citation Analysis]
382 Chan SL. Microbiome and cancer treatment: Are we ready to apply in clinics? Prog Mol Biol Transl Sci 2020;171:301-8. [PMID: 32475526 DOI: 10.1016/bs.pmbts.2020.04.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
383 Rutkowski MR, Conejo-Garcia JR. TLR5 signaling, commensal microbiota and systemic tumor promoting inflammation: the three parcae of malignant progression. Oncoimmunology 2015;4:e1021542. [PMID: 26405577 DOI: 10.1080/2162402X.2015.1021542] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
384 Galluzzi L, Rudqvist NP. Preface: More than two decades of modern tumor immunology. Methods Enzymol 2020;632:xxiii-xlii. [PMID: 32000917 DOI: 10.1016/S0076-6879(20)30043-4] [Reference Citation Analysis]
385 Hendler R, Zhang Y. Probiotics in the Treatment of Colorectal Cancer. Medicines (Basel). 2018;5. [PMID: 30205429 DOI: 10.3390/medicines5030101] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 9.3] [Reference Citation Analysis]
386 Nelson MH, Bowers JS, Bailey SR, Diven MA, Fugle CW, Kaiser AD, Wrzesinski C, Liu B, Restifo NP, Paulos CM. Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8(+) T cells without host preconditioning. J Immunother Cancer 2016;4:6. [PMID: 26885368 DOI: 10.1186/s40425-016-0110-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
387 De Re V, Caggiari L, Repetto O, Mussolin L, Mascarin M. Classical Hodgkin's Lymphoma in the Era of Immune Checkpoint Inhibition. J Clin Med 2019;8:E1596. [PMID: 31581738 DOI: 10.3390/jcm8101596] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
388 Severyn CJ, Brewster R, Andermann TM. Microbiota modification in hematology: still at the bench or ready for the bedside? Hematology Am Soc Hematol Educ Program 2019;2019:303-14. [PMID: 31808861 DOI: 10.1182/hematology.2019000365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
389 Calì B, Molon B, Viola A. Tuning cancer fate: the unremitting role of host immunity. Open Biol 2017;7:170006. [PMID: 28404796 DOI: 10.1098/rsob.170006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
390 Su J, Li D, Chen Q, Li M, Su L, Luo T, Liang D, Lai G, Shuai O, Jiao C, Wu Q, Xie Y, Zhou X. Anti-breast Cancer Enhancement of a Polysaccharide From Spore of Ganoderma lucidum With Paclitaxel: Suppression on Tumor Metabolism With Gut Microbiota Reshaping. Front Microbiol 2018;9:3099. [PMID: 30619178 DOI: 10.3389/fmicb.2018.03099] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
391 Cao X. Intestinal inflammation induced by oral bacteria. Science 2017;358:308-9. [PMID: 29051367 DOI: 10.1126/science.aap9298] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
392 Mager LF, Burkhard R, Pett N, Cooke NCA, Brown K, Ramay H, Paik S, Stagg J, Groves RA, Gallo M, Lewis IA, Geuking MB, McCoy KD. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy.Science. 2020;369:1481-1489. [PMID: 32792462 DOI: 10.1126/science.abc3421] [Cited by in Crossref: 97] [Cited by in F6Publishing: 111] [Article Influence: 97.0] [Reference Citation Analysis]
393 Adlung L, Elinav E, Greten TF, Korangy F. Microbiome genomics for cancer prediction. Nat Cancer 2020;1:379-81. [DOI: 10.1038/s43018-020-0059-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
394 Redinbo MR. The Microbiome Revolution Turns to Cholesterol. Cell Host Microbe 2020;28:154-6. [PMID: 32791107 DOI: 10.1016/j.chom.2020.07.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
395 Belcheva A, Irrazabal T, Martin A. Gut microbial metabolism and colon cancer: Can manipulations of the microbiota be useful in the management of gastrointestinal health? BioEssays 2015;37:403-12. [DOI: 10.1002/bies.201400204] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
396 Tonneau M, Elkrief A, Pasquier D, Paz Del Socorro T, Chamaillard M, Bahig H, Routy B. The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review. Radiother Oncol 2021;156:1-9. [PMID: 33137398 DOI: 10.1016/j.radonc.2020.10.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
397 Wilkinson EM, Ilhan ZE, Herbst-kralovetz MM. Microbiota–drug interactions: Impact on metabolism and efficacy of therapeutics. Maturitas 2018;112:53-63. [DOI: 10.1016/j.maturitas.2018.03.012] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 11.7] [Reference Citation Analysis]
398 Lu L, Zhuang T, Shao E, Liu Y, He H, Shu Z, Huang Y, Yao Y, Lin S, Lin S, Chen X, Chen X. Association of antibiotic exposure with the mortality in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy: A hospital-based retrospective cohort study. PLoS One 2019;14:e0221964. [PMID: 31504043 DOI: 10.1371/journal.pone.0221964] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
399 Gallois C, Emile JF, Kim S, Monterymard C, Gilabert M, Bez J, Lièvre A, Dahan L, Laurent-Puig P, Mineur L, Coriat R, Legoux JL, Hautefeuille V, Phelip JM, Lecomte T, Sokol H, Capron C, Randrian V, Lepage C, Lomenie N, Kurtz C, Taieb J, Tougeron D. Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trial. Dig Liver Dis 2021:S1590-8658(21)00324-8. [PMID: 34215534 DOI: 10.1016/j.dld.2021.06.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
400 Rabinovich GA, Conejo-garcía JR. Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways. Journal of Molecular Biology 2016;428:3266-81. [DOI: 10.1016/j.jmb.2016.03.021] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 8.8] [Reference Citation Analysis]
401 Meza-Perez S, Randall TD. Immunological Functions of the Omentum. Trends Immunol 2017;38:526-36. [PMID: 28579319 DOI: 10.1016/j.it.2017.03.002] [Cited by in Crossref: 108] [Cited by in F6Publishing: 99] [Article Influence: 27.0] [Reference Citation Analysis]
402 Rutkowski MR, Conejo-Garcia JR. Size does not matter: commensal microorganisms forge tumor-promoting inflammation and anti-tumor immunity. Oncoscience 2015;2:239-46. [PMID: 25897427 DOI: 10.18632/oncoscience.145] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
403 Alpuim Costa D, Nobre JG, Batista MV, Ribeiro C, Calle C, Cortes A, Marhold M, Negreiros I, Borralho P, Brito M, Cortes J, Braga SA, Costa L. Human Microbiota and Breast Cancer-Is There Any Relevant Link?-A Literature Review and New Horizons Toward Personalised Medicine. Front Microbiol 2021;12:584332. [PMID: 33716996 DOI: 10.3389/fmicb.2021.584332] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
404 Li Y, Yu T, Yan H, Li D, Yu T, Yuan T, Rahaman A, Ali S, Abbas F, Dian Z, Wu X, Baloch Z. Vaginal Microbiota and HPV Infection: Novel Mechanistic Insights and Therapeutic Strategies. Infect Drug Resist 2020;13:1213-20. [PMID: 32431522 DOI: 10.2147/IDR.S210615] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
405 Keung EZ, Lazar AJ, Torres KE, Wang WL, Cormier JN, Ashleigh Guadagnolo B, Bishop AJ, Lin H, Hunt KK, Bird J, Lewis VO, Patel SR, Wargo JA, Somaiah N, Roland CL. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer 2018;18:913. [PMID: 30249211 DOI: 10.1186/s12885-018-4829-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
406 Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents. Cancer Cell. 2015;28:690-714. [PMID: 26678337 DOI: 10.1016/j.ccell.2015.10.012] [Cited by in Crossref: 701] [Cited by in F6Publishing: 689] [Article Influence: 140.2] [Reference Citation Analysis]
407 Chehimi M, Vidal H, Eljaafari A. Pathogenic Role of IL-17-Producing Immune Cells in Obesity, and Related Inflammatory Diseases. J Clin Med. 2017;6:68. [PMID: 28708082 DOI: 10.3390/jcm6070068] [Cited by in Crossref: 75] [Cited by in F6Publishing: 65] [Article Influence: 18.8] [Reference Citation Analysis]
408 Nelson MH, Diven MA, Huff LW, Paulos CM. Harnessing the Microbiome to Enhance Cancer Immunotherapy. J Immunol Res 2015;2015:368736. [PMID: 26101781 DOI: 10.1155/2015/368736] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
409 Mendoza L. Potential effect of probiotics in the treatment of breast cancer. Oncol Rev 2019;13:422. [PMID: 31583054 DOI: 10.4081/oncol.2019.422] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
410 Lokody I. Tumour microenvironment: bacterial balance affects cancer treatment. Nat Rev Cancer 2014;14:10. [PMID: 24505616 DOI: 10.1038/nrc3658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
411 Castellani C, Singer G, Eibisberger M, Obermüller B, Warncke G, Miekisch W, Kolb-Lenz D, Summer G, Pauer TM, ElHaddad A, Kashofer K, Till H. The effects of neuroblastoma and chemotherapy on metabolism, fecal microbiome, volatile organic compounds, and gut barrier function in a murine model. Pediatr Res 2019;85:546-55. [PMID: 30696986 DOI: 10.1038/s41390-019-0283-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
412 Taur Y, Jenq RR, Ubeda C, van den Brink M, Pamer EG. Role of intestinal microbiota in transplantation outcomes. Best Pract Res Clin Haematol 2015;28:155-61. [PMID: 26590773 DOI: 10.1016/j.beha.2015.10.013] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]
413 Chen X, Wakefield LM, Oppenheim JJ. Synergistic antitumor effects of a TGFβ inhibitor and cyclophosphamide. Oncoimmunology 2014;3:e28247. [PMID: 25050195 DOI: 10.4161/onci.28247] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
414 Parra M, Espinoza D, Valdes N, Vargas R, Gonzalez A, Modak B, Tello M. Microbiota Modulates the Immunomodulatory Effects of Filifolinone on Atlantic Salmon. Microorganisms 2020;8:E1320. [PMID: 32872599 DOI: 10.3390/microorganisms8091320] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
415 Norenhag J, Du J, Olovsson M, Verstraelen H, Engstrand L, Brusselaers N. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis. BJOG 2020;127:171-80. [PMID: 31237400 DOI: 10.1111/1471-0528.15854] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 26.0] [Reference Citation Analysis]
416 Abedin-Do A, Taherian-Esfahani Z, Ghafouri-Fard S, Ghafouri-Fard S, Motevaseli E. Immunomodulatory effects of Lactobacillus strains: emphasis on their effects on cancer cells. Immunotherapy 2015;7:1307-29. [PMID: 26595390 DOI: 10.2217/imt.15.92] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
417 Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, Agdashian D, Terabe M, Berzofsky JA, Fako V, Ritz T, Longerich T, Theriot CM, McCulloch JA, Roy S, Yuan W, Thovarai V, Sen SK, Ruchirawat M, Korangy F, Wang XW, Trinchieri G, Greten TF. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018;360. [PMID: 29798856 DOI: 10.1126/science.aan5931] [Cited by in Crossref: 348] [Cited by in F6Publishing: 340] [Article Influence: 116.0] [Reference Citation Analysis]
418 Salek Farrokhi A, Darabi N, Yousefi B, Askandar RH, Shariati M, Eslami M. Is it true that gut microbiota is considered as panacea in cancer therapy? J Cell Physiol. 2019;. [PMID: 30786013 DOI: 10.1002/jcp.28333] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
419 Lauté-Caly DL, Raftis EJ, Cowie P, Hennessy E, Holt A, Panzica DA, Sparre C, Minter B, Stroobach E, Mulder IE. The flagellin of candidate live biotherapeutic Enterococcus gallinarum MRx0518 is a potent immunostimulant. Sci Rep 2019;9:801. [PMID: 30692549 DOI: 10.1038/s41598-018-36926-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
420 Mishra AA, Koh AY. Adaptation of Candida albicans during gastrointestinal tract colonization. Curr Clin Microbiol Rep 2018;5:165-72. [PMID: 30560045 DOI: 10.1007/s40588-018-0096-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
421 Møller SH, Wang L, Ho PC. Metabolic programming in dendritic cells tailors immune responses and homeostasis. Cell Mol Immunol 2021. [PMID: 34413487 DOI: 10.1038/s41423-021-00753-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
422 Manzo VE, Bhatt AS. The human microbiome in hematopoiesis and hematologic disorders. Blood 2015;126:311-8. [PMID: 26012569 DOI: 10.1182/blood-2015-04-574392] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 7.5] [Reference Citation Analysis]
423 Sharma A, Das P, Buschmann M, Gilbert JA. The Future of Microbiome-Based Therapeutics in Clinical Applications. Clin Pharmacol Ther 2020;107:123-8. [PMID: 31617205 DOI: 10.1002/cpt.1677] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
424 Vande Voorde J, Balzarini J, Liekens S. An emerging understanding of the Janus face of the human microbiome: enhancement versus impairment of cancer therapy. J Antimicrob Chemother 2014;69:2878-80. [PMID: 24925896 DOI: 10.1093/jac/dku201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
425 Kulkarni AA, Ebadi M, Zhang S, Meybodi MA, Ali AM, DeFor T, Shanley R, Weisdorf D, Ryan C, Vasu S, Rashidi A, Patel MR. Comparative analysis of antibiotic exposure association with clinical outcomes of chemotherapy versus immunotherapy across three tumour types. ESMO Open 2020;5:e000803. [PMID: 32900789 DOI: 10.1136/esmoopen-2020-000803] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
426 Goc J, Lv M, Bessman NJ, Flamar AL, Sahota S, Suzuki H, Teng F, Putzel GG, Eberl G, Withers DR, Arthur JC, Shah MA, Sonnenberg GF; JRI Live Cell Bank. Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer. Cell 2021;184:5015-5030.e16. [PMID: 34407392 DOI: 10.1016/j.cell.2021.07.029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
427 Ryu G, Kim H, Koh A. Approaching precision medicine by tailoring the microbiota. Mamm Genome 2021;32:206-22. [PMID: 33646347 DOI: 10.1007/s00335-021-09859-3] [Reference Citation Analysis]
428 Zhou A, Lei Y, Tang L, Hu S, Yang M, Wu L, Yang S, Tang B. Gut Microbiota: the Emerging Link to Lung Homeostasis and Disease. J Bacteriol 2021;203:e00454-20. [PMID: 33077630 DOI: 10.1128/JB.00454-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
429 Chen YC, Miao ZF, Yip KL, Cheng YA, Liu CJ, Li LH, Lin CY, Wang JW, Wu DC, Cheng TL, Wang JY. Gut Fecal Microbiota Transplant in a Mouse Model of Orthotopic Rectal Cancer. Front Oncol 2020;10:568012. [PMID: 33194651 DOI: 10.3389/fonc.2020.568012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
430 McCurdy SR, Luznik L. Immune reconstitution after T-cell replete HLA-haploidentical transplantation. Semin Hematol 2019;56:221-6. [PMID: 31202434 DOI: 10.1053/j.seminhematol.2019.03.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
431 Shi L, Sheng J, Wang M, Luo H, Zhu J, Zhang B, Liu Z, Yang X. Combination Therapy of TGF-β Blockade and Commensal-derived Probiotics Provides Enhanced Antitumor Immune Response and Tumor Suppression. Theranostics 2019;9:4115-29. [PMID: 31281535 DOI: 10.7150/thno.35131] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
432 Terenzi A, Pirker C, Keppler BK, Berger W. Anticancer metal drugs and immunogenic cell death. J Inorg Biochem 2016;165:71-9. [PMID: 27350082 DOI: 10.1016/j.jinorgbio.2016.06.021] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 12.2] [Reference Citation Analysis]
433 Hull R, Lolas G, Makrogkikas S, Jensen LD, Syrigos KN, Evangelou G, Padayachy L, Egbor C, Mehrotra R, Makhafola TJ, Oyomno M, Dlamini Z. Microbiomics in Collusion with the Nervous System in Carcinogenesis: Diagnosis, Pathogenesis and Treatment. Microorganisms 2021;9:2129. [PMID: 34683450 DOI: 10.3390/microorganisms9102129] [Reference Citation Analysis]
434 LaCourse KD, Johnston CD, Bullman S. The relationship between gastrointestinal cancers and the microbiota. Lancet Gastroenterol Hepatol 2021;6:498-509. [PMID: 33743198 DOI: 10.1016/S2468-1253(20)30362-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
435 Greil R, Hutterer E, Hartmann TN, Pleyer L. Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation. Cell Commun Signal 2017;15:5. [PMID: 28100240 DOI: 10.1186/s12964-016-0155-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
436 Dohlman AB, Arguijo Mendoza D, Ding S, Gao M, Dressman H, Iliev ID, Lipkin SM, Shen X. The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants. Cell Host Microbe 2021;29:281-298.e5. [PMID: 33382980 DOI: 10.1016/j.chom.2020.12.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
437 Aydin AM, Chahoud J, Adashek JJ, Azizi M, Magliocco A, Ross JS, Necchi A, Spiess PE. Understanding genomics and the immune environment of penile cancer to improve therapy. Nat Rev Urol 2020;17:555-70. [DOI: 10.1038/s41585-020-0359-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
438 Barrea L, Muscogiuri G, Frias-Toral E, Laudisio D, Pugliese G, Castellucci B, Garcia-Velasquez E, Savastano S, Colao A. Nutrition and immune system: from the Mediterranean diet to dietary supplementary through the microbiota. Crit Rev Food Sci Nutr 2020;:1-25. [PMID: 32691606 DOI: 10.1080/10408398.2020.1792826] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
439 Xie Z, Bai Y, Chen G, Rui Y, Chen D, Sun Y, Zeng X, Liu Z. Modulation of gut homeostasis by exopolysaccharides from Aspergillus cristatus (MK346334), a strain of fungus isolated from Fuzhuan brick tea, contributes to immunomodulatory activity in cyclophosphamide-treated mice. Food Funct 2020;11:10397-412. [PMID: 33237077 DOI: 10.1039/d0fo02272a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
440 Yi M, Yu S, Qin S, Liu Q, Xu H, Zhao W, Chu Q, Wu K. Gut microbiome modulates efficacy of immune checkpoint inhibitors. J Hematol Oncol. 2018;11:47. [PMID: 29580257 DOI: 10.1186/s13045-018-0592-6] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 21.7] [Reference Citation Analysis]
441 Defaye M, Gervason S, Altier C, Berthon JY, Ardid D, Filaire E, Carvalho FA. Microbiota: a novel regulator of pain. J Neural Transm (Vienna) 2020;127:445-65. [PMID: 31552496 DOI: 10.1007/s00702-019-02083-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
442 Serrano-Del Valle A, Naval J, Anel A, Marzo I. Novel Forms of Immunomodulation for Cancer Therapy. Trends Cancer 2020;6:518-32. [PMID: 32460005 DOI: 10.1016/j.trecan.2020.02.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
443 Uribe-Herranz M, Klein-González N, Rodríguez-Lobato LG, Juan M, de Larrea CF. Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure. Int J Mol Sci 2021;22:1026. [PMID: 33498529 DOI: 10.3390/ijms22031026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
444 Garajová I, Balsano R, Wang H, Leonardi F, Giovannetti E, Deng D, Peters GJ. The role of the microbiome in drug resistance in gastrointestinal cancers. Expert Rev Anticancer Ther 2021;21:165-76. [PMID: 33115280 DOI: 10.1080/14737140.2021.1844007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
445 Martins Lopes MS, Machado LM, Ismael Amaral Silva PA, Tome Uchiyama AA, Yen CT, Ricardo ED, Mutao TS, Pimenta JR, Shimba DS, Hanriot RM, Peixoto RD. Antibiotics, cancer risk and oncologic treatment efficacy: a practical review of the literature. Ecancermedicalscience 2020;14:1106. [PMID: 33144874 DOI: 10.3332/ecancer.2020.1106] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
446 El-Jurdi N, Ghannoum MA. The Mycobiome: Impact on Health and Disease States. Microbiol Spectr 2017;5. [PMID: 28597821 DOI: 10.1128/microbiolspec.FUNK-0045-2016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
447 Mantovani A, Allavena P. The interaction of anticancer therapies with tumor-associated macrophages. J Exp Med. 2015;212:435-445. [PMID: 25753580 DOI: 10.1084/jem.20150295] [Cited by in Crossref: 328] [Cited by in F6Publishing: 328] [Article Influence: 54.7] [Reference Citation Analysis]
448 Tuteja S, Ferguson JF. Gut Microbiome and Response to Cardiovascular Drugs. Circ Genom Precis Med 2019;12:421-9. [PMID: 31462078 DOI: 10.1161/CIRCGEN.119.002314] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 8.5] [Reference Citation Analysis]
449 Chavira A, Belda-ferre P, Kosciolek T, Ali F, Dorrestein PC, Knight R. The Microbiome and Its Potential for Pharmacology. In: Barrett JE, Page CP, Michel MC, editors. Concepts and Principles of Pharmacology. Cham: Springer International Publishing; 2019. pp. 301-26. [DOI: 10.1007/164_2019_317] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
450 Lakritz JR, Poutahidis T, Mirabal S, Varian BJ, Levkovich T, Ibrahim YM, Ward JM, Teng EC, Fisher B, Parry N, Lesage S, Alberg N, Gourishetti S, Fox JG, Ge Z, Erdman SE. Gut bacteria require neutrophils to promote mammary tumorigenesis. Oncotarget 2015;6:9387-96. [PMID: 25831236 DOI: 10.18632/oncotarget.3328] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 11.2] [Reference Citation Analysis]
451 Scher JU, Nayak RR, Ubeda C, Turnbaugh PJ, Abramson SB. Pharmacomicrobiomics in inflammatory arthritis: gut microbiome as modulator of therapeutic response. Nat Rev Rheumatol 2020;16:282-92. [PMID: 32157196 DOI: 10.1038/s41584-020-0395-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 24.0] [Reference Citation Analysis]
452 Lu SY, Hua J, Xu J, Wei MY, Liang C, Meng QC, Liu J, Zhang B, Wang W, Yu XJ, Shi S. Microorganisms in chemotherapy for pancreatic cancer: An overview of current research and future directions. Int J Biol Sci 2021;17:2666-82. [PMID: 34326701 DOI: 10.7150/ijbs.59117] [Reference Citation Analysis]
453 Considine B, Hurwitz ME. Key Factors in Clinical Protocols for Adoptive Cell Therapy in Melanoma. Methods Mol Biol 2020;2097:309-27. [PMID: 31776935 DOI: 10.1007/978-1-0716-0203-4_20] [Reference Citation Analysis]
454 Yamazaki T, Pitt JM, Vétizou M, Marabelle A, Flores C, Rekdal Ø, Kroemer G, Zitvogel L. The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade. Cell Death Differ 2016;23:1004-15. [PMID: 27082453 DOI: 10.1038/cdd.2016.35] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
455 Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014;157:121-141. [PMID: 24679531 DOI: 10.1016/j.cell.2014.03.011] [Cited by in Crossref: 1875] [Cited by in F6Publishing: 1705] [Article Influence: 267.9] [Reference Citation Analysis]
456 Leal-Lopes C, Velloso FJ, Campopiano JC, Sogayar MC, Correa RG. Roles of Commensal Microbiota in Pancreas Homeostasis and Pancreatic Pathologies. J Diabetes Res. 2015;2015:284680. [PMID: 26347203 DOI: 10.1155/2015/284680] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
457 Zhao L, Xing C, Sun W, Hou G, Yang G, Yuan L. Lactobacillus supplementation prevents cisplatin-induced cardiotoxicity possibly by inflammation inhibition. Cancer Chemother Pharmacol 2018;82:999-1008. [DOI: 10.1007/s00280-018-3691-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
458 Sears CL, Garrett WS. Microbes, microbiota, and colon cancer. Cell Host Microbe. 2014;15:317-328. [PMID: 24629338 DOI: 10.1016/j.chom.2014.02.007] [Cited by in Crossref: 430] [Cited by in F6Publishing: 392] [Article Influence: 61.4] [Reference Citation Analysis]
459 Romano E, Michielin O, Voelter V, Laurent J, Bichat H, Stravodimou A, Romero P, Speiser DE, Triebel F, Leyvraz S, Harari A. MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial. J Transl Med 2014;12:97. [PMID: 24726012 DOI: 10.1186/1479-5876-12-97] [Cited by in Crossref: 46] [Cited by in F6Publishing: 52] [Article Influence: 6.6] [Reference Citation Analysis]
460 Fan S, Zhang Z, Zhong Y, Li C, Huang X, Geng F, Nie S. Microbiota-related effects of prebiotic fibres in lipopolysaccharide-induced endotoxemic mice: short chain fatty acid production and gut commensal translocation. Food Funct 2021;12:7343-57. [PMID: 34180493 DOI: 10.1039/d1fo00410g] [Reference Citation Analysis]
461 McKenzie ND, Hong H, Ahmad S, Holloway RW. The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research. Crit Rev Oncol Hematol 2021;157:103165. [PMID: 33227575 DOI: 10.1016/j.critrevonc.2020.103165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
462 Ser HL, Letchumanan V, Goh BH, Wong SH, Lee LH. The Use of Fecal Microbiome Transplant in Treating Human Diseases: Too Early for Poop? Front Microbiol 2021;12:519836. [PMID: 34054740 DOI: 10.3389/fmicb.2021.519836] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
463 Brod S, Rattazzi L, Piras G, D'Acquisto F. 'As above, so below' examining the interplay between emotion and the immune system. Immunology 2014;143:311-8. [PMID: 24943894 DOI: 10.1111/imm.12341] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
464 Ciorba M. The Prevention and Treatment of Radiation and Chemotherapy-Induced Intestinal Mucositis. The Microbiota in Gastrointestinal Pathophysiology. Elsevier; 2017. pp. 383-7. [DOI: 10.1016/b978-0-12-804024-9.00041-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
465 Jain T, Sharma P, Are AC, Vickers SM, Dudeja V. New Insights Into the Cancer-Microbiome-Immune Axis: Decrypting a Decade of Discoveries. Front Immunol 2021;12:622064. [PMID: 33708214 DOI: 10.3389/fimmu.2021.622064] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
466 Song W, Anselmo AC, Huang L. Nanotechnology intervention of the microbiome for cancer therapy. Nat Nanotechnol 2019;14:1093-103. [DOI: 10.1038/s41565-019-0589-5] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 22.5] [Reference Citation Analysis]
467 D'Angelo CR, Sudakaran S, Callander NS. Clinical effects and applications of the gut microbiome in hematologic malignancies. Cancer 2021;127:679-87. [PMID: 33369893 DOI: 10.1002/cncr.33400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
468 Golden EB, Apetoh L. Radiotherapy and immunogenic cell death. Semin Radiat Oncol 2015;25:11-7. [PMID: 25481261 DOI: 10.1016/j.semradonc.2014.07.005] [Cited by in Crossref: 200] [Cited by in F6Publishing: 199] [Article Influence: 33.3] [Reference Citation Analysis]
469 Yu Q, Jobin C, Thomas RM. Implications of the microbiome in the development and treatment of pancreatic cancer: Thinking outside of the box by looking inside the gut. Neoplasia 2021;23:246-56. [PMID: 33418277 DOI: 10.1016/j.neo.2020.12.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
470 Zou W, Wolchok JD, Chen L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations. Sci Transl Med. 2016;8:328rv4. [PMID: 26936508 DOI: 10.1126/scitranslmed.aad7118] [Cited by in Crossref: 1022] [Cited by in F6Publishing: 1034] [Article Influence: 204.4] [Reference Citation Analysis]
471 Madondo MT, Quinn M, Plebanski M. Low dose cyclophosphamide: Mechanisms of T cell modulation. Cancer Treat Rev 2016;42:3-9. [PMID: 26620820 DOI: 10.1016/j.ctrv.2015.11.005] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 11.0] [Reference Citation Analysis]
472 Lee SH, Cho SY, Yoon Y, Park C, Sohn J, Jeong JJ, Jeon BN, Jang M, An C, Lee S, Kim YY, Kim G, Kim S, Kim Y, Lee GB, Lee EJ, Kim SG, Kim HS, Kim Y, Kim H, Yang HS, Kim S, Kim S, Chung H, Moon MH, Nam MH, Kwon JY, Won S, Park JS, Weinstock GM, Lee C, Yoon KW, Park H. Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice. Nat Microbiol 2021;6:277-88. [PMID: 33432149 DOI: 10.1038/s41564-020-00831-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
473 Markowski MC, Boorjian SA, Burton JP, Hahn NM, Ingersoll MA, Maleki Vareki S, Pal SK, Sfanos KS. The Microbiome and Genitourinary Cancer: A Collaborative Review. Eur Urol 2019;75:637-46. [PMID: 30655087 DOI: 10.1016/j.eururo.2018.12.043] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 17.5] [Reference Citation Analysis]
474 Dietert RR. The microbiome-immune-host defense barrier complex (microimmunosome) and developmental programming of noncommunicable diseases. Reproductive Toxicology 2017;68:49-58. [DOI: 10.1016/j.reprotox.2016.04.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
475 Toor D, Wsson MK, Kumar P, Karthikeyan G, Kaushik NK, Goel C, Singh S, Kumar A, Prakash H. Dysbiosis Disrupts Gut Immune Homeostasis and Promotes Gastric Diseases. Int J Mol Sci. 2019;20. [PMID: 31100929 DOI: 10.3390/ijms20102432] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
476 Hayase E, Jenq RR. Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer. Genome Med 2021;13:107. [PMID: 34162429 DOI: 10.1186/s13073-021-00923-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
477 Wu X, Zhang T, Chen X, Ji G, Zhang F. Microbiota transplantation: Targeting cancer treatment. Cancer Letters 2019;452:144-51. [DOI: 10.1016/j.canlet.2019.03.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
478 Buchta Rosean C, Feng TY, Azar FN, Rutkowski MR. Impact of the microbiome on cancer progression and response to anti-cancer therapies. Adv Cancer Res 2019;143:255-94. [PMID: 31202360 DOI: 10.1016/bs.acr.2019.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
479 Goubet AG, Wheeler R, Fluckiger A, Qu B, Lemaître F, Iribarren K, Mondragón L, Tidjani Alou M, Pizzato E, Durand S, Derosa L, Aprahamian F, Bossut N, Moya-Nilges M, Derrien D, Chen G, Leduc M, Joseph A, Pons N, Le Chatelier E, Segata N, Yonekura S, Iebba V, Kepp O, Raoult D, André F, Kroemer G, Boneca IG, Zitvogel L, Daillère R. Multifaceted modes of action of the anticancer probiotic Enterococcus hirae. Cell Death Differ 2021;28:2276-95. [PMID: 33976389 DOI: 10.1038/s41418-021-00753-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
480 Almonte AA, Rangarajan H, Yip D, Fahrer AM. How does the gut microbiome influence immune checkpoint blockade therapy? Immunol Cell Biol 2021;99:361-72. [PMID: 33147357 DOI: 10.1111/imcb.12423] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
481 McVey Neufeld KA, Bienenstock J, Bharwani A, Champagne-Jorgensen K, Mao Y, West C, Liu Y, Surette MG, Kunze W, Forsythe P. Oral selective serotonin reuptake inhibitors activate vagus nerve dependent gut-brain signalling. Sci Rep 2019;9:14290. [PMID: 31582799 DOI: 10.1038/s41598-019-50807-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
482 Defazio J, Fleming ID, Shakhsheer B, Zaborina O, Alverdy JC. The opposing forces of the intestinal microbiome and the emerging pathobiome. Surg Clin North Am 2014;94:1151-61. [PMID: 25440116 DOI: 10.1016/j.suc.2014.08.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
483 Seliger B. The Role of the Lymphocyte Functional Crosstalk and Regulation in the Context of Checkpoint Inhibitor Treatment-Review. Front Immunol 2019;10:2043. [PMID: 31555274 DOI: 10.3389/fimmu.2019.02043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
484 Pickard JM, Zeng MY, Caruso R, Núñez G. Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease. Immunol Rev 2017;279:70-89. [PMID: 28856738 DOI: 10.1111/imr.12567] [Cited by in Crossref: 344] [Cited by in F6Publishing: 329] [Article Influence: 114.7] [Reference Citation Analysis]
485 Dubin KA, Mathur D, McKenney PT, Taylor BP, Littmann ER, Peled JU, van den Brink MRM, Taur Y, Pamer EG, Xavier JB. Diversification and Evolution of Vancomycin-Resistant Enterococcus faecium during Intestinal Domination. Infect Immun 2019;87:e00102-19. [PMID: 31010813 DOI: 10.1128/IAI.00102-19] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 9.5] [Reference Citation Analysis]
486 Morkūnas E, Skiecevičienė J, Kupčinskas J. The impact of modulating the gastrointestinal microbiota in cancer patients. Best Pract Res Clin Gastroenterol 2020;48-49:101700. [PMID: 33317795 DOI: 10.1016/j.bpg.2020.101700] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
487 Gorjifard S, Goldszmid RS. Microbiota-myeloid cell crosstalk beyond the gut. J Leukoc Biol 2016;100:865-79. [PMID: 27605211 DOI: 10.1189/jlb.3RI0516-222R] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 6.6] [Reference Citation Analysis]
488 Al-qadami G, Van Sebille Y, Le H, Bowen J. Gut microbiota: implications for radiotherapy response and radiotherapy-induced mucositis. Expert Review of Gastroenterology & Hepatology 2019;13:485-96. [DOI: 10.1080/17474124.2019.1595586] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
489 Pezo RC, Wong M, Martin A. Impact of the gut microbiota on immune checkpoint inhibitor-associated toxicities. Therap Adv Gastroenterol 2019;12:1756284819870911. [PMID: 31555343 DOI: 10.1177/1756284819870911] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
490 Fay EK, Graff JN. Immunotherapy in Prostate Cancer. Cancers (Basel) 2020;12:E1752. [PMID: 32630247 DOI: 10.3390/cancers12071752] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
491 Moreno-Gonzalez M, Beraza N. The Role of the Microbiome in Liver Cancer. Cancers (Basel) 2021;13:2330. [PMID: 34066064 DOI: 10.3390/cancers13102330] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
492 Saeed A, Eshrat FF, Umar S, Saeed A. The Duplex Interaction of Microbiome with Chemoradiation and Immunotherapy: Potential Implications for Colorectal Cancer. Curr Colorectal Cancer Rep 2019;15:98-104. [PMID: 31680787 DOI: 10.1007/s11888-019-00435-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
493 Vorontsova A, Kan T, Raviv Z, Shaked Y. The Dichotomous Role of Bone Marrow Derived Cells in the Chemotherapy-Treated Tumor Microenvironment. J Clin Med 2020;9:E3912. [PMID: 33276524 DOI: 10.3390/jcm9123912] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
494 Sun J, Yin T, Zhou J, Xu J, Lu X. Gut microbiome and cancer immunotherapy. J Cell Physiol 2020;235:4082-8. [DOI: 10.1002/jcp.29359] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
495 Guo H, Zhao L, Zhu J, Chen P, Wang H, Jiang M, Liu X, Sun H, Zhao W, Zheng Z, Li W, Chen B, Fang Q, Yang M, He Y, Yang Y. Microbes in lung cancer initiation, treatment, and outcome: Boon or bane? Semin Cancer Biol 2021:S1044-579X(21)00154-1. [PMID: 34029741 DOI: 10.1016/j.semcancer.2021.05.025] [Reference Citation Analysis]
496 Dutta D, Lim SH. Bidirectional interaction between intestinal microbiome and cancer: opportunities for therapeutic interventions. Biomark Res. 2020;8:31. [PMID: 32817793 DOI: 10.1186/s40364-020-00211-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
497 Liu K, Ren XM, You QS, Gu MM, Wang F, Wang S, Ma CH, Li WN, Ye Q. Ameliorative Effect of Dangguibuxue Decoction against Cyclophosphamide-Induced Heart Injury in Mice. Biomed Res Int 2018;2018:8503109. [PMID: 30515415 DOI: 10.1155/2018/8503109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
498 Inamura K. Roles of microbiota in response to cancer immunotherapy. Semin Cancer Biol 2020;65:164-75. [PMID: 31911189 DOI: 10.1016/j.semcancer.2019.12.026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 17.0] [Reference Citation Analysis]
499 Matsuo K, Haku A, Bi B, Takahashi H, Kamada N, Yaguchi T, Saijo S, Yoneyama M, Goto Y. Fecal microbiota transplantation prevents Candida albicans from colonizing the gastrointestinal tract. Microbiol Immunol 2019;63:155-63. [DOI: 10.1111/1348-0421.12680] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
500 Picchianti-Diamanti A, Rosado MM, D'Amelio R. Infectious Agents and Inflammation: The Role of Microbiota in Autoimmune Arthritis. Front Microbiol 2017;8:2696. [PMID: 29387048 DOI: 10.3389/fmicb.2017.02696] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 11.7] [Reference Citation Analysis]
501 Goldszmid RS, Dzutsev A, Trinchieri G. Host immune response to infection and cancer: unexpected commonalities. Cell Host Microbe 2014;15:295-305. [PMID: 24629336 DOI: 10.1016/j.chom.2014.02.003] [Cited by in Crossref: 85] [Cited by in F6Publishing: 72] [Article Influence: 12.1] [Reference Citation Analysis]
502 Vande Voorde J, Sabuncuoğlu S, Noppen S, Hofer A, Ranjbarian F, Fieuws S, Balzarini J, Liekens S. Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine. J Biol Chem 2014;289:13054-65. [PMID: 24668817 DOI: 10.1074/jbc.M114.558924] [Cited by in Crossref: 51] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
503 Pierrard J, Seront E. Impact of the gut microbiome on immune checkpoint inhibitor efficacy-a systematic review. Curr Oncol 2019;26:395-403. [PMID: 31896938 DOI: 10.3747/co.26.5177] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
504 Jayasinghe TN, Chiavaroli V, Holland DJ, Cutfield WS, O'Sullivan JM. The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation. Front Cell Infect Microbiol 2016;6:15. [PMID: 26925392 DOI: 10.3389/fcimb.2016.00015] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 8.2] [Reference Citation Analysis]
505 Becattini S, Littmann ER, Carter RA, Kim SG, Morjaria SM, Ling L, Gyaltshen Y, Fontana E, Taur Y, Leiner IM, Pamer EG. Commensal microbes provide first line defense against Listeria monocytogenes infection. J Exp Med 2017;214:1973-89. [PMID: 28588016 DOI: 10.1084/jem.20170495] [Cited by in Crossref: 94] [Cited by in F6Publishing: 82] [Article Influence: 23.5] [Reference Citation Analysis]
506 Liu T, Wu Y, Wang L, Pang X, Zhao L, Yuan H, Zhang C. A More Robust Gut Microbiota in Calorie-Restricted Mice Is Associated with Attenuated Intestinal Injury Caused by the Chemotherapy Drug Cyclophosphamide. mBio. 2019;10:e02903-18. [PMID: 30862756 DOI: 10.1128/mbio.02903-18] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
507 Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, Rotter-Maskowitz A, Weiser R, Mallel G, Gigi E, Meltser A, Douglas GM, Kamer I, Gopalakrishnan V, Dadosh T, Levin-Zaidman S, Avnet S, Atlan T, Cooper ZA, Arora R, Cogdill AP, Khan MAW, Ologun G, Bussi Y, Weinberger A, Lotan-Pompan M, Golani O, Perry G, Rokah M, Bahar-Shany K, Rozeman EA, Blank CU, Ronai A, Shaoul R, Amit A, Dorfman T, Kremer R, Cohen ZR, Harnof S, Siegal T, Yehuda-Shnaidman E, Gal-Yam EN, Shapira H, Baldini N, Langille MGI, Ben-Nun A, Kaufman B, Nissan A, Golan T, Dadiani M, Levanon K, Bar J, Yust-Katz S, Barshack I, Peeper DS, Raz DJ, Segal E, Wargo JA, Sandbank J, Shental N, Straussman R. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 2020;368:973-80. [PMID: 32467386 DOI: 10.1126/science.aay9189] [Cited by in Crossref: 185] [Cited by in F6Publishing: 199] [Article Influence: 185.0] [Reference Citation Analysis]
508 Diefenbach CS, Peters BA, Li H, Raphael B, Moskovits T, Hymes K, Schluter J, Chen J, Bennani NN, Witzig TE, Ahn J. Microbial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphoma. Blood Adv 2021;5:1194-8. [PMID: 33635332 DOI: 10.1182/bloodadvances.2020003129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
509 Soularue E, Lepage P, Colombel JF, Coutzac C, Faleck D, Marthey L, Collins M, Chaput N, Robert C, Carbonnel F. Enterocolitis due to immune checkpoint inhibitors: a systematic review. Gut 2018;67:2056-67. [DOI: 10.1136/gutjnl-2018-316948] [Cited by in Crossref: 74] [Cited by in F6Publishing: 63] [Article Influence: 24.7] [Reference Citation Analysis]
510 Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14:399-416. [PMID: 28117416 DOI: 10.1038/nrclinonc.2016.217] [Cited by in Crossref: 1232] [Cited by in F6Publishing: 1253] [Article Influence: 308.0] [Reference Citation Analysis]
511 Patrizz A, Dono A, Zorofchian S, Hines G, Takayasu T, Husein N, Otani Y, Arevalo O, Choi HA, Savarraj J, Tandon N, Ganesh BP, Kaur B, McCullough LD, Ballester LY, Esquenazi Y. Glioma and temozolomide induced alterations in gut microbiome. Sci Rep 2020;10:21002. [PMID: 33273497 DOI: 10.1038/s41598-020-77919-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
512 Katayama Y, Yamada T, Tanimura K, Yoshimura A, Takeda T, Chihara Y, Tamiya N, Kaneko Y, Uchino J, Takayama K. Impact of bowel movement condition on immune checkpoint inhibitor efficacy in patients with advanced non-small cell lung cancer. Thorac Cancer 2019;10:526-32. [PMID: 30666802 DOI: 10.1111/1759-7714.12969] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
513 Lynch DB, Jeffery IB, O'Toole PW. The role of the microbiota in ageing: current state and perspectives. Wiley Interdiscip Rev Syst Biol Med 2015;7:131-8. [PMID: 25777986 DOI: 10.1002/wsbm.1293] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
514 Chen D, Xiao C, Jin H, Yang B, Niu J, Yan S, Sun Y, Zhou Y, Wang X. Exposure to atmospheric pollutants is associated with alterations of gut microbiota in spontaneously hypertensive rats. Exp Ther Med 2019;18:3484-92. [PMID: 31602224 DOI: 10.3892/etm.2019.7934] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
515 Javed I, Cui X, Wang X, Mortimer M, Andrikopoulos N, Li Y, Davis TP, Zhao Y, Ke PC, Chen C. Implications of the Human Gut–Brain and Gut–Cancer Axes for Future Nanomedicine. ACS Nano 2020;14:14391-416. [DOI: 10.1021/acsnano.0c07258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
516 Song Y, Himmel B, Öhrmalm L, Gyarmati P. The Microbiota in Hematologic Malignancies. Curr Treat Options Oncol 2020;21:2. [PMID: 31927673 DOI: 10.1007/s11864-019-0693-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
517 Shi Y, Zheng W, Yang K, Harris KG, Ni K, Xue L, Lin W, Chang EB, Weichselbaum RR, Fu YX. Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling. J Exp Med 2020;217:e20192282. [PMID: 32142585 DOI: 10.1084/jem.20192282] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 32.0] [Reference Citation Analysis]
518 Yan C, Tu XX, Wu W, Tong Z, Liu LL, Zheng Y, Jiang WQ, Zhao P, Fang WJ, Zhang HY. Antibiotics and immunotherapy in gastrointestinal tumors: Friend or foe? World J Clin Cases 2019; 7(11): 1253-1261 [PMID: 31236389 DOI: 10.12998/wjcc.v7.i11.1253] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
519 Jaye K, Li CG, Bhuyan DJ. The complex interplay of gut microbiota with the five most common cancer types: From carcinogenesis to therapeutics to prognoses. Crit Rev Oncol Hematol 2021;165:103429. [PMID: 34293459 DOI: 10.1016/j.critrevonc.2021.103429] [Reference Citation Analysis]
520 Pearson JA, Voisey AC, Boest-Bjerg K, Wong FS, Wen L. Circadian Rhythm Modulation of Microbes During Health and Infection. Front Microbiol 2021;12:721004. [PMID: 34512600 DOI: 10.3389/fmicb.2021.721004] [Reference Citation Analysis]
521 Zhuang H, Jing N, Wang L, Jiang G, Liu Z. Jujube Powder Enhances Cyclophosphamide Efficiency against Murine Colon Cancer by Enriching CD8+ T Cells While Inhibiting Eosinophilia. Nutrients 2021;13:2700. [PMID: 34444860 DOI: 10.3390/nu13082700] [Reference Citation Analysis]
522 Galli G, Triulzi T, Proto C, Signorelli D, Imbimbo M, Poggi M, Fucà G, Ganzinelli M, Vitali M, Palmieri D, Tessari A, de Braud F, Garassino MC, Colombo MP, Lo Russo G. Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer. Lung Cancer 2019;132:72-8. [DOI: 10.1016/j.lungcan.2019.04.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
523 Nellore A, Fishman JA. The Microbiome, Systemic Immune Function, and Allotransplantation. Clin Microbiol Rev 2016;29:191-9. [PMID: 26656674 DOI: 10.1128/CMR.00063-15] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 4.4] [Reference Citation Analysis]
524 Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, Zhang D, Xia H, Xu X, Jie Z, Su L, Li X, Li X, Li J, Xiao L, Huber-schönauer U, Niederseer D, Xu X, Al-aama JY, Yang H, Wang J, Kristiansen K, Arumugam M, Tilg H, Datz C, Wang J. Gut microbiome development along the colorectal adenoma–carcinoma sequence. Nat Commun 2015;6. [DOI: 10.1038/ncomms7528] [Cited by in Crossref: 508] [Cited by in F6Publishing: 456] [Article Influence: 84.7] [Reference Citation Analysis]
525 Pfirschke C, Garris C, Pittet MJ. Common TLR5 mutations control cancer progression. Cancer Cell. 2015;27:1-3. [PMID: 25584886 DOI: 10.1016/j.ccell.2014.12.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
526 Kumar M, Singh P, Murugesan S, Vetizou M, McCulloch J, Badger JH, Trinchieri G, Al Khodor S. Microbiome as an Immunological Modifier. Methods Mol Biol 2020;2055:595-638. [PMID: 31502171 DOI: 10.1007/978-1-4939-9773-2_27] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
527 Zitvogel L, Ma Y, Raoult D, Kroemer G, Gajewski TF. The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies. Science. 2018;359:1366-1370. [PMID: 29567708 DOI: 10.1126/science.aar6918] [Cited by in Crossref: 268] [Cited by in F6Publishing: 245] [Article Influence: 89.3] [Reference Citation Analysis]
528 Esfahani K, Roudaia L, Buhlaiga N, Del Rincon SV, Papneja N, Miller WH Jr. A review of cancer immunotherapy: from the past, to the present, to the future. Curr Oncol 2020;27:S87-97. [PMID: 32368178 DOI: 10.3747/co.27.5223] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 86.0] [Reference Citation Analysis]
529 Villéger R, Lopès A, Veziant J, Gagnière J, Barnich N, Billard E, Boucher D, Bonnet M. Microbial markers in colorectal cancer detection and/or prognosis. World J Gastroenterol 2018; 24(22): 2327-2347 [PMID: 29904241 DOI: 10.3748/wjg.v24.i22.2327] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 36] [Article Influence: 14.7] [Reference Citation Analysis]
530 Ziegler M, Han JH, Landsburg D, Pegues D, Reesey E, Gilmar C, Gorman T, Bink K, Moore A, Kelly BJ; CDC Prevention Epicenters Program. Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients With Hematologic Malignancy. Open Forum Infect Dis 2019;6:ofz252. [PMID: 31281857 DOI: 10.1093/ofid/ofz252] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
531 Dearing KR, Weiss GJ. Translating next-generation sequencing from clinical trials to clinical practice for the treatment of advanced cancers. Per Med 2015;12:155-62. [PMID: 29754537 DOI: 10.2217/pme.14.54] [Reference Citation Analysis]
532 Kang YB, Cai Y. Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer. World J Gastroenterol 2021; 27(32): 5362-5375 [PMID: 34539138 DOI: 10.3748/wjg.v27.i32.5362] [Reference Citation Analysis]
533 Lu S, Zuo T, Zhang N, Shi H, Liu F, Wu J, Wang Y, Xue C, Tang Q. High throughput sequencing analysis reveals amelioration of intestinal dysbiosis by squid ink polysaccharide. Journal of Functional Foods 2016;20:506-15. [DOI: 10.1016/j.jff.2015.11.017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 6.8] [Reference Citation Analysis]
534 Malesci A, Bianchi P, Celesti G, Basso G, Marchesi F, Grizzi F, Di Caro G, Cavalleri T, Rimassa L, Palmqvist R. Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer. Oncoimmunology. 2017;6:e1342918. [PMID: 29209561 DOI: 10.1080/2162402x.2017.1342918] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 13.3] [Reference Citation Analysis]
535 Goodman B, Gardner H. The microbiome and cancer. J Pathol. 2018;244:667-676. [PMID: 29377130 DOI: 10.1002/path.5047] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 25.3] [Reference Citation Analysis]
536 Smet A, Kupcinskas J, Link A, Hold GL, Bornschein J. The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment - Chance or Curse? Cell Mol Gastroenterol Hepatol 2021:S2352-345X(21)00180-6. [PMID: 34506954 DOI: 10.1016/j.jcmgh.2021.08.013] [Reference Citation Analysis]
537 Osman AEG, Luke JJ. The Impact of the Fecal Microbiome on Cancer Immunotherapy. BioDrugs 2019;33:1-7. [PMID: 30604388 DOI: 10.1007/s40259-018-0328-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
538 Uribe-Herranz M, Bittinger K, Rafail S, Guedan S, Pierini S, Tanes C, Ganetsky A, Morgan MA, Gill S, Tanyi JL, Bushman FD, June CH, Facciabene A. Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12. JCI Insight 2018;3:94952. [PMID: 29467322 DOI: 10.1172/jci.insight.94952] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 17.7] [Reference Citation Analysis]
539 Brodin P, Davis MM. Human immune system variation. Nat Rev Immunol 2017;17:21-9. [PMID: 27916977 DOI: 10.1038/nri.2016.125] [Cited by in Crossref: 251] [Cited by in F6Publishing: 222] [Article Influence: 50.2] [Reference Citation Analysis]
540 Tung J, Barreiro LB, Burns MB, Grenier JC, Lynch J, Grieneisen LE, Altmann J, Alberts SC, Blekhman R, Archie EA. Social networks predict gut microbiome composition in wild baboons. Elife 2015;4. [PMID: 25774601 DOI: 10.7554/eLife.05224] [Cited by in Crossref: 233] [Cited by in F6Publishing: 135] [Article Influence: 38.8] [Reference Citation Analysis]
541 Chen J, Douglass J, Prasath V, Neace M, Atrchian S, Manjili MH, Shokouhi S, Habibi M. The microbiome and breast cancer: a review. Breast Cancer Res Treat 2019;178:493-6. [PMID: 31456069 DOI: 10.1007/s10549-019-05407-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
542 Zhang X, Wu L, Xu Y, Yu H, Chen Y, Zhao H, Lei J, Zhou Y, Zhang J, Wang J, Peng J, Jiang L, Sheng H, Li Y. Microbiota-derived SSL6 enhances the sensitivity of hepatocellular carcinoma to sorafenib by down-regulating glycolysis. Cancer Lett 2020;481:32-44. [PMID: 32246956 DOI: 10.1016/j.canlet.2020.03.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
543 Sansone C, Bruno A, Piscitelli C, Baci D, Fontana A, Brunet C, Noonan DM, Albini A. Natural Compounds of Marine Origin as Inducers of Immunogenic Cell Death (ICD): Potential Role for Cancer Interception and Therapy. Cells 2021;10:231. [PMID: 33504012 DOI: 10.3390/cells10020231] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
544 Andreeva NV, Gabbasova RR, Grivennikov SI. Microbiome in cancer progression and therapy. Curr Opin Microbiol 2020;56:118-26. [PMID: 33147555 DOI: 10.1016/j.mib.2020.09.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
545 Zimmermann M, Patil KR, Typas A, Maier L. Towards a mechanistic understanding of reciprocal drug-microbiome interactions. Mol Syst Biol 2021;17:e10116. [PMID: 33734582 DOI: 10.15252/msb.202010116] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
546 Schneider G, Schmidt-Supprian M, Rad R, Saur D. Tissue-specific tumorigenesis: context matters. Nat Rev Cancer 2017;17:239-53. [PMID: 28256574 DOI: 10.1038/nrc.2017.5] [Cited by in Crossref: 149] [Cited by in F6Publishing: 134] [Article Influence: 37.3] [Reference Citation Analysis]
547 Tralau T, Sowada J, Luch A. Insights on the human microbiome and its xenobiotic metabolism: what is known about its effects on human physiology? Expert Opin Drug Metab Toxicol 2015;11:411-25. [PMID: 25476418 DOI: 10.1517/17425255.2015.990437] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
548 Rizvi ZA, Dalal R, Sadhu S, Kumar Y, Kumar S, Gupta SK, Tripathy MR, Rathore DK, Awasthi A. High-salt diet mediates interplay between NK cells and gut microbiota to induce potent tumor immunity. Sci Adv 2021;7:eabg5016. [PMID: 34516769 DOI: 10.1126/sciadv.abg5016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
549 Bubnov RV, Spivak MY, Lazarenko LM, Bomba A, Boyko NV. Probiotics and immunity: provisional role for personalized diets and disease prevention. EPMA J 2015;6:14. [PMID: 26221192 DOI: 10.1186/s13167-015-0036-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 6.5] [Reference Citation Analysis]
550 Liu NN, Ma Q, Ge Y, Yi CX, Wei LQ, Tan JC, Chu Q, Li JQ, Zhang P, Wang H. Microbiome dysbiosis in lung cancer: from composition to therapy. NPJ Precis Oncol 2020;4:33. [PMID: 33303906 DOI: 10.1038/s41698-020-00138-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
551 D'Haens GR, Jobin C. Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection. Gastroenterology 2019;157:624-36. [PMID: 31220424 DOI: 10.1053/j.gastro.2019.04.053] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 16.0] [Reference Citation Analysis]
552 Frankel AE, Deshmukh S, Reddy A, Lightcap J, Hayes M, McClellan S, Singh S, Rabideau B, Glover TG, Roberts B, Koh AY. Cancer Immune Checkpoint Inhibitor Therapy and the Gut Microbiota. Integr Cancer Ther 2019;18:1534735419846379. [PMID: 31014119 DOI: 10.1177/1534735419846379] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
553 Ciernikova S, Mego M, Chovanec M. Exploring the Potential Role of the Gut Microbiome in Chemotherapy-Induced Neurocognitive Disorders and Cardiovascular Toxicity. Cancers (Basel) 2021;13:782. [PMID: 33668518 DOI: 10.3390/cancers13040782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
554 Sears CL, Pardoll DM. The intestinal microbiome influences checkpoint blockade. Nat Med 2018;24:254-5. [PMID: 29509750 DOI: 10.1038/nm.4511] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
555 Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R. Publisher Correction: The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol 2018;15:785. [PMID: 29785003 DOI: 10.1038/s41575-018-0031-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
556 Kim J, Chae CS, Kim G, Hwang W, Hwang J, Hwang S, Kim Y, Ahn Y, Park S, Jun C, Rudra D, Im S. Lactobacillus helveticus suppresses experimental rheumatoid arthritis by reducing inflammatory T cell responses. Journal of Functional Foods 2015;13:350-62. [DOI: 10.1016/j.jff.2015.01.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
557 Sha S, Ni L, Stefil M, Dixon M, Mouraviev V. The human gastrointestinal microbiota and prostate cancer development and treatment. Investig Clin Urol 2020;61:S43-50. [PMID: 32055753 DOI: 10.4111/icu.2020.61.S1.S43] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
558 Wang B, Yao M, Lv L, Ling Z, Li L. The Human Microbiota in Health and Disease. Engineering 2017;3:71-82. [DOI: 10.1016/j.eng.2017.01.008] [Cited by in Crossref: 266] [Article Influence: 66.5] [Reference Citation Analysis]
559 Byrne KT, Vonderheide RH, Jaffee EM, Armstrong TD. Special Conference on Tumor Immunology and Immunotherapy: A New Chapter. Cancer Immunol Res. 2015;Epub ahead of print. [PMID: 25968457 DOI: 10.1158/2326-6066.cir-15-0106] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
560 Wang D, Hao H, Li X, Wang Z. The effect of intestinal flora on immune checkpoint inhibitors in tumor treatment: a narrative review. Ann Transl Med 2020;8:1097. [PMID: 33145316 DOI: 10.21037/atm-20-4535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
561 Ivanova EA, Orekhov AN. T Helper Lymphocyte Subsets and Plasticity in Autoimmunity and Cancer: An Overview. Biomed Res Int 2015;2015:327470. [PMID: 26583100 DOI: 10.1155/2015/327470] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 10.5] [Reference Citation Analysis]
562 Lanitis E, Dangaj D, Irving M, Coukos G. Mechanisms regulating T-cell infiltration and activity in solid tumors. Ann Oncol 2017;28:xii18-32. [PMID: 29045511 DOI: 10.1093/annonc/mdx238] [Cited by in Crossref: 130] [Cited by in F6Publishing: 129] [Article Influence: 43.3] [Reference Citation Analysis]
563 Park JA, Cheung NV. Limitations and opportunities for immune checkpoint inhibitors in pediatric malignancies. Cancer Treat Rev 2017;58:22-33. [PMID: 28622628 DOI: 10.1016/j.ctrv.2017.05.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 10.8] [Reference Citation Analysis]
564 Fluckiger A, Daillère R, Sassi M, Sixt BS, Liu P, Loos F, Richard C, Rabu C, Alou MT, Goubet AG, Lemaitre F, Ferrere G, Derosa L, Duong CPM, Messaoudene M, Gagné A, Joubert P, De Sordi L, Debarbieux L, Simon S, Scarlata CM, Ayyoub M, Palermo B, Facciolo F, Boidot R, Wheeler R, Boneca IG, Sztupinszki Z, Papp K, Csabai I, Pasolli E, Segata N, Lopez-Otin C, Szallasi Z, Andre F, Iebba V, Quiniou V, Klatzmann D, Boukhalil J, Khelaifia S, Raoult D, Albiges L, Escudier B, Eggermont A, Mami-Chouaib F, Nistico P, Ghiringhelli F, Routy B, Labarrière N, Cattoir V, Kroemer G, Zitvogel L. Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage. Science 2020;369:936-42. [PMID: 32820119 DOI: 10.1126/science.aax0701] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 45.0] [Reference Citation Analysis]
565 Guven DC, Aktas BY, Simsek C, Aksoy S. Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications. Future Oncol 2020;16:497-506. [PMID: 32100550 DOI: 10.2217/fon-2019-0783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
566 Montalban-Arques A, Katkeviciute E, Busenhart P, Bircher A, Wirbel J, Zeller G, Morsy Y, Borsig L, Glaus Garzon JF, Müller A, Arnold IC, Artola-Boran M, Krauthammer M, Sintsova A, Zamboni N, Leventhal GE, Berchtold L, de Wouters T, Rogler G, Baebler K, Schwarzfischer M, Hering L, Olivares-Rivas I, Atrott K, Gottier C, Lang S, Boyman O, Fritsch R, Manz MG, Spalinger MR, Scharl M. Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors. Cell Host Microbe 2021;29:1573-1588.e7. [PMID: 34453895 DOI: 10.1016/j.chom.2021.08.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
567 Pearson JA, Wong FS, Wen L. Crosstalk between circadian rhythms and the microbiota. Immunology 2020;161:278-90. [PMID: 33090484 DOI: 10.1111/imm.13278] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
568 Guipaud O, Jaillet C, Clément-Colmou K, François A, Supiot S, Milliat F. The importance of the vascular endothelial barrier in the immune-inflammatory response induced by radiotherapy. Br J Radiol 2018;91:20170762. [PMID: 29630386 DOI: 10.1259/bjr.20170762] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
569 Delaux PM, Varala K, Edger PP, Coruzzi GM, Pires JC, Ané JM. Comparative phylogenomics uncovers the impact of symbiotic associations on host genome evolution. PLoS Genet 2014;10:e1004487. [PMID: 25032823 DOI: 10.1371/journal.pgen.1004487] [Cited by in Crossref: 149] [Cited by in F6Publishing: 118] [Article Influence: 21.3] [Reference Citation Analysis]
570 Lyu Y, Yang H, Chen L. Metabolic regulation on the immune environment of glioma through gut microbiota. Semin Cancer Biol 2021:S1044-579X(21)00133-4. [PMID: 33971263 DOI: 10.1016/j.semcancer.2021.05.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
571 Rea D, Coppola G, Palma G, Barbieri A, Luciano A, Del Prete P, Rossetti S, Berretta M, Facchini G, Perdonà S, Turco MC, Arra C. Microbiota effects on cancer: from risks to therapies. Oncotarget 2018;9:17915-27. [PMID: 29707157 DOI: 10.18632/oncotarget.24681] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 27.3] [Reference Citation Analysis]
572 Temraz S, Nassar F, Nasr R, Charafeddine M, Mukherji D, Shamseddine A. Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer. Int J Mol Sci 2019;20:E4155. [PMID: 31450712 DOI: 10.3390/ijms20174155] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 12.0] [Reference Citation Analysis]
573 Gately S. Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients. In: Von Hoff DD, Han H, editors. Precision Medicine in Cancer Therapy. Cham: Springer International Publishing; 2019. pp. 253-64. [DOI: 10.1007/978-3-030-16391-4_10] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
574 Khan MAW, Ologun G, Arora R, McQuade JL, Wargo JA. Gut Microbiome Modulates Response to Cancer Immunotherapy. Dig Dis Sci 2020;65:885-96. [PMID: 32067144 DOI: 10.1007/s10620-020-06111-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
575 Shahnazari M, Samadi P, Pourjafar M, Jalali A. Cell-based immunotherapy approaches for colorectal cancer: main achievements and challenges. Future Oncol 2021;17:3253-70. [PMID: 34156258 DOI: 10.2217/fon-2020-1218] [Reference Citation Analysis]
576 Badgeley A, Anwar H, Modi K, Murphy P, Lakshmikuttyamma A. Effect of probiotics and gut microbiota on anti-cancer drugs: Mechanistic perspectives. Biochim Biophys Acta Rev Cancer 2021;1875:188494. [PMID: 33346129 DOI: 10.1016/j.bbcan.2020.188494] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
577 Chambers LM, Kuznicki M, Yao M, Chichura A, Gruner M, Reizes O, Debernardo R, Rose PG, Michener C, Vargas R. Impact of antibiotic treatment during platinum chemotherapy on survival and recurrence in women with advanced epithelial ovarian cancer. Gynecol Oncol 2020;159:699-705. [PMID: 32950250 DOI: 10.1016/j.ygyno.2020.09.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
578 Flandroy L, Poutahidis T, Berg G, Clarke G, Dao MC, Decaestecker E, Furman E, Haahtela T, Massart S, Plovier H, Sanz Y, Rook G. The impact of human activities and lifestyles on the interlinked microbiota and health of humans and of ecosystems. Sci Total Environ. 2018;627:1018-1038. [PMID: 29426121 DOI: 10.1016/j.scitotenv.2018.01.288] [Cited by in Crossref: 112] [Cited by in F6Publishing: 86] [Article Influence: 37.3] [Reference Citation Analysis]
579 Baiden-Amissah REM, Tuyaerts S. Contribution of Aging, Obesity, and Microbiota on Tumor Immunotherapy Efficacy and Toxicity. Int J Mol Sci 2019;20:E3586. [PMID: 31340438 DOI: 10.3390/ijms20143586] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
580 Abid MB. Could the menagerie of the gut microbiome really cure cancer? Hope or hype. J Immunother Cancer 2019;7:92. [PMID: 30940203 DOI: 10.1186/s40425-019-0561-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
581 Wang J, Jia H. Metagenome-wide association studies: fine-mining the microbiome. Nat Rev Microbiol 2016;14:508-22. [PMID: 27396567 DOI: 10.1038/nrmicro.2016.83] [Cited by in Crossref: 215] [Cited by in F6Publishing: 172] [Article Influence: 43.0] [Reference Citation Analysis]
582 West NR, Powrie F. Immunotherapy Not Working? Cancer Cell. 2015;28:687-689. [PMID: 26678336 DOI: 10.1016/j.ccell.2015.11.010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
583 Górska A, Przystupski D, Niemczura MJ, Kulbacka J. Probiotic Bacteria: A Promising Tool in Cancer Prevention and Therapy. Curr Microbiol 2019;76:939-49. [PMID: 30949803 DOI: 10.1007/s00284-019-01679-8] [Cited by in Crossref: 63] [Cited by in F6Publishing: 48] [Article Influence: 31.5] [Reference Citation Analysis]
584 Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, Qian Y, Kryczek I, Sun D, Nagarsheth N, Chen Y, Chen H, Hong J, Zou W, Fang JY. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell. 2017;170:548-563.e16. [PMID: 28753429 DOI: 10.1016/j.cell.2017.07.008] [Cited by in Crossref: 531] [Cited by in F6Publishing: 543] [Article Influence: 132.8] [Reference Citation Analysis]
585 Lohinai Z, Megyesfalvi Z, Dome B, Weiss GJ. Next-Generation Sequencing May Discriminate Extreme Long-term versus Short-term Survival in Patients with Metastatic Small Cell Lung Cancer (SCLC). Transl Oncol 2019;12:1539-48. [PMID: 31476386 DOI: 10.1016/j.tranon.2019.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
586 Liu J, Liu C, Yue J. Radiotherapy and the gut microbiome: facts and fiction. Radiat Oncol 2021;16:9. [PMID: 33436010 DOI: 10.1186/s13014-020-01735-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
587 Khan AA, Sirsat AT, Singh H, Cash P. Microbiota and cancer: current understanding and mechanistic implications. Clin Transl Oncol 2021. [PMID: 34387847 DOI: 10.1007/s12094-021-02690-x] [Reference Citation Analysis]
588 Vyshenska D, Lam KC, Shulzhenko N, Morgun A. Interplay between viruses and bacterial microbiota in cancer development. Semin Immunol 2017;32:14-24. [PMID: 28602713 DOI: 10.1016/j.smim.2017.05.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
589 Nikfarjam S, Rezaie J, Kashanchi F, Jafari R. Dexosomes as a cell-free vaccine for cancer immunotherapy. J Exp Clin Cancer Res 2020;39:258. [PMID: 33228747 DOI: 10.1186/s13046-020-01781-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
590 Groza D, Gehrig S, Kudela P, Holcmann M, Pirker C, Dinhof C, Schueffl HH, Sramko M, Hoebart J, Alioglu F, Grusch M, Ogris M, Lubitz W, Keppler BK, Pashkunova-Martic I, Kowol CR, Sibilia M, Berger W, Heffeter P. Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis. Oncoimmunology 2018;7:e1424676. [PMID: 29721389 DOI: 10.1080/2162402X.2018.1424676] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
591 Yamamura K, Izumi D, Kandimalla R, Sonohara F, Baba Y, Yoshida N, Kodera Y, Baba H, Goel A. Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma. Clin Cancer Res 2019;25:6170-9. [PMID: 31358543 DOI: 10.1158/1078-0432.CCR-19-0318] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 13.0] [Reference Citation Analysis]
592 Pröbstel AK, Baranzini SE. The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the "MS Microbiome". Neurotherapeutics 2018;15:126-34. [PMID: 29147991 DOI: 10.1007/s13311-017-0587-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 19.0] [Reference Citation Analysis]
593 Cao Y, Yang L, Qiao X, Xue C, Xu J. Dietary astaxanthin: an excellent carotenoid with multiple health benefits. Crit Rev Food Sci Nutr 2021;:1-27. [PMID: 34581210 DOI: 10.1080/10408398.2021.1983766] [Reference Citation Analysis]
594 Brandi G, Frega G. Microbiota: Overview and Implication in Immunotherapy-Based Cancer Treatments. Int J Mol Sci 2019;20:E2699. [PMID: 31159348 DOI: 10.3390/ijms20112699] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
595 Tikka C, Manthari RK, Ommati MM, Niu R, Sun Z, Zhang J, Wang J. Immune disruption occurs through altered gut microbiome and NOD2 in arsenic induced mice: Correlation with colon cancer markers. Chemosphere 2020;246:125791. [PMID: 31927375 DOI: 10.1016/j.chemosphere.2019.125791] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
596 Liu S, Alexander RK, Lee CH. Lipid metabolites as metabolic messengers in inter-organ communication. Trends Endocrinol Metab 2014;25:356-63. [PMID: 24895003 DOI: 10.1016/j.tem.2014.05.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
597 Zidi O, Souai N, Raies H, Ben Ayed F, Mezlini A, Mezrioui S, Tranchida F, Sabatier JM, Mosbah A, Cherif A, Shintu L, Kouidhi S. Fecal Metabolic Profiling of Breast Cancer Patients during Neoadjuvant Chemotherapy Reveals Potential Biomarkers. Molecules 2021;26:2266. [PMID: 33919750 DOI: 10.3390/molecules26082266] [Reference Citation Analysis]
598 Suárez-Rivero JM, Pastor-Maldonado CJ, Povea-Cabello S, Álvarez-Córdoba M, Villalón-García I, Talaverón-Rey M, Suárez-Carrillo A, Munuera-Cabeza M, Sánchez-Alcázar JA. Mitochondria and Antibiotics: For Good or for Evil? Biomolecules 2021;11:1050. [PMID: 34356674 DOI: 10.3390/biom11071050] [Reference Citation Analysis]
599 Jiang JW, Chen XH, Ren Z, Zheng SS. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis. Hepatobiliary Pancreat Dis Int 2019;18:19-27. [PMID: 30527903 DOI: 10.1016/j.hbpd.2018.11.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
600 Sfanos KS, Yegnasubramanian S, Nelson WG, De Marzo AM. The inflammatory microenvironment and microbiome in prostate cancer development. Nat Rev Urol. 2018;15:11-24. [PMID: 29089606 DOI: 10.1038/nrurol.2017.167] [Cited by in Crossref: 135] [Cited by in F6Publishing: 129] [Article Influence: 33.8] [Reference Citation Analysis]
601 Guyton K, Alverdy JC. The gut microbiota and gastrointestinal surgery. Nat Rev Gastroenterol Hepatol. 2017;14:43-54. [PMID: 27729657 DOI: 10.1038/nrgastro.2016.139] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 12.4] [Reference Citation Analysis]
602 Spencer HG, Zuk M. For Host's Sake: The Pluses of Parasite Preservation. Trends in Ecology & Evolution 2016;31:341-3. [DOI: 10.1016/j.tree.2016.02.021] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
603 Niederreiter L, Adolph TE, Tilg H. Food, microbiome and colorectal cancer. Dig Liver Dis 2018;50:647-52. [PMID: 29705028 DOI: 10.1016/j.dld.2018.03.030] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
604 Su J, Su L, Li D, Shuai O, Zhang Y, Liang H, Jiao C, Xu Z, Lai Y, Xie Y. Antitumor Activity of Extract From the Sporoderm-Breaking Spore of Ganoderma lucidum: Restoration on Exhausted Cytotoxic T Cell With Gut Microbiota Remodeling. Front Immunol 2018;9:1765. [PMID: 30108589 DOI: 10.3389/fimmu.2018.01765] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
605 Sumransub N, Vantanasiri K, Prakash A, Lou E. Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success? Mol Ther Oncolytics 2021;22:1-12. [PMID: 34307839 DOI: 10.1016/j.omto.2021.05.001] [Reference Citation Analysis]
606 De Wolf K, Rottey S, Vermaelen K, Decaestecker K, Sundahl N, De Lobel L, Goetghebeur E, De Meerleer G, Lumen N, Fonteyne V, De Maeseneer D, Ost P. Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial. Radiat Oncol 2017;12:157. [PMID: 28938918 DOI: 10.1186/s13014-017-0893-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
607 El-Sayed A, Aleya L, Kamel M. The link among microbiota, epigenetics, and disease development. Environ Sci Pollut Res Int 2021;28:28926-64. [PMID: 33860421 DOI: 10.1007/s11356-021-13862-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
608 Veziant J, Villéger R, Barnich N, Bonnet M. Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer. Cancers (Basel) 2021;13:2215. [PMID: 34063108 DOI: 10.3390/cancers13092215] [Reference Citation Analysis]
609 Wagner AD, Özdemir B, Csajka C. Reply to L. Pala et al. JCO 2019;37:439-40. [DOI: 10.1200/jco.18.01668] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
610 Shono Y, van den Brink MRM. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation. Nat Rev Cancer 2018;18:283-95. [PMID: 29449660 DOI: 10.1038/nrc.2018.10] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 29.3] [Reference Citation Analysis]
611 Zhang X, Liu Q, Liao Q, Zhao Y. Pancreatic Cancer, Gut Microbiota, and Therapeutic Efficacy. J Cancer. 2020;11:2749-2758. [PMID: 32226493 DOI: 10.7150/jca.37445] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
612 Bindels LB, Neyrinck AM, Loumaye A, Catry E, Walgrave H, Cherbuy C, Leclercq S, Van Hul M, Plovier H, Pachikian B, Bermúdez-Humarán LG, Langella P, Cani PD, Thissen JP, Delzenne NM. Increased gut permeability in cancer cachexia: mechanisms and clinical relevance. Oncotarget 2018;9:18224-38. [PMID: 29719601 DOI: 10.18632/oncotarget.24804] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 13.7] [Reference Citation Analysis]
613 Klevorn LE, Teague RM. Adapting Cancer Immunotherapy Models for the Real World. Trends Immunol 2016;37:354-63. [PMID: 27105824 DOI: 10.1016/j.it.2016.03.010] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 10.6] [Reference Citation Analysis]
614 Bordon Y. Tumour immunology: Anticancer drugs need bugs. Nat Rev Immunol 2014;14:1. [PMID: 24336106 DOI: 10.1038/nri3591] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
615 ElRakaiby M, Dutilh BE, Rizkallah MR, Boleij A, Cole JN, Aziz RK. Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics. OMICS 2014;18:402-14. [PMID: 24785449 DOI: 10.1089/omi.2014.0018] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 10.3] [Reference Citation Analysis]
616 Goldszmid RS, Dzutsev A, Viaud S, Zitvogel L, Restifo NP, Trinchieri G. Microbiota modulation of myeloid cells in cancer therapy. Cancer Immunol Res 2015;3:103-9. [PMID: 25660553 DOI: 10.1158/2326-6066.CIR-14-0225] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
617 Anfossi S, Calin GA. Gut microbiota: a new player in regulating immune- and chemo-therapy efficacy. Cancer Drug Resist 2020;3:356-70. [PMID: 33062956 DOI: 10.20517/cdr.2020.04] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
618 Irfan M, Delgado RZR, Frias-Lopez J. The Oral Microbiome and Cancer. Front Immunol 2020;11:591088. [PMID: 33193429 DOI: 10.3389/fimmu.2020.591088] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
619 Lenoir M, del Carmen S, Cortes-perez NG, Lozano-ojalvo D, Muñoz-provencio D, Chain F, Langella P, de Moreno de Leblanc A, Leblanc JG, Bermúdez-humarán LG. RETRACTED ARTICLE: Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer. J Gastroenterol 2016;51:862-73. [DOI: 10.1007/s00535-015-1158-9] [Cited by in Crossref: 94] [Cited by in F6Publishing: 78] [Article Influence: 18.8] [Reference Citation Analysis]
620 Cammarota G, Ianiro G, Ahern A, Carbone C, Temko A, Claesson MJ, Gasbarrini A, Tortora G. Gut microbiome, big data and machine learning to promote precision medicine for cancer. Nat Rev Gastroenterol Hepatol 2020;17:635-48. [DOI: 10.1038/s41575-020-0327-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 31.0] [Reference Citation Analysis]
621 Xu D, Huang Y, Wang J. Gut microbiota modulate the immune effect against hepatitis B virus infection.Eur J Clin Microbiol Infect Dis. 2015;34:2139-2147. [PMID: 26272175 DOI: 10.1007/s10096-015-2464-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
622 Gonçalves SM, Lagrou K, Duarte-Oliveira C, Maertens JA, Cunha C, Carvalho A. The microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases. Virulence 2017;8:673-84. [PMID: 27820674 DOI: 10.1080/21505594.2016.1257458] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
623 Chamseddine AN, Ducreux M, Armand J, Paoletti X, Satar T, Paci A, Mir O. Intestinal bacterial β-glucuronidase as a possible predictive biomarker of irinotecan-induced diarrhea severity. Pharmacology & Therapeutics 2019;199:1-15. [DOI: 10.1016/j.pharmthera.2019.03.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
624 Qu J, Sun Z, Peng C, Li D, Yan W, Xu Z, Hou Y, Shen S, Chen P, Wang T. C. tropicalis promotes chemotherapy resistance in colon cancer through increasing lactate production to regulate the mismatch repair system. Int J Biol Sci 2021;17:2756-69. [PMID: 34345205 DOI: 10.7150/ijbs.59262] [Reference Citation Analysis]
625 Prelaj A, Tay R, Ferrara R, Chaput N, Besse B, Califano R. Predictive biomarkers of response for immune checkpoint inhibitors in non-small-cell lung cancer. Eur J Cancer 2019;106:144-59. [PMID: 30528799 DOI: 10.1016/j.ejca.2018.11.002] [Cited by in Crossref: 80] [Cited by in F6Publishing: 85] [Article Influence: 26.7] [Reference Citation Analysis]
626 Geng R, Liu H, Tan K, Wang Z, Wang W. RNase1 can modulate gut microbiota and metabolome after Aeromonas hydrophila infection in blunt snout bream. Environ Microbiol 2021. [PMID: 33973327 DOI: 10.1111/1462-2920.15564] [Reference Citation Analysis]
627 Sári Z, Mikó E, Kovács T, Jankó L, Csonka T, Lente G, Sebő É, Tóth J, Tóth D, Árkosy P, Boratkó A, Ujlaki G, Török M, Kovács I, Szabó J, Kiss B, Méhes G, Goedert JJ, Bai P. Indolepropionic Acid, a Metabolite of the Microbiome, Has Cytostatic Properties in Breast Cancer by Activating AHR and PXR Receptors and Inducing Oxidative Stress. Cancers (Basel) 2020;12:E2411. [PMID: 32854297 DOI: 10.3390/cancers12092411] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
628 Kareva I. Metabolism and Gut Microbiota in Cancer Immunoediting, CD8/Treg Ratios, Immune Cell Homeostasis, and Cancer (Immuno)Therapy: Concise Review. Stem Cells 2019;37:1273-80. [PMID: 31260163 DOI: 10.1002/stem.3051] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
629 Yuan L, Zhang S, Li H, Yang F, Mushtaq N, Ullah S, Shi Y, An C, Xu J. The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer. Biomed Pharmacother 2018;108:184-93. [PMID: 30219675 DOI: 10.1016/j.biopha.2018.08.165] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 17.0] [Reference Citation Analysis]
630 Roberti MP, Rauber C, Kroemer G, Zitvogel L. Impact of the ileal microbiota on colon cancer. Semin Cancer Biol 2021:S1044-579X(21)00250-9. [PMID: 34624451 DOI: 10.1016/j.semcancer.2021.09.016] [Reference Citation Analysis]
631 Pichon M, Burucoa C. Impact of the Gastro-Intestinal Bacterial Microbiome on Helicobacter-Associated Diseases. Healthcare (Basel). 2019;7. [PMID: 30813360 DOI: 10.3390/healthcare7010034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
632 Cohen I, Ruff WE, Longbrake EE. Influence of immunomodulatory drugs on the gut microbiota. Transl Res 2021;233:144-61. [PMID: 33515779 DOI: 10.1016/j.trsl.2021.01.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
633 Fischer JC, Wintges A, Haas T, Poeck H. Assessment of mucosal integrity by quantifying neutrophil granulocyte influx in murine models of acute intestinal injury. Cell Immunol 2017;316:70-6. [PMID: 28413062 DOI: 10.1016/j.cellimm.2017.04.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
634 Mulcahy-O'Grady H, Workentine ML. The Challenge and Potential of Metagenomics in the Clinic. Front Immunol 2016;7:29. [PMID: 26870044 DOI: 10.3389/fimmu.2016.00029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
635 Gaya A, Akle CA, Mudan S, Grange J. The Concept of Hormesis in Cancer Therapy - Is Less More? Cureus 2015;7:e261. [PMID: 26180685 DOI: 10.7759/cureus.261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
636 Attili I, Tarantino P, Passaro A, Stati V, Curigliano G, de Marinis F. Strategies to overcome resistance to immune checkpoint blockade in lung cancer. Lung Cancer 2021;154:151-60. [PMID: 33684660 DOI: 10.1016/j.lungcan.2021.02.035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
637 Hahn AW, Froerer C, Vanalstine S, Rathi N, Bailey EB, Stenehjem DD, Agarwal N. Targeting Bacteroides in Stool Microbiome and Response to Treatment With First-Line VEGF Tyrosine Kinase Inhibitors in Metastatic Renal-Cell Carcinoma. Clinical Genitourinary Cancer 2018;16:365-8. [DOI: 10.1016/j.clgc.2018.05.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
638 Tsilimigras MC, Fodor A, Jobin C. Carcinogenesis and therapeutics: The microbiota perspective. Nat Microbiol. 2017;2:17008. [PMID: 28225000 DOI: 10.1038/nmicrobiol.2017.8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 15.5] [Reference Citation Analysis]
639 Singh KP, Dhruva A, Flowers E, Paul SM, Hammer MJ, Wright F, Cartwright F, Conley YP, Melisko M, Levine JD, Miaskowski C, Kober KM. Alterations in Patterns of Gene Expression and Perturbed Pathways in the Gut-Brain Axis Are Associated With Chemotherapy-Induced Nausea. J Pain Symptom Manage 2020;59:1248-1259.e5. [PMID: 31923555 DOI: 10.1016/j.jpainsymman.2019.12.352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
640 Wertman JN, Dunn KA, Kulkarni K. The impact of the host intestinal microbiome on carcinogenesis and the response to chemotherapy. Future Oncol 2021;17:4371-87. [PMID: 34448411 DOI: 10.2217/fon-2021-0087] [Reference Citation Analysis]
641 Koontz JM, Dancy BCR, Horton CL, Stallings JD, DiVito VT, Lewis JA. The Role of the Human Microbiome in Chemical Toxicity. Int J Toxicol 2019;38:251-64. [PMID: 31220972 DOI: 10.1177/1091581819849833] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
642 Porter CM, Shrestha E, Peiffer LB, Sfanos KS. The microbiome in prostate inflammation and prostate cancer. Prostate Cancer Prostatic Dis 2018;21:345-54. [PMID: 29795140 DOI: 10.1038/s41391-018-0041-1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 15.0] [Reference Citation Analysis]
643 Diamanti AP, Manuela Rosado M, Laganà B, D'Amelio R. Microbiota and chronic inflammatory arthritis: an interwoven link. J Transl Med 2016;14:233. [PMID: 27492386 DOI: 10.1186/s12967-016-0989-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
644 Palucka AK, Coussens LM. The Basis of Oncoimmunology. Cell. 2016;164:1233-1247. [PMID: 26967289 DOI: 10.1016/j.cell.2016.01.049] [Cited by in Crossref: 405] [Cited by in F6Publishing: 393] [Article Influence: 81.0] [Reference Citation Analysis]
645 Wei W, Sun W, Yu S, Yang Y, Ai L. Butyrate production from high-fiber diet protects against lymphoma tumor. Leukemia & Lymphoma 2016;57:2401-8. [DOI: 10.3109/10428194.2016.1144879] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 7.2] [Reference Citation Analysis]
646 Lu P, Xu M, Xiong Z, Zhou F, Wang L. Fusobacterium nucleatum prevents apoptosis in colorectal cancer cells via the ANO1 pathway. Cancer Manag Res 2019;11:9057-66. [PMID: 31802939 DOI: 10.2147/CMAR.S185766] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
647 Hannachi N, Camoin-Jau L. Drug Response Diversity: A Hidden Bacterium? J Pers Med 2021;11:345. [PMID: 33922920 DOI: 10.3390/jpm11050345] [Reference Citation Analysis]
648 Lee JC, Lee HY, Kim TK, Kim MS, Park YM, Kim J, Park K, Kweon MN, Kim SH, Bae JW, Hur KY, Lee MS. Obesogenic diet-induced gut barrier dysfunction and pathobiont expansion aggravate experimental colitis. PLoS One 2017;12:e0187515. [PMID: 29107964 DOI: 10.1371/journal.pone.0187515] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 7.8] [Reference Citation Analysis]
649 Huang ST, Chen J, Lian LY, Cai HH, Zeng HS, Zheng M, Liu MB. Intratumoral levels and prognostic significance of Fusobacterium nucleatum in cervical carcinoma. Aging (Albany NY) 2020;12:23337-50. [PMID: 33197886 DOI: 10.18632/aging.104188] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
650 Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA. The microbiome, cancer, and cancer therapy. Nat Med 2019;25:377-88. [DOI: 10.1038/s41591-019-0377-7] [Cited by in Crossref: 250] [Cited by in F6Publishing: 218] [Article Influence: 125.0] [Reference Citation Analysis]
651 Dong L, Xie J, Wang Y, Zuo D. Gut Microbiota and Immune Responses. Adv Exp Med Biol 2020;1238:165-93. [PMID: 32323185 DOI: 10.1007/978-981-15-2385-4_10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
652 McQuade JL, Daniel CR, Helmink BA, Wargo JA. Modulating the microbiome to improve therapeutic response in cancer. Lancet Oncol 2019;20:e77-91. [PMID: 30712808 DOI: 10.1016/S1470-2045(18)30952-5] [Cited by in Crossref: 108] [Cited by in F6Publishing: 56] [Article Influence: 108.0] [Reference Citation Analysis]
653 Chalabi M, Cardona A, Nagarkar DR, Dhawahir Scala A, Gandara DR, Rittmeyer A, Albert ML, Powles T, Kok M, Herrera FG; imCORE working group of early career investigators. Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trials. Ann Oncol 2020;31:525-31. [PMID: 32115349 DOI: 10.1016/j.annonc.2020.01.006] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 57.0] [Reference Citation Analysis]
654 Rinninella E, Raoul P, Cintoni M, Palombaro M, Pulcini G, Gasbarrini A, Mele MC. Nutritional Interventions Targeting Gut Microbiota during Cancer Therapies. Microorganisms 2021;9:1469. [PMID: 34361904 DOI: 10.3390/microorganisms9071469] [Reference Citation Analysis]
655 Alegre ML, Mannon RB, Mannon PJ. The microbiota, the immune system and the allograft. Am J Transplant 2014;14:1236-48. [PMID: 24840316 DOI: 10.1111/ajt.12760] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
656 Chambers LM, Bussies P, Vargas R, Esakov E, Tewari S, Reizes O, Michener C. The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities. Curr Oncol Rep 2021;23:92. [PMID: 34125319 DOI: 10.1007/s11912-021-01079-x] [Reference Citation Analysis]
657 McAllister F, Housseau F, Sears CL. Microbiota and immune responses in colon cancer: more to learn. Cancer J 2014;20:232-6. [PMID: 24855013 DOI: 10.1097/PPO.0000000000000051] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
658 Ohadian Moghadam S, Momeni SA. Human microbiome and prostate cancer development: current insights into the prevention and treatment. Front Med 2021;15:11-32. [PMID: 32607819 DOI: 10.1007/s11684-019-0731-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
659 Dono A, Patrizz A, McCormack RM, Putluri N, Ganesh BP, Kaur B, McCullough LD, Ballester LY, Esquenazi Y. Glioma induced alterations in fecal short-chain fatty acids and neurotransmitters. CNS Oncol 2020;9:CNS57. [PMID: 32602743 DOI: 10.2217/cns-2020-0007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
660 Zhang F, He F, Li L, Guo L, Zhang B, Yu S, Zhao W. Bioavailability Based on the Gut Microbiota: a New Perspective. Microbiol Mol Biol Rev 2020;84:e00072-19. [PMID: 32350027 DOI: 10.1128/MMBR.00072-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
661 Andrews MC, Reuben A, Gopalakrishnan V, Wargo JA. Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy. Front Immunol 2018;9:946. [PMID: 29780391 DOI: 10.3389/fimmu.2018.00946] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
662 Russo E, Nannini G, Dinu M, Pagliai G, Sofi F, Amedei A. Exploring the food-gut axis in immunotherapy response of cancer patients. World J Gastroenterol 2020; 26(33): 4919-4932 [PMID: 32952339 DOI: 10.3748/wjg.v26.i33.4919] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
663 Yamamoto M, Matsumoto S. Gut microbiota and colorectal cancer. Genes Environ 2016;38:11. [PMID: 27350830 DOI: 10.1186/s41021-016-0038-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
664 Carroll CSE, Andrew ER, Malik L, Elliott KF, Brennan M, Meyer J, Hintze A, Almonte AA, Lappin C, MacPherson P, Schulte KM, Dahlstrom JE, Tamhane R, Neeman T, Herbert EW, Orange M, Yip D, Allavena R, Fahrer AM. Simple and effective bacterial-based intratumoral cancer immunotherapy. J Immunother Cancer 2021;9:e002688. [PMID: 34531247 DOI: 10.1136/jitc-2021-002688] [Reference Citation Analysis]
665 Pinato DJ, Gramenitskaya D, Altmann DM, Boyton RJ, Mullish BH, Marchesi JR, Bower M. Antibiotic therapy and outcome from immune-checkpoint inhibitors. J Immunother Cancer 2019;7:287. [PMID: 31694714 DOI: 10.1186/s40425-019-0775-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 18.0] [Reference Citation Analysis]
666 Khan N, Lindner S, Gomes ALC, Devlin SM, Shah GL, Sung AD, Sauter CS, Landau HJ, Dahi PB, Perales MA, Chung DJ, Lesokhin AM, Dai A, Clurman A, Slingerland JB, Slingerland AE, Brereton DG, Giardina PA, Maloy M, Armijo GK, Rondon-Clavo C, Fontana E, Bohannon L, Ramalingam S, Bush AT, Lew MV, Messina JA, Littmann E, Taur Y, Jenq RR, Chao NJ, Giralt S, Markey KA, Pamer EG, van den Brink MRM, Peled JU. Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study. Blood 2021;137:1527-37. [PMID: 33512409 DOI: 10.1182/blood.2020006923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
667 Viaud S, Daillère R, Boneca IG, Lepage P, Langella P, Chamaillard M, Pittet MJ, Ghiringhelli F, Trinchieri G, Goldszmid R, Zitvogel L. Gut microbiome and anticancer immune response: really hot Sh*t! Cell Death Differ 2015;22:199-214. [PMID: 24832470 DOI: 10.1038/cdd.2014.56] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 10.3] [Reference Citation Analysis]
668 Zhu XH, Lang HD, Wang XL, Hui SC, Zhou M, Kang C, Yi L, Mi MT, Zhang Y. Synergy between dihydromyricetin intervention and irinotecan chemotherapy delays the progression of colon cancer in mouse models. Food Funct 2019;10:2040-9. [PMID: 30907395 DOI: 10.1039/c8fo01756e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
669 Li W, Deng Y, Chu Q, Zhang P. Gut microbiome and cancer immunotherapy. Cancer Lett. 2019;447:41-47. [PMID: 30684593 DOI: 10.1016/j.canlet.2019.01.015] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 22.5] [Reference Citation Analysis]
670 Bélanger V, Benmoussa A, Napartuk M, Warin A, Laverdière C, Marcoux S, Levy E, Marcil V. The Role of Oxidative Stress and Inflammation in Cardiometabolic Health of Children During Cancer Treatment and Potential Impact of Key Nutrients. Antioxid Redox Signal 2021;35:293-318. [PMID: 33386063 DOI: 10.1089/ars.2020.8143] [Reference Citation Analysis]
671 Bessell CA, Isser A, Havel JJ, Lee S, Bell DR, Hickey JW, Chaisawangwong W, Glick Bieler J, Srivastava R, Kuo F, Purohit T, Zhou R, Chan TA, Schneck JP. Commensal bacteria stimulate antitumor responses via T cell cross-reactivity. JCI Insight 2020;5:135597. [PMID: 32324171 DOI: 10.1172/jci.insight.135597] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
672 Hamm AK, Weir TL. Editorial on "Cancer and the microbiota" published in Science. Ann Transl Med 2015;3:175. [PMID: 26366392 DOI: 10.3978/j.issn.2305-5839.2015.07.16] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
673 李豪, 张鹏. 肠道微生态在大肠癌精准治疗中作用的研究进展. 世界华人消化杂志 2016; 24(32): 4354-4361 [DOI: 10.11569/wcjd.v24.i32.4354] [Reference Citation Analysis]
674 Innao V, Allegra AG, Musolino C, Allegra A. New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era. Int J Mol Sci 2020;21:E8902. [PMID: 33255336 DOI: 10.3390/ijms21238902] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
675 Pandey K, Umar S. Microbiome in drug resistance to colon cancer. Curr Opin Physiol 2021;23:100472. [PMID: 34514218 DOI: 10.1016/j.cophys.2021.100472] [Reference Citation Analysis]
676 Jiang P, Sellers WR, Liu XS. Big Data Approaches for Modeling Response and Resistance to Cancer Drugs. Annu Rev Biomed Data Sci 2018;1:1-27. [PMID: 31342013 DOI: 10.1146/annurev-biodatasci-080917-013350] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 5.7] [Reference Citation Analysis]
677 Ortiz AM, Klase ZA, DiNapoli SR, Vujkovic-Cvijin I, Carmack K, Perkins MR, Calantone N, Vinton CL, Riddick NE, Gallagher J, Klatt NR, McCune JM, Estes JD, Paiardini M, Brenchley JM. IL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques. Mucosal Immunol 2016;9:458-67. [PMID: 26286233 DOI: 10.1038/mi.2015.75] [Cited by in Crossref: 53] [Cited by in F6Publishing: 59] [Article Influence: 8.8] [Reference Citation Analysis]
678 Vigneron C, Mirouse A, Merdji H, Rousseau C, Cousin C, Alby-Laurent F, Mira JP, Chiche JD, Llitjos JF, Pène F. Sepsis inhibits tumor growth in mice with cancer through Toll-like receptor 4-associated enhanced Natural Killer cell activity. Oncoimmunology 2019;8:e1641391. [PMID: 31646090 DOI: 10.1080/2162402X.2019.1641391] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
679 Shen S, Lim G, You Z, Ding W, Huang P, Ran C, Doheny J, Caravan P, Tate S, Hu K, Kim H, McCabe M, Huang B, Xie Z, Kwon D, Chen L, Mao J. Gut microbiota is critical for the induction of chemotherapy-induced pain. Nat Neurosci 2017;20:1213-6. [PMID: 28714953 DOI: 10.1038/nn.4606] [Cited by in Crossref: 87] [Cited by in F6Publishing: 82] [Article Influence: 21.8] [Reference Citation Analysis]
680 Vétizou M, Daillère R, Zitvogel L. [The role of intestinal microbiota in the response to anti-tumor therapies].Med Sci (Paris). 2016;32:974-982. [PMID: 28008838 DOI: 10.1051/medsci/20163211013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
681 Gagliani N, Hu B, Huber S, Elinav E, Flavell RA. The fire within: microbes inflame tumors. Cell 2014;157:776-83. [PMID: 24813605 DOI: 10.1016/j.cell.2014.03.006] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 10.9] [Reference Citation Analysis]
682 Vande Voorde J, Vervaeke P, Liekens S, Balzarini J. Mycoplasma hyorhinis-encoded cytidine deaminase efficiently inactivates cytosine-based anticancer drugs. FEBS Open Bio 2015;5:634-9. [PMID: 26322268 DOI: 10.1016/j.fob.2015.07.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
683 Oldenburg M, Rüchel N, Janssen S, Borkhardt A, Gössling KL. The Microbiome in Childhood Acute Lymphoblastic Leukemia. Cancers (Basel) 2021;13:4947. [PMID: 34638430 DOI: 10.3390/cancers13194947] [Reference Citation Analysis]
684 Pouncey AL, Scott AJ, Alexander JL, Marchesi J, Kinross J. Gut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatment. Ecancermedicalscience. 2018;12:868. [PMID: 30263059 DOI: 10.3332/ecancer.2018.868] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 10.7] [Reference Citation Analysis]
685 Azevedo MM, Pina-Vaz C, Baltazar F. Microbes and Cancer: Friends or Faux? Int J Mol Sci 2020;21:E3115. [PMID: 32354115 DOI: 10.3390/ijms21093115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
686 Morcrette G, Hirsch TZ, Badour E, Pilet J, Caruso S, Calderaro J, Martin Y, Imbeaud S, Letouzé E, Rebouissou S, Branchereau S, Taque S, Chardot C, Guettier C, Scoazec JY, Fabre M, Brugières L, Zucman-Rossi J. APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures. Oncoimmunology 2019;8:e1583547. [PMID: 31069152 DOI: 10.1080/2162402X.2019.1583547] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
687 Schupack DA, Mars RAT, Voelker DH, Abeykoon JP, Kashyap PC. The promise of the gut microbiome as part of individualized treatment strategies. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34453142 DOI: 10.1038/s41575-021-00499-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
688 Liu Q, Yang Y, Tan X, Tao Z, Adah D, Yu S, Lu J, Zhao S, Qin L, Qin L, Chen X. Plasmodium parasite as an effective hepatocellular carcinoma antigen glypican-3 delivery vector. Oncotarget 2017;8:24785-96. [PMID: 28445973 DOI: 10.18632/oncotarget.15806] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
689 Bajic JE, Johnston IN, Howarth GS, Hutchinson MR. From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation. Front Behav Neurosci 2018;12:104. [PMID: 29872383 DOI: 10.3389/fnbeh.2018.00104] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
690 Slowicka K, Petta I, Blancke G, Hoste E, Dumas E, Sze M, Vikkula H, Radaelli E, Haigh JJ, Jonckheere S, Taminau J, Vandamme N, Wullaert A, Tulchinsky E, Nittner D, Van Vlierberghe P, De Hertogh G, Baldin P, Etlioglu E, Wirapati P, Boon L, Lambrecht BN, Callewaert C, Tejpar S, Goossens S, Berx G, Vereecke L, van Loo G. Zeb2 drives invasive and microbiota-dependent colon carcinoma. Nat Cancer 2020;1:620-34. [DOI: 10.1038/s43018-020-0070-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 13.0] [Reference Citation Analysis]
691 Liu Y, Li X, Li J, Chen W. The gut microbiome composition and degradation enzymes activity of black Amur bream (Megalobrama terminalis) in response to breeding migratory behavior. Ecol Evol 2021;11:5150-63. [PMID: 34025998 DOI: 10.1002/ece3.7407] [Reference Citation Analysis]
692 Zhu R, Lang T, Yan W, Zhu X, Huang X, Yin Q, Li Y. Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy. Adv Sci (Weinh) 2021;8:2003542. [PMID: 34026439 DOI: 10.1002/advs.202003542] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
693 Yao Y, Fu C, Zhou L, Mi QS, Jiang A. DC-Derived Exosomes for Cancer Immunotherapy. Cancers (Basel) 2021;13:3667. [PMID: 34359569 DOI: 10.3390/cancers13153667] [Reference Citation Analysis]
694 Tomalova B, Sirova M, Rossmann P, Pola R, Strohalm J, Chytil P, Cerny V, Tomala J, Kabesova M, Rihova B, Ulbrich K, Etrych T, Kovar M. The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia. J Control Release 2016;223:1-10. [PMID: 26708020 DOI: 10.1016/j.jconrel.2015.12.023] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
695 Bellone M, Brevi A, Huber S. Microbiota-Propelled T Helper 17 Cells in Inflammatory Diseases and Cancer. Microbiol Mol Biol Rev 2020;84:e00064-19. [PMID: 32132244 DOI: 10.1128/MMBR.00064-19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
696 Lazar V, Ditu LM, Pircalabioru GG, Gheorghe I, Curutiu C, Holban AM, Picu A, Petcu L, Chifiriuc MC. Aspects of Gut Microbiota and Immune System Interactions in Infectious Diseases, Immunopathology, and Cancer. Front Immunol 2018;9:1830. [PMID: 30158926 DOI: 10.3389/fimmu.2018.01830] [Cited by in Crossref: 148] [Cited by in F6Publishing: 135] [Article Influence: 49.3] [Reference Citation Analysis]
697 Pernigoni N, Zagato E, Calcinotto A, Troiani M, Mestre RP, Calì B, Attanasio G, Troisi J, Minini M, Mosole S, Revandkar A, Pasquini E, Elia AR, Bossi D, Rinaldi A, Rescigno P, Flohr P, Hunt J, Neeb A, Buroni L, Guo C, Welti J, Ferrari M, Grioni M, Gauthier J, Gharaibeh RZ, Palmisano A, Lucchini GM, D'Antonio E, Merler S, Bolis M, Grassi F, Esposito A, Bellone M, Briganti A, Rescigno M, Theurillat JP, Jobin C, Gillessen S, de Bono J, Alimonti A. Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis. Science 2021;374:216-24. [PMID: 34618582 DOI: 10.1126/science.abf8403] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
698 Jiang Q, He X, Zou Y, Ding Y, Li H, Chen H. Altered gut microbiome promotes proteinuria in mice induced by Adriamycin. AMB Express 2018;8:31. [PMID: 29492783 DOI: 10.1186/s13568-018-0558-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]